
<html lang="en"     class="pb-page"  data-request-id="602f3efb-26a0-457c-93fa-3c27fff52253"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm0501275;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2005.48.issue-12;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors" /></meta><meta name="dc.Creator" content="Robert M.  Borzilleri,*,†" /></meta><meta name="dc.Creator" content="Xiaoping  Zheng,†" /></meta><meta name="dc.Creator" content="Ligang  Qian,†" /></meta><meta name="dc.Creator" content="Christopher  Ellis,†" /></meta><meta name="dc.Creator" content="Zhen-wei  Cai,†" /></meta><meta name="dc.Creator" content="Barri S.  Wautlet,‡" /></meta><meta name="dc.Creator" content="Steve  Mortillo,‡" /></meta><meta name="dc.Creator" content="Robert  Jeyaseelan, Sr.,‡" /></meta><meta name="dc.Creator" content="Daniel W.  Kukral,‡" /></meta><meta name="dc.Creator" content="Aberra  Fura,§" /></meta><meta name="dc.Creator" content="Amrita  Kamath,§" /></meta><meta name="dc.Creator" content="Viral  Vyas,§" /></meta><meta name="dc.Creator" content="John S.  Tokarski,‖" /></meta><meta name="dc.Creator" content="Joel C.  Barrish,†" /></meta><meta name="dc.Creator" content="John T.  Hunt,‡" /></meta><meta name="dc.Creator" content="Louis J.  Lombardo,†" /></meta><meta name="dc.Creator" content="Joseph  Fargnoli,‡ and" /></meta><meta name="dc.Creator" content="Rajeev S.  Bhide†" /></meta><meta name="dc.Description" content="A series of substituted 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines was identified as potent and selective inhibitors of the tyrosine kinase activity of the growt..." /></meta><meta name="Description" content="A series of substituted 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines was identified as potent and selective inhibitors of the tyrosine kinase activity of the growt..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="May 17, 2005" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm0501275" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-48-12-3991" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(05)00127-5" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2005 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm0501275" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm0501275" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm0501275" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm0501275" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275n00001.jpeg" /></meta><meta property="og:description" content=" A series of substituted 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines was identified as potent and selective inhibitors of the tyrosine kinase activity of the growth factor receptors VEGFR-2 (Flk-1, KDR) and FGFR-1. The enzyme kinetics associated with the VEGFR-2 inhibition of compound 50 (Ki = 52 ± 3 nM) confirmed that the pyrrolo[2,1-f][1,2,4]triazine analogues are competitive with ATP. Several analogues demonstrated low-nanomolar inhibition of VEGF- and FGF-dependent human umbilical vein endothelial cell (HUVEC) proliferation. Replacement of the C6-ester substituent of the pyrrolo[2,1-f][1,2,4]triazine core with heterocyclic bioisosteres, such as substituted 1,3,5-oxadiazoles, afforded compounds with excellent oral bioavailability in mice (i.e., 50 Fpo = 79%). Significant antitumor efficacy was observed with compounds 44, 49, and 50 against established L2987 human lung carcinoma xenografts implanted in athymic mice. A full account of the synthesis, structure−activity relationships, pharmacology, and pharmacokinetic properties of analogues within the series is presented.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm0501275"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm0501275">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm0501275&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm0501275&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm0501275&amp;href=/doi/10.1021/jm0501275" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2005</span><span class="cit-fg-volume">, 48</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 3991-4008</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/48/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm049276y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm0491492" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Borzilleri">Robert M. Borzilleri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoping++Zheng">Xiaoping Zheng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ligang++Qian">Ligang Qian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Ellis">Christopher Ellis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen-wei++Cai">Zhen-wei Cai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barri+S.++Wautlet">Barri S. Wautlet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Mortillo">Steve Mortillo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Jeyaseelan%2C">Robert Jeyaseelan,</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Kukral">Daniel W. Kukral</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aberra++Fura">Aberra Fura</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amrita++Kamath">Amrita Kamath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Viral++Vyas">Viral Vyas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+S.++Tokarski">John S. Tokarski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Hunt">John T. Hunt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+J.++Lombardo">Louis J. Lombardo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Fargnoli">Joseph Fargnoli</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajeev+S.++Bhide">Rajeev S. Bhide</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm0501275&amp;href=/doi/10.1021%2Fjm0501275" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2005</span></span><span class="cit-volume">, 48</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 3991–4008</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 17, 2005</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 February 2005</li><li><span class="item_label"><b>Published</b> online</span>17 May 2005</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 June 2005</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm0501275" title="DOI URL">https://doi.org/10.1021/jm0501275</a></div><div class="article_header-article-copyright"><strong>Copyright © 2005 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3991%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BM.%2BBorzilleri%252C%2BXiaoping%2BZheng%252C%2BLigang%2BQian%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D48%26issueNum%3D12%26contentID%3Djm0501275%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOrally%2BActive%2B4-%25282%252C4-Difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2Bas%2BDual%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2Band%2BFibroblast%2BGrowth%2BFactor%2BReceptor-1%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4008%26publicationDate%3DJune%2B2005">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm0501275"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2453</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm0501275" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Xiaoping&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Ligang&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Ellis&quot;},{&quot;first_name&quot;:&quot;Zhen-wei&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Barri&quot;,&quot;last_name&quot;:&quot;S. Wautlet&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Mortillo&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Jeyaseelan,&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Kukral&quot;},{&quot;first_name&quot;:&quot;Aberra&quot;,&quot;last_name&quot;:&quot;Fura&quot;},{&quot;first_name&quot;:&quot;Amrita&quot;,&quot;last_name&quot;:&quot;Kamath&quot;},{&quot;first_name&quot;:&quot;Viral&quot;,&quot;last_name&quot;:&quot;Vyas&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;S. Tokarski&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Hunt&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;J. Lombardo&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Fargnoli&quot;},{&quot;first_name&quot;:&quot;Rajeev&quot;,&quot;last_name&quot;:&quot;S. Bhide&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2005&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;48&quot;,&quot;pages&quot;:&quot;3991-4008&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm0501275&quot;},&quot;abstract&quot;:&quot;A series of substituted 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines was identified as potent and selective inhibitors of the tyrosine kinase activity of the growth factor receptors VEGFR-2 (Flk-1, KDR) and FGFR-1. The enzyme kinetics associated with the VEGFR-2 inhibition of compound 50 (Ki = 52 ± 3 nM) confirmed that the pyrrolo[2,1-f][1,2,4]triazine analogues are competitive with ATP. Several analogues demonstrated low-nanomolar inhibition of VEGF- and FGF-dependent human umbilical vein endothelial cell (HUVEC) proliferation. Replacement of the C6-ester substituent of the pyrrolo[2,1-f][1,2,4]triazine core with heterocyclic bioisosteres, such as substituted 1,3,5-oxadiazoles, afforded compounds with excellent oral bioavailability in mice (i.e., 50 Fpo = 79%). Significant antitumor efficacy was observed with compounds 44, 49, and 50 against established L2987 human lung carcinoma xenografts implanted in athymic mice. A full account of the synthesis, structure−activity relati&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0501275&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0501275" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0501275&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0501275" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0501275&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0501275" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm0501275&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0501275&amp;href=/doi/10.1021/jm0501275" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm0501275" /></input><a href="/doi/pdf/10.1021/jm0501275" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (299 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm0501275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm0501275%26sid%3Dliteratum%253Aachs%26pmid%3D15943473%26genre%3Darticle%26aulast%3DBorzilleri%26date%3D2005%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOrally%2BActive%2B4-%25282%252C4-Difluoro-5-%2528methoxycarbamoyl%2529phenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2Bas%2BDual%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2Band%2BFibroblast%2BGrowth%2BFactor%2BReceptor-1%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D48%26issue%3D12%26spage%3D3991%26epage%3D4008%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/48/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of substituted 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines was identified as potent and selective inhibitors of the tyrosine kinase activity of the growth factor receptors VEGFR-2 (Flk-1, KDR) and FGFR-1. The enzyme kinetics associated with the VEGFR-2 inhibition of compound <b>50 </b>(<i>K</i><sub>i</sub> = 52 ± 3 nM) confirmed that the pyrrolo[2,1-<i>f</i>][1,2,4]triazine analogues are competitive with ATP. Several analogues demonstrated low-nanomolar inhibition of VEGF- and FGF-dependent human umbilical vein endothelial cell (HUVEC) proliferation. Replacement of the C6-ester substituent of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine core with heterocyclic bioisosteres, such as substituted 1,3,5-oxadiazoles, afforded compounds with excellent oral bioavailability in mice (i.e., <b>50</b><i>F</i><sub>po</sub> = 79%). Significant antitumor efficacy was observed with compounds <b>44</b>, <b>49</b>, and <b>50</b> against established L2987 human lung carcinoma xenografts implanted in athymic mice. A full account of the synthesis, structure−activity relationships, pharmacology, and pharmacokinetic properties of analogues within the series is presented. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm0501275AF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone:  (609) 252-6236. Fax:  (609) 252-7410. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f0829f92958284de929f828a999c9c958299b0929d83de939f9dde">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm0501275AF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Department of Oncology Chemistry.</p></span></div><div class="fnGroupItem" id="jm0501275AF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Department of Discovery Biology.</p></span></div><div class="fnGroupItem" id="jm0501275AF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Department of Metabolism and Pharmacokinetics.</p></span></div><div class="fnGroupItem" id="jm0501275AF5"><span><h4><span class="NLM_fn-symbol">‖</span></h4></span><span><p class="last">  Department of Structural Biology and Modeling.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiogenesis is an essential series of molecular events that occurs during the formation of new blood vessels from the endothelium of preexisting vasculature.<sup><a onclick="showRef(event, 'jm0501275b00001'); return false;" href="javascript:void(0);" class="ref jm0501275b00001">1</a></sup> This tightly regulated process is dependent on a delicate balance between pro- and antiangiogenic factors,<sup><a onclick="showRef(event, 'jm0501275b00002'); return false;" href="javascript:void(0);" class="ref jm0501275b00002">2</a></sup> and serves as an integral component for physiological processes, such as embryonic development, female reproductive function, and wound healing. Uncontrollable or pathological angiogenesis, however, has been implicated in a wide array of vascular hyperproliferative disorders, most notably cancer, rheumatoid arthritis, diabetic retinopathy, age-related macular degeneration, and psoriasis.<sup><a onclick="showRef(event, 'jm0501275b00003 jm0501275b00004'); return false;" href="javascript:void(0);" class="ref jm0501275b00003 jm0501275b00004">3-4</a></sup> It is well established that an efficient blood supply is required for solid tumors to sustain growth beyond a critical size and to metastasize to other organs. Tumor-induced angiogenesis is responsible for the newly formed capillary networks between host and tumor that allow for effective delivery of oxygen and essential nutrients to cancer cells, elimination of waste materials generated from tumor metabolism, and migration of cancer cells to remote sites leading to metastasis.<sup><a onclick="showRef(event, 'jm0501275b00005'); return false;" href="javascript:void(0);" class="ref jm0501275b00005">5</a></sup></div><div class="NLM_p">Tumor cells respond to a variety of stimuli, such as hypoxia, low pH, changes in interstitial fluid pressure, growth factors, or cytokines by up-regulating the expression of proangiogenic factors. Vascular endothelial growth factor (VEGF; vascular permeability factor, VPF),<sup><a onclick="showRef(event, 'jm0501275b00006'); return false;" href="javascript:void(0);" class="ref jm0501275b00006">6</a></sup> a key stimulator of tumor angiogenesis, promotes endothelial cell proliferation, survival, migration, invasion, and differentiation. The intrinsic activity responsible for these cellular events is dependent on the highly specific binding of the VEGF ligands (isoforms) to their respective cell surface expressed receptors VEGFR-1 (Flt-1), VEGFR-2 (KDR, Flk-1), and VEGFR-3 (Flt-4). Activation of the VEGF receptor tyrosine kinases (RTKs), which are highly expressed on vascular endothelial cells, leads to receptor dimerization, autophosphorylation of key tyrosine residues within the catalytic domain, and the initiation of downstream signaling cascades that regulate tumor progression and dissemination. </div><div class="NLM_p">Throughout the past decade, RTKs have received considerable attention as attractive molecular targets for drug discovery.<sup><a onclick="showRef(event, 'jm0501275b00007 jm0501275b00008'); return false;" href="javascript:void(0);" class="ref jm0501275b00007 jm0501275b00008">7,8</a></sup> Monoclonal antibodies specific for kinase ligands or their receptors, and small molecule inhibitors that interact at the ATP-binding site of a given kinase domain have demonstrated promising therapeutic utility.<sup><a onclick="showRef(event, 'jm0501275b00009'); return false;" href="javascript:void(0);" class="ref jm0501275b00009">9</a></sup> For example, the chimeric anti-VEGF monoclonal antibody bevacizumab (Genentech) recently afforded a significant survival benefit in metastatic colorectal cancer patients when combined with standard chemotherapy (IFL or Saltz regimen).<sup><a onclick="showRef(event, 'jm0501275b00010'); return false;" href="javascript:void(0);" class="ref jm0501275b00010">10</a></sup> These key clinical findings provided the proof-of-concept for therapies aimed at controlling abnormal vascular development operative in cancer progression. Orally active, small molecule inhibitors of VEGFR-2 kinase activity from several structural classes<sup><a onclick="showRef(event, 'jm0501275b00011'); return false;" href="javascript:void(0);" class="ref jm0501275b00011">11</a></sup> (i.e., phthalazines,<sup><a onclick="showRef(event, 'jm0501275b00012'); return false;" href="javascript:void(0);" class="ref jm0501275b00012">12</a></sup> indolinones,<sup><a onclick="showRef(event, 'jm0501275b00013'); return false;" href="javascript:void(0);" class="ref jm0501275b00013">13</a></sup> quinazolines,<sup><a onclick="showRef(event, 'jm0501275b00014'); return false;" href="javascript:void(0);" class="ref jm0501275b00014">14</a></sup> isothiazoles,<sup>15a</sup> thienopyridines,<sup>15b</sup> indeno[2,1-α]pyrrolo[3,4-<i>c</i>]carbazolones,<sup>16</sup> thiazoles,<sup>17a</sup> pyridines,<sup>17b</sup> indoles,<sup>17c,d</sup><a name="jm004801203992" id="jm004801203992"></a> imidazopyridines,<sup>17e</sup> benzimidazoles,<sup>17f</sup> pyrimidines,<sup>17g-i</sup> diamino[1,3,5]triazines,<sup>18a</sup> biheteroaryls<sup>18b</sup>) have also progressed to various stages of preclinical and clinical development. Representative examples of VEGFR-2 inhibitors currently undergoing clinical evaluation are illustrated in Chart 1<a data-tab="pane-pcw-Figures" href="#jm0501275c00001" id="" class=" internalNav"></a>. Novartis' anilinophthalazine PTK-787 (vatalanib, <b>1a</b>)<sup>12a,b</sup> and Pfizer's (Sugen/Pharmacia) third-generation indolinone SU-11248 (<b>1b</b>)<sup>13a,b</sup> are the most advanced agents, currently in phase III clinical trials. AstraZeneca and Pfizer have initiated phase II clinical trials for quinazoline ZD-6474 (vandetanib, <b>1c</b>)<sup>14a,b</sup> and isothiazole CP-547632 (<b>1e</b>),<sup>15a</sup> respectively. The indenopyrrolocarbazole <i>N</i>,<i>N</i>-dimethylglycine ester prodrug CEP-7055<sup>16</sup> (<b>1f</b>, Cephalon) and a second-generation quinazoline AZD-2171 (<b>1d</b>, AstraZeneca) have also entered the clinic. Each of these structurally diverse chemotypes offer distinct kinase selectivity profiles relative to VEGFR-2 activity that may ultimately influence their overall therapeutic potential. <div id="_i4"><figure id="jm0501275c00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275c00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275c00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Examples of VEGFR-2 Inhibitors Undergoing Clinical Trials </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275c00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275c00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Fibroblast growth factor (FGF) represents another important family of angiogenic growth factors.<sup>19</sup> While the exact role of FGF in tumor angiogenesis remains elusive, this potent mitogen of vascular endothelial cells and fibroblasts is believed to cooperate with VEGF during blood vessel development.<sup>20</sup> Since VEGFR-2 and FGFR-1 have been shown to directly influence tumor angiogenesis, simultaneous inhibition of these two RTKs is postulated to enhance antitumor activity. To this end, small molecule inhibitors of FGFR-1,<sup>21</sup> including indolinone derivatives<sup>13c</sup> that inhibit VEGFR-2, FGFR-1, and PDGFR-β have appeared in the literature. Furthermore, since antiangiogenic therapies are directed toward highly regulated endothelial cells of the host, rather than genetically unstable tumor cells, it is anticipated that selective VEGFR-2 and/or FGFR-1 inhibition will lead to cancer therapeutics that have a lower risk of developing classical drug resistance compared to traditional chemotherapy.<sup>22</sup></div><div class="NLM_p last">As part of our continuing effort to identify selective small molecule RTK inhibitors for various oncology indications, we have identified the pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus as a general kinase inhibitor template.<sup>23</sup> In our search for selective VEGFR-2 kinase inhibitors, we have recently disclosed the structure−activity relationships (SARs) of 4-(3-hydroxy-4-methylphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines <b>2a</b> (Figure 1<a data-tab="pane-pcw-Figures" href="#jm0501275f00001" id="" class=" internalNav"></a>).<sup>24a</sup> Herein, we describe the SAR, pharmacokinetics, and pharmacology of the novel series of 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines <b>2b</b> that were derived from the phenol analogues and a structurally related series of p38 MAP kinase inhibitors.<sup>24b</sup> These studies culminated in the identification of potent, orally active dual inhibitors of VEGFR-2 and FGFR-1 from the hydroxamate series that demonstrated robust antitumor activity in the L2987 human lung carcinoma xenograft model. <div id="_i6"><figure id="jm0501275f00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00001.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Evolution of the hydroxamate series of VEGFR-2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pyrrolo[2,1-<i>f</i>][1,2,4]triazine derivatives <b>8</b><b>−</b><b>18</b> were prepared according to the general synthetic sequence outlined in Scheme 1<a data-tab="pane-pcw-Figures" href="#jm0501275h00001" id="" class=" internalNav"></a>. The pyrrolotriazinone core <b>5</b> was assembled using a modified version of the literature procedure of Patil et al.<sup>25</sup><i>N</i>-Amination of diethyl 3-isopropyl-1<i>H</i>-pyrrole-2,4-dicarboxylate (<b>3</b>)<sup>26</sup> using either <i>O</i>-(diphenylphosphinyl)hydroxylamine or <i>O</i>-(mesitylenesulfonyl)hydroxylamine provided aminopyrrole <b>4</b>. Cyclization of <b>4</b> upon heating in formamide generated the desired bicycle <b>5</b>. Treatment of intermediate <b>5</b> with phosphorus oxychloride afforded chloroimidate <b>6</b>, which was subsequently coupled with the appropriately functionalized 3-hydroxy or 3-amino-<i>N</i>-alkoxybenzamides <b>7</b> to furnish the corresponding analogues <b>8</b><b>−</b><b>18</b> in good overall yield. <div id="_i9"><figure id="jm0501275h00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00001.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) Ph<sub>2</sub>PO<sub>2</sub>NH<sub>2</sub> or Me<sub>3</sub>PhSO<sub>3</sub>NH<sub>2</sub>, NaH, DMF, 85%; (b) formamide, 165 °C, 90%; (c) POCl<sub>3</sub>, 110 °C, 3 h, 90%; (d) X = O:  K<sub>2</sub>CO<sub>3</sub>, DMF, 25 °C, 18 h, X = NH:  DMF, 25 °C, 12−18 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A small library of C6-carbamate analogues (cf. Supporting Information) was prepared from the stable acyl azide intermediate <b>20</b> using a parallel, solution phase format (Scheme 2<a data-tab="pane-pcw-Figures" href="#jm0501275h00002" id="" class=" internalNav"></a>). Thus, carboxylic acid <b>19</b>, derived from base-promoted hydrolysis of ethyl ester <b>14</b>, was treated with diphenylphosphoryl azide (DPPA) in the presence of triethylamine to furnish compound <b>20</b>. Curtius rearrangement of the acyl azide <b>20</b>, in the presence of commercially available alcohols, produced the desired carbamate derivatives, including examples <b>21</b><b>−</b><b>26</b>. <div id="_i11"><figure id="jm0501275h00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00002.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) 1 N NaOH, THF−H<sub>2</sub>O, 60 °C, 27 h, 98%; (b) DPPA, 1,4-dioxane, Et<sub>3</sub>N, 40 °C, 1 h, 99%; (c) R<sup>2</sup>OH, DMF, 85 °C, 2 h, 50−65%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Five-membered ring heterocycles were installed at the 6-position of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus <a name="jm004801203993" id="jm004801203993"></a> according to the synthetic sequences illustrated in Schemes<a data-tab="pane-pcw-Figures" href="#jm0501275h00003" id="" class=" internalNav"></a> 3−5.<sup><a onclick="showRef(event, 'jm0501275b00015 jm0501275b00016 jm0501275b00017 jm0501275b00018 jm0501275b00019 jm0501275b00020 jm0501275b00021 jm0501275b00022 jm0501275b00023 jm0501275b00024 jm0501275b00025 jm0501275b00026 jm0501275b00027 jm0501275b00028 jm0501275b00029 jm0501275b00030 jm0501275b00031 jm0501275b00032'); return false;" href="javascript:void(0);" class="ref jm0501275b00015 jm0501275b00016 jm0501275b00017 jm0501275b00018 jm0501275b00019 jm0501275b00020 jm0501275b00021 jm0501275b00022 jm0501275b00023 jm0501275b00024 jm0501275b00025 jm0501275b00026 jm0501275b00027 jm0501275b00028 jm0501275b00029 jm0501275b00030 jm0501275b00031 jm0501275b00032">27-32</a></sup> As shown in Scheme 3, the pyrrolotriazinone ester <b>5</b> was hydrolyzed under mild heating to provide carboxylic acid <b>27</b>. Oxazole <b>28</b> and 1,2,4-oxadiazole <b>30</b> were prepared from intermediate <b>27</b> by two independent routes. Standard amide bond coupling of compound <b>27</b> with 1-aminopropan-2-one was accomplished with benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP). The amide intermediate was heated with phosphorus oxychloride to promote simultaneous cyclization and chloroimidate formation to furnish <b>28</b>.<a data-tab="pane-pcw-Figures" href="#jm0501275h00004" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm0501275h00005" id="" class=" internalNav"></a> Alternatively, acid <b>27</b> was coupled to <i>N</i>-hydroxyacetamidine in the presence of <i>O</i>-(1<i>H</i>-benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>‘,<i>N</i>‘-tetramethyluronium tetrafluoroborate (TBTU) and then cyclized under thermal conditions to generate <b>30</b> in good overall yield. Treatment of compound <b>28</b> and the chloroimidate derived from pyrrolotriazinone <b>30</b> with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide provided the fully elaborated analogues <b>29</b> and <b>31</b>, respectively. The regioisomeric 1,2,4-oxadiazole <b>34</b> was prepared from the chloroimidate obtained from pyrrolotriazinone <b>33</b> using similar chemistry (Scheme 4). The nitrile <b>32</b>, derived from carboxylic acid <b>27</b>, was converted to the 1,2,4-oxadiazole <b>33</b> using an unoptimized, two-step procedure involving the cyclization of the requisite <i>N</i>-hydroxyacetamidine intermediate with acetyl chloride in refluxing pyridine.<div id="_i13"><figure id="jm0501275h00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00003.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) 1 N NaOH, THF−H<sub>2</sub>O, 60 °C, 98%; (b) 1-aminopropan-2-one, BOP reagent, Et<sub>3</sub>N, DMF, 50 °C, 2 h, 61%; (c) POCl<sub>3</sub>, 120 °C, 6 h; (d) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, MeCN, 25 °C, 18 h; (e) (1) <i>N</i>-hydroxyacetamidine, TBTU, cat. HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 1.5 h, (2) DMF, 140 °C, 3 h, 57% overall.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0501275h00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00004.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) (1) NH<sub>2</sub>OH−HCl, K<sub>2</sub>CO<sub>3</sub>, EtOH reflux, 28 h, (2) AcCl, pyridine reflux, 7 h, 11% overall; (b) POCl<sub>3</sub>, 120 °C, 5 h; (c) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, MeCN, 25 °C, 14 h; 30% from <b>33</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0501275h00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) RCO<sub>2</sub>H, POCl<sub>3</sub>, 100 °C, 1 h then 120 °C, 3 h; (b) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, DMF, 50 °C, 1−6 h; (c) LiN[Si(CH<sub>3</sub>)<sub>3</sub>]<sub>2</sub>, (PhSO<sub>2</sub>)<sub>2</sub>NF, THF, −78 to −30 °C, 1 h, 65%; (d) acetamidine-HCl, DMF, 120 °C, 1 h, 86%; (e) POCl<sub>3</sub>, 120 °C, 5 h; (f) 71% overall yield from <b>51</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last"><a name="jm004801203994" id="jm004801203994"></a>The hydrazide intermediate <b>35</b>, obtained from the reaction of ester <b>5</b> with hydrazine, was used to prepare 1,3,4-oxadiazoles <b>37</b><b>−</b><b>49</b> and triazole <b>52</b> (Scheme 5). The C6-heterocycles of compounds <b>36 </b>and<b> 51</b> were installed under thermal conditions, using either the corresponding carboxylic acid in phosphorus oxychloride or acetamidine hydrochloride in DMF. Alternatively, the oxadiazole rings of compounds <b>38</b> and <b>47</b> were prepared from hydrazide <b>35</b> using triethyl orthoformate<sup>30</sup> and phosgene imminium chloride,<sup><a onclick="showRef(event, 'jm0501275b00033'); return false;" href="javascript:void(0);" class="ref jm0501275b00033">33</a></sup> respectively (cf. Experimental Section). Chemistry described previously was used to convert compounds <b>36</b> and <b>51</b> to the desired VEGFR-2 inhibitors <b>37</b><b>−</b><b>49</b> and <b>52</b>, respectively. Difluorination of compound <b>49</b> was carried out at low temperature in THF using excess lithium bis(trimethylsilyl)amide and 2.5 equiv of commercially available <i>N</i>-fluorobenzenesulfonimide to furnish the desired oxazole analogue <b>50</b> in 65% yield. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>In Vitro Pharmacology and SAR.</b> The pyrrolo[2,1-<i>f</i>][1,2,4]triazine analogues depicted in Tables<a class="ref showTableEvent internalNav" data-ID="jm0501275t00001" href="#jm0501275t00001"></a><a class="ref showTableEvent internalNav" data-ID="jm0501275t00002" href="#jm0501275t00002"></a><a class="ref showTableEvent internalNav" data-ID="jm0501275t00003" href="#jm0501275t00003"></a> 1−4 were initially screened and optimized for inhibition of human VEGFR-2 tyrosine kinase activity. Potent analogues (IC<sub>50</sub> < 100 nM) identified in the primary biochemical assay<sup>23</sup> were then evaluated for inhibition of FGFR-1 kinase activity. Select compounds were subsequently screened for enzyme inhibition against a small panel of RTKs [Flk-1, PDGFR-β, HER-1 (EGFR), HER-2, IGF-1R] utilizing a previously reported assay format.<sup>23</sup> In each case, the entire cytoplasmic domain sequence of the RTK was fused to glutathione <i>S</i>-transferase and the biological activity was determined by quantitation of the amount of radioactive phosphate transferred to an artificial poly(Glu<sub>4</sub>/Tyr) substrate. Procedures for measuring activity against the representative nonreceptor kinase LCK and the serine-threonine kinases PKCα and CDK2 have also been described previously.<sup><a onclick="showRef(event, 'jm0501275b00034 jm0501275b00035'); return false;" href="javascript:void(0);" class="ref jm0501275b00034 jm0501275b00035">34,35</a></sup> The most potent and selective VEGFR-2 and FGFR-1 inhibitors were evaluated for their ability to inhibit growth-factor-stimulated cellular proliferation of human umbilical vein endothelial cells (HUVECs) using either VEGF or FGF as the mitogen.<sup>23</sup> As a positive control for general cytotoxicity, compounds evaluated in the HUVEC assays were also tested for their ability to inhibit the proliferation of the L2987 human lung carcinoma cell line. In all cases, the pyrrolotriazine analogues described <a name="jm004801203995" id="jm004801203995"></a> herein provided IC<sub>50</sub> values >1.3 μM in the unstimulated growth of L2987 cells. <div class="NLM_table-wrap" id="jm0501275t00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Effect of the C4-Substituent on Enzymatic Activity<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275u00001a.gif" alt="" id="_i18" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">R<sup>1</sup></td><td class="colsep2 rowsep2">R<sup>2</sup></td><td class="colsep2 rowsep2">R<sup>3</sup></td><td class="colsep2 rowsep2">IC<sub>50 </sub>(nM) for VEGFR-2 kinase inhibn<i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">270 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">130 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>10</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">120 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">270 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>12</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">79 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>13</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">34 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>14</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">13 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>16</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2"><i>i</i>-Pr </td><td class="colsep2 rowsep2">350 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2"><i>i</i>-Bu </td><td class="colsep2 rowsep2">1200 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">CH<sub>2</sub>-cyc<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">190</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three determinations. Variability around the mean value was <25%. <i><sup>c</sup></i><sup></sup> cyc = cyclopropyl.</p></div></div><div class="NLM_table-wrap" id="jm0501275t00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Effect of C6-Carbamates on Enzymatic and Cellular Activity<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275u00002a.gif" alt="" id="_i19" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three determinations. Variability around the mean value was <25%.<i><sup>c</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>d</sup></i><sup></sup> ND = not determined.</p></div></div><div class="NLM_table-wrap" id="jm0501275t00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Comparison of VEGFR-2 and FGFR-1 Biochemical and Cellular Potencies<i><sup>a</sup></i><sup></sup> for C6-Heterocyclic Analogues</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275u00003a.gif" alt="" id="_i20" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three determinations. Variability around the mean value was <50%.<i><sup>c</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>d</sup></i><sup></sup> ND = not determined. </p></div></div></div><div class="NLM_p">The pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus with the C5-isopropyl and C6-ethyl ester substituents served as the starting template for the hydroxamate series of VEGFR-2 kinase inhibitors based on our previous SAR investigations involving the 4-(3-hydroxy-4-methylphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines.<sup>24</sup> Table 1 summarizes the SAR of the C4-hydroxamate group with respect to inhibition of VEGFR-2 kinase activity. Consistent with our earlier observations in the phenol series,<sup>24</sup> the amine linker (X = NH) provided compounds that were slightly more potent against VEGFR-2 kinase than the corresponding ether analogues (i.e., <b>9</b> versus <b>8)</b>. <i>N</i>-Methylation of the hydroxamate group of compound <b>9</b> provided ethyl 5-isopropyl-4-(3-(methoxy(methyl)carbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]-triazine-6-carboxylate (structure not shown), which was >30-fold less potent in the biochemical assay. The significant reduction in activity supports the hypothesis that the hydroxamate-NH participates in hydrogen-bonding interactions within the VEGFR-2 kinase domain (vide infra). Addition of a methyl substituent at R<sup>2</sup> (i.e., <b>10</b>) had minimal effect on the intrinsic activity, while the bromide analogue <b>11</b> (R<sup>2</sup> = Br) was >2-fold less potent than the parent hydroxamate derivative <b>9</b>. Incorporation of a fluorine atom at R<sup>2</sup> was well-tolerated, although the fluorine atom of analogue <b>13</b> (R<sup>1</sup> = F) had a greater impact on the VEGFR-2 kinase activity compared to compound <b>12</b>. The 2,4-difluoro analogue <b>14</b> was one order of magnitude more potent than the original lead <b>9 </b>in the kinase assay and displayed excellent cellular potency (IC<sub>50</sub> = 4.8 nM) in the VEGF-driven HUVEC proliferation assay. Increasing the size of hydroxamate substituent R<sup>3</sup> (i.e., <b>15</b><b>−</b><b>18</b>) was detrimental to the kinase activity. Since an electron-deficient phenyl ring provides a significant enhancement in the VEGFR-2 kinase inhibition, the 2,4-difluoro-5-(methoxycarbamoyl)phenylamino group was selected as the preferred C4-substituent for subsequent SAR studies.<a class="ref showTableEvent internalNav" data-ID="jm0501275t00004" href="#jm0501275t00004"></a><div class="NLM_table-wrap" id="jm0501275t00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  VEGFR-2 and FGFR-1 Biochemical and Cellular Potencies<i><sup>a</sup></i><sup></sup> of C6-Oxadiazole Analogues<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275u00004a.gif" alt="" id="_i21" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="4">IC<sub>50 </sub>(nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase inhibition<sup><i>b</i></sup></td><td class="colsep2 rowsep2" colspan="2">growth inhibition of HUVECs<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">VEGFR-2</td><td class="colsep2 rowsep2">FGFR-1</td><td class="colsep2 rowsep2">VEGF</td><td class="colsep2 rowsep2">FGF </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">77 </td><td class="colsep2 rowsep2">160 </td><td class="colsep2 rowsep2">91 </td><td class="colsep2 rowsep2">54 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">28 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">4.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2"><i>i</i>-Pr </td><td class="colsep2 rowsep2">22 </td><td class="colsep2 rowsep2">39 </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">1.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2"><i>i</i>-Bu </td><td class="colsep2 rowsep2">23 </td><td class="colsep2 rowsep2">33 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">6.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">cyclopropyl </td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2">5.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>43</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>-cyclopropyl </td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">4.0 </td><td class="colsep2 rowsep2">9.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b></td><td class="colsep2 rowsep2">CHF<sub>2</sub></td><td class="colsep2 rowsep2">57 </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">21 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>45</b></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">76 </td><td class="colsep2 rowsep2">84 </td><td class="colsep2 rowsep2">35 </td><td class="colsep2 rowsep2">33 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep2 rowsep2">29 </td><td class="colsep2 rowsep2">68 </td><td class="colsep2 rowsep2">25 </td><td class="colsep2 rowsep2">44 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47</b></td><td class="colsep2 rowsep2">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">6.7 </td><td class="colsep2 rowsep2">7.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>48</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep2 rowsep2">66 </td><td class="colsep2 rowsep2">149 </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>SO<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">16 </td><td class="colsep2 rowsep2">16 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">4.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">CF<sub>2</sub>SO<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">53 </td><td class="colsep2 rowsep2">220 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">130</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three determinations. Variability around the mean value was <50%.<i><sup>c</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>d</sup></i><sup></sup> ND = not determined.</p></div></div></div><div class="NLM_p">The C6-carbamate analogues obtained from the library synthesis were initially screened for VEGFR-2 kinase inhibition at concentrations of 0.2 and 0.05 μM (cf. Supporting Information). The IC<sub>50</sub> values were then determined for select compounds of interest, which provided ≥50% inhibition at 0.05 μM in the preliminary two-point assay. Table 2 highlights representative carbamate analogues from the library that offer different physicochemical properties and a range of in vitro rates of metabolism in human liver microsomes (vide infra). In contrast to the SAR observed with the phenol series,<sup>24</sup> replacement of the metabolically labile C6-ester moiety<sup><a onclick="showRef(event, 'jm0501275b00036'); return false;" href="javascript:void(0);" class="ref jm0501275b00036">36</a></sup> of compound <b>14</b> with a carbamate group provided pyrrolotriazine analogues that were consistently less potent against VEGFR-2 kinase. For example, carbamates <b>21</b> and <b>22 </b>were 5- and 14-fold less potent than ester analogue <b>14</b>, respectively. On the basis of the proposed binding mode of the pyrrolo[2,1-<i>f</i>][1,2,4]triazines in the VEGFR-2 kinase domain, the C6-substituents extend out toward the protein surface and potentially interact with solvent. Thus, appending a terminal piperidine or methyl sulfone substituent to the carbamate via a 3-carbon linker was found to be well-tolerated (i.e., <b>23</b> and <b>24</b>). Tetrahydrofuran analogue <b>25</b> provided comparable enzymatic activity to compound <b>21</b>, whereas the <i>N</i>-methylpiperazine derivative <b>26</b> was the most potent carbamate analogue in both the kinase and cellular proliferation assays, providing IC<sub>50</sub> values of 36 and 19 nM, respectively. As shown in Table 2, in most cases there is good agreement between the IC<sub>50</sub> values obtained in the VEGFR-2 kinase and VEGF-stimulated HUVEC proliferation assays for the carbamate series. </div><div class="NLM_p"><a name="jm004801203996" id="jm004801203996"></a>It is well-documented in the literature that five-membered heteroaromatic rings, such as oxazoles and oxadiazoles, serve as excellent, hydrolytically stable bioisosteres for an ester substituent.<sup>29,30</sup> As shown in Table 3, a series of methyl-substituted five-membered ring heterocycles was identified as acceptable replacements for the C6-ester or acid functionality of pyrrolo[2,1-<i>f</i>][1,2,4]triazine <b>14</b>. Oxazole <b>29</b> and 1,3,4-oxadiazole <b>37</b> demonstrated essentially equivalent VEGFR-2 kinase inhibitory activity compared to ester <b>14</b>, and both compounds inhibited FGFR-1 kinase activity with IC<sub>50</sub> values ca. 20 nM. The triazole <b>52</b> and the two regioisomeric 1,2,4 oxadiazole analogues <b>31</b> and <b>34</b> were less potent than <b>29</b> and <b>37</b> in the biochemical assays. The cellular potencies of <b>52</b> in the VEGF or FGF-driven HUVEC proliferation assays were consistent with the enzymatic activities obtained in the corresponding kinase assays. Compounds <b>29</b>, <b>31</b>, and <b>37</b> were significantly more potent inhibitors of HUVEC proliferation, regardless of the mitogen employed (IC<sub>50</sub> < 10 nM). Although the in vitro pharmacology of <b>29</b> was impressive, the oxazole analogue demonstrated significant activity against a panel of cytochrome (CYP) P450 isozymes (IC<sub>50</sub> values:  CYP1A2, 0.064 μM; CYP2C9, 3.6 μM; and CYP3A4, 5.1 μM). </div><div class="NLM_p">Since compound <b>37</b> provided an encouraging in vitro biological profile and an efficient synthesis of the 1,3,4-oxadiazole ring was available, the SAR of a series of substituted C6-oxadiazole analogues was investigated (Table 4). The unsubstituted oxadiazole <b>38</b> provided a significant reduction in biochemical and cellular potency compared to <b>37</b>, whereas substitution of the oxadiazole ring with larger aliphatic groups (i.e., <b>39</b><b>−</b><b>43</b>) was well-tolerated. Interestingly, while fluorination of the ethyl substituent of oxadiazole <b>39</b> did not significantly affect the kinase inhibitory activity for the two enzymes, compound <b>46</b> demonstrated an order of magnitude decrease in cellular potency against VEGF- and FGF-stimulated HUVECs. Gradually increasing the electron-withdrawing capacity (higher σ value) of the R-substituent on the oxadiazole ring, as in the case of compounds <b>44</b> and <b>45</b>, provided a proportional decrease in biochemical potency and growth inhibition in the HUVEC proliferation assay. Alternatively, introduction of an electron-donating group, such as the dimethylamino substituent of compound <b>47</b>, led to improved potency in both the kinase and HUVEC proliferation assays. In an effort to optimize the ADME properties and enhance the aqueous solubility of the series, polar substituents, such as the dimethylaminomethyl and methylsulfonylmethyl groups, were appended to the oxadiazole core. Amine analogue <b>48</b> was less potent than methyloxadiazole <b>37</b> in the kinase assays; however, the sulfone derivative <b>49</b> afforded excellent biochemical and cellular potency. Consistent with previous results, the more electron deficient difluorosulfone oxadiazole <b>50</b> demonstrated comparable VEGFR-2 and FGFR-1 kinase activity to that of analogue <b>44</b> with IC<sub>50</sub> values of 53 and 220 nM, respectively. The cellular behavior of compound <b>50</b> in the VEGF- and FGF-simulated HUVEC proliferation assays was consistent with the biochemical data obtained for the two enzymes. To better understand the enzyme inhibitory properties of <b>50</b>, the <i>K</i><sub>i</sub> value was determined for VEGFR-2 kinase. Oxadiazole <b>50</b> was confirmed to be an ATP-competitive inhibitor of VEGFR-2, with an apparent <i>K</i><sub>i</sub> value of 52 ± 3 nM. The ability of the VEGFR-2 and FGFR-1 proteins to accommodate the diverse set of R groups illustrated in Table 4 again suggests that the C6-oxadiazole ring and appended substituents occupy a more flexible portion of the receptor that extends out toward solvent. </div><div class="NLM_p"><b>Proposed Binding Model for Compound 50.</b> To better understand the binding mode of the 4-(5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazines, a binding model of oxadiazole <b>50 </b>in the ATP site of VEGFR-2 was developed using a reported crystal structure of the VEGFR-2 kinase domain.<sup><a onclick="showRef(event, 'jm0501275b00037'); return false;" href="javascript:void(0);" class="ref jm0501275b00037">37</a></sup> Compound <b>50</b> was docked into the VEGFR-2 structure using the GLIDE software<sup><a onclick="showRef(event, 'jm0501275b00038'); return false;" href="javascript:void(0);" class="ref jm0501275b00038">38</a></sup> and then energy-minimized with the CFF force field for 2000 steps of conjugate gradient minimization.<sup><a onclick="showRef(event, 'jm0501275b00039'); return false;" href="javascript:void(0);" class="ref jm0501275b00039">39</a></sup> VEGFR-2 residues within 6 Å of the ligand were allowed to relax. Figure 2<a data-tab="pane-pcw-Figures" href="#jm0501275f00002" id="" class=" internalNav"></a> depicts the proposed binding mode of <b>50</b> in the ATP binding pocket. <div id="_i22"><figure id="jm0501275f00002" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00002.jpeg" id="_i23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Binding model of compound <b>50</b> in the ATP binding site of VEGFR-2 kinase. Carbon atoms of <b>50</b> are in green and carbon atoms of the protein are in gray. Potential hydrogen-bond interactions are indicated by magenta dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A highly conserved hydrogen-bond interaction between the backbone amide-NH of Cys919 and the N1 nitrogen of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine ring anchors the inhibitor to the hinge region of the adenine binding pocket. The aniline portion of the inhibitor is oriented into a mostly hydrophobic pocket, deep within the binding site formed by residues such as Val916 and Leu889. The carbonyl and NH groups of the hydroxamate moiety form critical hydrogen bonds with the backbone NH of Asp1046 and the side chain of Glu885, respectively. The C5-isopropyl group makes van der Waals contacts with a hydrophobic cleft created by the proximal Val848 and Leu1035 residues. These same residues along with Cys1045 and Leu840 (not labeled in figure) roughly define the pocket occupied by the ribose ring of ATP. The oxadiazole heterocycle, while nearly coplanar with the pyrrolo[2,1-<i>f</i>][1,2,4]triazine <a name="jm004801203997" id="jm004801203997"></a> ring, points toward surface-exposed protein. Although not ultimately required for activity, the sulfone oxygen atoms likely form hydrogen bonds with the backbone NH and side chain of Asn923. In general, the binding model is consistent with the SAR and enzyme kinetics described above for the hydroxamate series. </div><div class="NLM_p"><b>Kinase Selectivity Profile for Select Analogues.</b> The most promising carbamate and oxadiazole analogues were screened against a representative panel of kinases, which included RTKs, non-RTKs, and serine/threonine kinases (Table 5<a class="ref showTableEvent internalNav" data-ID="jm0501275t00005" href="#jm0501275t00005"></a>). Since antiangiogenesis therapies target endothelial cells (of the host) rather than the tumor and preclinical efficacy studies are conducted in mice, Flk-1, the mouse homologue of human VEGFR-2 was also included in the panel. Compared to their VEGFR-2 inhibitory activity, a significant reduction in potency was observed for Flk-1, particularly for carbamate <b>24</b> (24-fold) and oxadiazoles <b>44</b> and <b>50</b> (8−15-fold). Although carbamate analogues <b>24</b> and <b>25</b> demonstrated single-digit micromolar activity against the HER-1 and HER-2 enzymes, the oxadiazole derivatives exhibited >150-fold selectivity for VEGFR-2 versus these epidermal growth factor receptor family members. Both the carbamate and oxadiazole analogues provided excellent VEGFR-2 kinase selectivity relative to other RTKs, such as PDGFR-β and IGF-1R. While maintaining reasonable selectivity for VEGFR-2 and FGFR-1 kinases (33- and 25-fold, respectively), oxadiazole <b>37</b> provided an IC<sub>50</sub> = 500 nM against the non-RTK LCK. The other analogues depicted in Table 5 were considerably less potent against LCK. Similarly, no significant activity was detected with any of the hydroxamate-based, dual VEGFR-2 and FGFR-1 inhibitors versus the serine/threonine kinases PKCα and CDK2. <div class="NLM_table-wrap" id="jm0501275t00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Kinase Selectivity Profile for Select Carbamate and Oxadiazole Analogues<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="10">enzyme inhibition IC<sub>50</sub> (μM )</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">VEGFR-2</td><td class="colsep2 rowsep2">Flk-1</td><td class="colsep2 rowsep2">FGFR-1</td><td class="colsep2 rowsep2">HER-1</td><td class="colsep2 rowsep2">HER-2</td><td class="colsep2 rowsep2">PDGFR-β</td><td class="colsep2 rowsep2">IGF-1R</td><td class="colsep2 rowsep2">LCK</td><td class="colsep2 rowsep2">PKCα</td><td class="colsep2 rowsep2">CDK2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">0.062 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">0.058 </td><td class="colsep2 rowsep2">4.2 </td><td class="colsep2 rowsep2">5.3 </td><td class="colsep2 rowsep2">>2.0 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">5.1 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2">>50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">0.058 </td><td class="colsep2 rowsep2">0.27 </td><td class="colsep2 rowsep2">0.046 </td><td class="colsep2 rowsep2">5.5 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>2.0 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">4.7 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2">>50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">0.018 </td><td class="colsep2 rowsep2">0.086 </td><td class="colsep2 rowsep2">0.019 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">8.0 </td><td class="colsep2 rowsep2">>2.0 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">0.50 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2">>50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b></td><td class="colsep2 rowsep2">0.057 </td><td class="colsep2 rowsep2">0.84 </td><td class="colsep2 rowsep2">0.10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>2.0 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">18 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2">>50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">0.053 </td><td class="colsep2 rowsep2">0.42 </td><td class="colsep2 rowsep2">0.22 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">>2.0 </td><td class="colsep2 rowsep2">>25 </td><td class="colsep2 rowsep2">7.8 </td><td class="colsep2 rowsep2">>50 </td><td class="colsep2 rowsep2">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><sup>a</sup> See Experimental Section for a description of assay conditions.</p></div></div></div><div class="NLM_p"><b>In Vitro Metabolic Stability and Pharmacokinetics.</b> Several C6-carbamate and C6-heterocyclic pyrrolo[2,1-<i>f</i>][1,2,4]triazines with suitable inhibitory activity in the kinase and cellular proliferation assays were screened for metabolic stability in human liver microsomes (HLM). In general, the carbamate analogues exhibited a wide range of rates in this in vitro system (cf. Supporting Information). For example, incubation of the methyl sulfone, tetrahydrofuran, and <i>N</i>-methylpiperazinecarbamates <b>24</b><b>−</b><b>26</b> in HLM at 3 μM for 10 min provided metabolic rates of 0.30, 0.074, and 0.104 nmol/min/mg protein, respectively. Moderate to high rates of drug conversion were obtained in HLM with the oxadiazole derivatives, which suggests the potential for high clearance in humans. Incubation of a 10 μM concentration of the methyl sulfone oxadiazole <b>49</b> in HLM for 10 min provided a high metabolic rate of 0.60 nmol/min/mg protein. However, the HLM values for the fluorinated sulfone derivative <b>50</b> and the difluoromethyl analogue <b>44</b> were ca. 2-fold lower (0.27 and 0.35 nmol/min/mg protein, respectively), presumably due to removal of a potential site of oxidative metabolism. </div><div class="NLM_p">To quickly assess the preliminary pharmacokinetic (PK) properties of this class of pyrrolo[2,1-<i>f</i>][1,2,4]triazines, several carbamate and oxadiazole analogues were administered orally (50 mg/kg dose except for compound <b>50</b>) to male Balb/C mice and the plasma level concentrations were recorded at 1 and 4 h time points (Table 6<a class="ref showTableEvent internalNav" data-ID="jm0501275t00006" href="#jm0501275t00006"></a>). Carbamates <b>24</b><b>−</b><b>26</b> yielded relatively low drug exposures during the 4 h study. In contrast, oxadiazole analogues <b>37</b>, <b>44</b>, <b>49</b>, and <b>50</b> were all well-absorbed, producing remarkably high plasma level concentrations at the 1 h time point. Oxadiazoles <b>44</b> and <b>49</b> maintained high plasma exposures over the 4 h period, while the drug concentrations of compounds <b>50</b> and <b>37</b> decreased 2- and 3.5-fold, respectively. <div class="NLM_table-wrap" id="jm0501275t00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Mouse Exposure Data Following Oral Administration of Select Compounds</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">plasma levels (μM)<i><sup>a,b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">at 1 h</td><td class="colsep2 rowsep2">at 4 h </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">7.9 ± 0.7 </td><td class="colsep2 rowsep2">13.8 ± 2.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">29.5 ± 15.4 </td><td class="colsep2 rowsep2">2.9 ± 1.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">5.1 ± 0.8 </td><td class="colsep2 rowsep2">3.0 ± 0.9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">131.6 ± 45.7 </td><td class="colsep2 rowsep2">37.7 ± 17.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">187.4 ± 54.6 </td><td class="colsep2 rowsep2">154.9 ± 63.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49</b><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">287.8 ± 14.2 </td><td class="colsep2 rowsep2">231.6 ± 23.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b><i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">26.6 ± 3.2 </td><td class="colsep2 rowsep2">13.8 ± 1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Average of three male mice.<i><sup>b</sup></i><sup></sup> Vehicle:  3:1:6 PEG400/EtOH/water.<i><sup>c</sup></i><sup></sup> 50 mg/kg dose.<i><sup>d</sup></i><sup></sup> 10 mg/kg dose.</p></div></div></div><div class="NLM_p">Further assessment of the pharmacokinetics associated with compound <b>50</b> in Balb/C mice revealed that the steady-state volume of distribution (<i>V</i><sub>ss</sub>) was greater than total plasma/blood volume but less than total body water. These results are indicative of moderate extravascular distribution. The systemic plasma clearance (Cl) of compound <b>50</b> was less than 2% of hepatic blood flow. A 10 mg/kg oral dose administered as a solution in 3:1:6 poly(ethylene glycol):ethanol:water was readily absorbed and demonstrated a favorable half-life (<i>t</i><sub>1/2</sub>) and mean residence time (MRT). The measured oral bioavailability (<i>F</i><sub>po</sub>) of compound <b>50</b> in this study was 79%. The PK parameters from the comprehensive mouse study are summarized in Table 7<a class="ref showTableEvent internalNav" data-ID="jm0501275t00007" href="#jm0501275t00007"></a>. The plasma protein binding (PB) of compound <b>50</b> was calculated to be 99.8 ± 0.04% and 98.8 ± 0.11% in mouse and human serum, respectively, using the equilibrium dialysis method (at 10 μM). Although the unbound (free) fraction available in mice was predicted to be low (0.2%), the favorable pharmacokinetic prolife of <b>50</b> and the high plasma concentrations obtained with several analogues in the 4 h oral exposure studies warranted the advancement of these analogues into in vivo efficacy studies. <div class="NLM_table-wrap" id="jm0501275t00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Pharmacokinetic Properties of Compound <b>50</b> in Mice<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">parameter</td><td class="colsep2 rowsep2">unit</td><td class="colsep2 rowsep2">iv dose</td><td class="colsep2 rowsep2">po dose </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose </td><td class="colsep2 rowsep2">mg/kg </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max</sub></td><td class="colsep2 rowsep2">μM </td><td class="colsep2 rowsep2">23.7 </td><td class="colsep2 rowsep2">27.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>T</i><sub>max</sub></td><td class="colsep2 rowsep2">h </td><td class="colsep2 rowsep2">− </td><td class="colsep2 rowsep2">0.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>tot</sub></td><td class="colsep2 rowsep2">μM·h </td><td class="colsep2 rowsep2">97.4 </td><td class="colsep2 rowsep2">155 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub></td><td class="colsep2 rowsep2">h </td><td class="colsep2 rowsep2">2.5 </td><td class="colsep2 rowsep2">3.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">MRT </td><td class="colsep2 rowsep2">h </td><td class="colsep2 rowsep2">4.9 </td><td class="colsep2 rowsep2">5.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">mL/min/kg </td><td class="colsep2 rowsep2">1.53 </td><td class="colsep2 rowsep2">− </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>V</i><sub>ss</sub></td><td class="colsep2 rowsep2">L/kg </td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">− </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>F</i><sub>po</sub></td><td class="colsep2 rowsep2">% </td><td class="colsep2 rowsep2">− </td><td class="colsep2 rowsep2">79</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Composite serum concentration−time profiles were constructed for the PK analysis.<i><sup>b</sup></i><sup></sup> Vehicle:  3:1:6 PEG400/ethanol/water.</p></div></div></div><div class="NLM_p"><b>In Vivo Antitumor Activity.</b> Four oxadiazole analogues were evaluated for antitumor efficacy in a L2987 human lung carcinoma xenograft model (Table 8<a class="ref showTableEvent internalNav" data-ID="jm0501275t00008" href="#jm0501275t00008"></a>). An active result in this study is defined as greater than 50% tumor growth inhibition (TGI) over at least one tumor volume doubling time (cf. Experimental Section). Compounds <b>37</b>, <b>44</b>, <b>49</b>, and <b>50</b> were administered orally for 10 consecutive days (qd × 10) to nude mice bearing tumors staged to 100−150 mm<sup>3</sup>. Oxadiazole <b>37</b>, the most potent inhibitor of Flk-1 kinase activity (IC<sub>50</sub> = 0.086 μM), was toxic at the 50 mg/kg/day dose level in the L2987 model. However, administration of compound <b>37</b> at a 5-fold lower dose (10 mg/kg), twice daily for 20 consecutive days (2qd × 20) provided good in vivo efficacy (79% TGI) in this model. Even with the <a name="jm004801203998" id="jm004801203998"></a> significant potency against Flk-1, the twice daily (2qd) dosing requirement for compound <b>37</b> may be a result of a considerable decline in plasma level concentrations following each dose, as observed in the 4 h oral exposure studies (vide supra). Analogues <b>44</b> and <b>49</b> exhibited antitumor activity at doses of 150 and 100 mg/kg/day, respectively, while compound <b>50</b>, provided robust in vivo efficacy at multiple dose levels. No overt toxicity (morbidity or weight loss) was observed with oxadiazole analogues <b>44</b>, <b>49</b>, and <b>50 </b>at any dose level throughout the dosing regimen. The higher doses required for efficacy in this model with <b>44</b> and <b>50</b> may be attributed to the reduced Flk-1 activity of these compounds (IC<sub>50</sub> values of 0.84 and 0.42 μM) compared to oxazole <b>37</b> (IC<sub>50</sub> = 0.086 μM). <div class="NLM_table-wrap" id="jm0501275t00008"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 8.  Growth Inhibition for Oxadiazole Analogues against Established L2987 Human Lung Carcinoma Xenografts Implanted Subcutaneously in Athymic Mice</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">dose (mg/kg/day)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">% TGI<i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">toxic<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b></td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">30.0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">46.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">150 </td><td class="colsep2 rowsep2">88.4 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49</b></td><td class="colsep2 rowsep2">60 </td><td class="colsep2 rowsep2">42.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">74.9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">63.9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">87.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">150 </td><td class="colsep2 rowsep2">94.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Daily oral administration of compound for 10 consecutive days using 7:1:2 PEG 400/ethanol/water as the vehicle.<i><sup>b</sup></i><sup></sup> Maximum percent tumor growth inhibition over one tumor doubling time; >50% TGI is considered active in this study.<i><sup>c</sup></i><sup></sup> Compound <b>37</b> was active when dosed at 10 mg/kg/d on a 2qd × 20 schedule.</p></div></div></div><div class="NLM_p last">Figure 3<a data-tab="pane-pcw-Figures" href="#jm0501275f00003" id="" class=" internalNav"></a> illustrates the dose-dependent growth inhibition of compound <b>50</b> in the L2987 tumor model. The two highest dose levels of 100 and 150 mg/kg/day provided similar antitumor activity (% TGI = 88 and 94%, respectively) with nearly complete tumor stasis throughout the dosing regimen (maximum efficacy). Consistent with the mechanisms of antiangiogenic therapy relative to VEGFR-2/FGFR-1 inhibition, tumor growth again commenced once compound dosing was terminated. Even at the low dose of 50 mg/kg/day, compound <b>50</b> was active, providing 64% tumor growth inhibition. A minimum effective dose for oxadiazole <b>50</b> was not established in this study. <div id="_i24"><figure id="jm0501275f00003" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00003.jpeg" id="_i25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Antitumor activity of compound <b>50</b> against established L2987 human tumor xenografts implanted subcutaneously in athymic mice. Arrows indicate dosing (qd × 10).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Incorporation of the 2,4-difluoro-5-(methoxycarbamoyl)phenylamino substituent at the C4-position of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine scaffold resulted in potent and selective inhibitors of the VEGFR-2 and FGFR-1 kinases. In addition to the biochemical potency, many analogues demonstrated significant antiproliferative effects in growth factor-dependent HUVEC assays. Critical to the discovery of orally bioavailable analogues in the series were the SAR studies carried out at the 6-position of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus. A survey of various C6-heterocycles led to the identification of substituted 1,3,5-oxadiazoles that served as metabolically stable bioisosteres for the C6-ester substituent. Preliminary assessment of the pharmacokinetic properties associated with compounds in the series revealed that the C6-carbamate analogues suffered from poor absorption, while several C6-heterocycles provided high exposures following oral administration in mice. <a name="jm004801203999" id="jm004801203999"></a> Further evaluation of oxadiazole <b>50</b> in mice showed that this compound possessed excellent oral bioavailability and a good half-life. The favorable in vitro pharmacology and pharmacokinetic properties exhibited by the oxadiazole analogues <b>44</b>, <b>49</b>, and <b>50</b> translated into significant antitumor activity in the L2987 human lung carcinoma xenograft model. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Chemistry. </b>All nonaqueous reactions were carried out under an argon or nitrogen atmosphere at room temperature, unless otherwise noted. All commercial reagents and anhydrous solvents were purchased from Aldrich and were used without further purification or distillation, unless otherwise stated. Analytical thin-layer chromatography (TLC) was performed on EM Science silica gel 60 F<sub>254</sub> (0.25 mm). Compounds were visualized by UV light and/or stained with either <i>p</i>-anisaldehyde, potassium permanganate, or cerium molybdate solutions followed by heating. Flash column chromatography was performed on EM Science silica gel 60 (particle size of 40−63 μm). Analytical high-pressure liquid chromatography (HPLC) and LC−MS analyses were conducted using Shimadzu LC-10AS pumps and a SPD-10AV UV−vis detector set at 220 nm with the MS detection performed with a Micromass Platform LC spectrometer. Analytical HPLC analyses were performed using one of the following conditions:  column A, phenom-prime S5 C18 4.6 × 30 mm column; solvent A, 10% MeOH−90% H<sub>2</sub>O−0.1% TFA; solvent B, 90% MeOH−10% H<sub>2</sub>O−0.1% TFA; flow rate = 4 mL/min; linear gradient time = 2 min; start %B = 0, final %B = 100; or column B, Phenomenex Su C18 4.6 × 50 mm column; solvent A, 10% MeOH−90% H<sub>2</sub>O−0.1% TFA; solvent B, 90% MeOH−10% H<sub>2</sub>O−0.1% TFA; flow rate = 4 mL/min; linear gradient time = 4 min; start %B = 0, final %B = 100. Preparative reverse phase (RP) HPLC was performed using two Shimadzu LC-8A pumps, a SPD-10AV UV−vis detector set at 220 nm, and a YMC C18 ODS-A 5 μm, 20 × 100 mm column (eluting at 20 mL/min with a 12 min gradient of 0−100% B, where solvent A = 10% MeOH−90% H<sub>2</sub>O−0.1% TFA and solvent B = 90% MeOH−10% H<sub>2</sub>O−0.1% TFA). Following preparative HPLC purification, the fractions containing the desired product were concentrated under reduced pressure to remove the MeOH, neutralized with saturated aqueous NaHCO<sub>3</sub> to pH 7 and extracted with ethyl acetate (3 × 5 mL). The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to afford the desired compounds. </div><div class="NLM_p">NMR (<sup>1</sup>H and <sup>13</sup>C) spectra were recorded on JEOL GSX 500 MHz or Bruker ARX 400 MHz spectrometers and calibrated using an internal reference. High-resolution mass spectra (HMRS) were recorded on a JEOL SX102 mass spectrometer. Elemental analyses were performed by Robertson Microlit Laboratories, and the results obtained are within ±0.4% of the theoretical values. </div><div class="NLM_p"><b>Diethyl 1-Amino-3-isopropyl-1</b><b><i>H</i></b><b>-pyrrole-2,4-dicarboxylate</b><b>(4).</b> To a solution of diethyl 3-isopropyl-1<i>H</i>-pyrrole-2,4-dicarboxylate<sup>26</sup> (<b>3</b>, 3.75 g, 14.8 mmol) in DMF (280 mL) at 0 °C was added NaH (60% dispersion in mineral oil, 0.890 g, 22.2 mmol) and the suspension was stirred for 10 min. <i>O</i>-(Diphenylphosphinyl)hydroxylamine (6.91 g, 29.6 mmol) was added to the reaction mixture and stirring was continued for 2 h. The reaction was quenched by the addition of pH 7 phosphate buffer (100 mL) and the mixture was extracted with EtOAc (4 × 100 mL). The combined EtOAc layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The residue was purified by flash chromatography (SiO<sub>2</sub>, 20−25% EtOAc/hexanes gradient elution) to give <b>4 </b>(3.38 g, 85%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.29 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49 (s, 1H), 5.56 (s, 2H), 4.37 (q, 2H, <i>J</i> = 7.1 Hz), 4.32 (q, 2H, <i>J</i> = 7.1 Hz), 3.99 (hep, 1H, <i>J</i> = 7.2 Hz), 1.42−1.35 (m, 12H); MS (ESI) <i>m</i>/<i>z</i> 269 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Ethyl 5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxylate (5).</b> A solution of <b>4</b> (4.8 g, 18 mmol) in formamide (18 mL) was heated to 165 °C for 6 h and cooled to room temperature. The resulting precipitate was filtered, washed with water, and dried overnight to afford <b>5</b> (4.0 g, 90%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.56 min (column A, purity 99%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.68 (s, 1H), 7.90 (s, 1H), 7.86 (d, 1H, <i>J</i> = 4.0 Hz), 4.24 (q, 2H, <i>J</i> = 7.1 Hz), 4.20 (m, 1H), 1.31 (d, 6H, <i>J</i> = 7.2 Hz), 1.29 (t, 3H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 155.0, 140.4, 134.7, 124.5, 117.6, 114.1, 60.1, 24.3, 21.8, 14.6; HRMS for C<sub>12</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 250.1113, found 250.1102. Anal. (C<sub>12</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>Ethyl 4-Chloro-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxylate (6).</b> A mixture of <b>5</b> (17.8 g, 71.5 mmol), POCl<sub>3</sub> (12.0 g, 78.6 mmol), and a catalytic amount of Et<sub>3</sub>N (1.00 mL, 7.15 mmol) in toluene (210 mL) was heated to reflux for 6 h and cooled to room temperature. The toluene was removed under reduced pressure. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and filtered through a pad of silica gel to give <b>6</b> (17.3 g, 90%) as a light yellow solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.95 min (column A, purity 95%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 8.14 (s, 1H), 4.31 (hep, 1H, <i>J</i> = 7.2 Hz), 4.21 (q, 2H, <i>J</i> = 7.0 Hz), 1.46 (d, 6H, <i>J</i> = 7.2 Hz), 1.27 (t, 3H, <i>J</i> = 7.0 Hz). </div><div class="NLM_p"><b>Ethyl </b><b>5-Isopropyl-4-(3-(methoxycarbamoyl)phenoxy)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxylate </b><b>(8). </b>To a solution of 3-hydroxybenzoic acid (0.69 g, 5.0 mmol) in THF (50 mL) were added EDCI (1.9 g, 10 mmol) and HOBt (1.4 g, 10 mmol) at room temperature. After 5 min, diisopropylethylamine (0.71 g, 5.5 mmol) and methyl hydroxylamine hydrochloride (0.63 g, 7.5 mmol) were added to the reaction, and the resulting mixture was stirred for 6 h. The reaction was diluted with EtOAc (150 mL) and washed with water (3 × 100 mL), 1 N HCl (1 × 50 mL), and brine (1 × 50 mL). The EtOAc layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to give 3-hydroxy-<i>N</i>-methoxybenzamide (0.72 g, 86%), which was sufficiently pure to use in the subsequent step. </div><div class="NLM_p">The crude 3-hydroxy-<i>N</i>-methoxybenzamide (25 mg, 0.15 mmol) was dissolved in DMF (2 mL) and treated with K<sub>2</sub>CO<sub>3</sub> (21 mg, 0.15 mmol), and the resulting suspension was stirred at room temperature for 5 min. Ethyl 4-chloro-5-isopropylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate was added to the reaction and the mixture was stirred for 18 h. The resulting solid was filtered and washed with MeOH. The filtrate was concentrated in vacuo to give a yellow oil, which was dissolved in MeOH and purified by preparative HPLC to afford <b>8</b> (18 mg, 60%) as a clear film:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.89 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23 (s, 1H), 7.92 (s, 1H), 7.75 (d, 1 H, <i>J</i> = 8.1 Hz), 7.69 (s, 1H), 7.60 (t, 1H, <i>J</i> = 8.1 Hz), 7.50 (d, 1H, <i>J</i> = 8.1 Hz), 4.37−4.31 (m, 3H), 3.82 (s, 3H), 1.48 (d, 6H, <i>J</i> = 7.1 Hz), 1.39 (t, 3H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 164.2, 163.1, 151.5, 147.0, 137.4, 130.2, 130.0, 125.7, 124.8, 123.6, 121.7, 118.5, 117.0, 114.0, 64.8, 60.6, 25.2, 24.9, 21.5, 14.4; HRMS for C<sub>20</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub> (M + H)<sup>+</sup> calcd 399.1624, found 399.1679. </div><div class="NLM_p"><b>Ethyl </b><b>4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin</b><b>e-6-carbox-ylate (14).</b><b>Representative Procedure for the Preparation of a </b><b><i>m</i></b><b>-Amino-</b><b><i>N</i></b><b>-methoxybenzamide Intermediate 7 and Subsequent Coupling to Ethyl </b><b>4-Chloro-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxylate.</b> To a solution of 2,4-difluoro-5-nitrobenzoic acid<sup><a onclick="showRef(event, 'jm0501275b00040'); return false;" href="javascript:void(0);" class="ref jm0501275b00040">40</a></sup> (5.00 g, 24.6 mmol) in EtOH (250 mL) was added tin chloride dihydrate (27.7 g, 123 mmol). The reaction mixture was heated to 50 °C for 10 min and then cooled to room temperature. EtOH was removed from the reaction mixture under reduced pressure. Ice water was added to the resulting residue, which was neutralized with saturated aqueous NaHCO<sub>3</sub> to pH 7 and extracted with EtOAc (3 × 300 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to give 5-amino-2,4-difluorobenzoic acid (3.20 g, 18.5 mmol, 75%), which was used directly in the subsequent reaction without further purification. </div><div class="NLM_p">EDCI (9.45 g, 49.2 mmol) and HOBt (6.64 g, 49.2 mmol) were added to a solution of 5-amino-2,4-difluorobenzoic acid (4.26 g, 24.6 mmol) in THF (500 mL) and stirred at room temperature for 5 min. Diisopropyl ethylamine (3.30 g, 25.0 mmol) and methyl hydroxylamine hydrochloride (3.10 g, 37.5 <a name="jm004801204000" id="jm004801204000"></a> mmol) were then added to the reaction and the mixture was stirred for 6 h. The reaction mixture was diluted with EtOAc (500 mL) and washed with saturated aqueous NaHCO<sub>3</sub> (3 × 200 mL), 1 N HCl (2 × 200 mL), and brine (1 × 200 mL). The EtOAc layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The resulting oil was purified by flash chromatography (SiO<sub>2</sub>, 0−2% MeOH/CHCl<sub>3</sub> gradient elution) to give 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (2.98 g, 14.8 mmol, 60%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 0.97 min (column A, purity 99%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.19 (dd, 1H, <i>J</i> = 7.0 Hz), 6.95 (t, 1H, <i>J</i> = 10.5 Hz), 3.81 (s, 3H); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 163.5, 153.5 (dd, <i>J</i> = 247, 11 Hz), 152.5 (dd, <i>J</i> = 241, 10 Hz), 133.9 (d, <i>J</i> = 13 Hz), 117.4, 117.0 (d, <i>J</i> = 15 Hz), 104.6 (dd, <i>J</i> = 28, 26 Hz), 64.0; HRMS for C<sub>8</sub>H<sub>8</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M − H)<sup>-</sup> calcd 201.0475, found 201.0474. Anal. (C<sub>8</sub>H<sub>8</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p">A solution of 5-amino-<i>N</i>-methoxy-2,4-difluorobenzamide (20 mg, 0.10 mmol) and ethyl 4-chloro-5-isopropylpyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxylate (27 mg, 0.10 mmol) in DMF (2 mL) was stirred for 18 h. The crude reaction mixture was purified by preparative HPLC to afford <b>14</b> (34 mg, 78% yield) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.70 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.42 (bs, 1H), 9.33 (bs, 1H), 8.18 (s, 1H), 7.60 (t, 1H, <i>J</i> = 10.4 Hz), 7.17 (t, 1H, <i>J</i> = 10.4 Hz), 4.40 (q, 2H, <i>J</i> = 7.2 Hz), 4.13 (hep, 1H, <i>J</i> = 7.2 Hz), 3.98 (s, 3H), 1.66 (d, 6H, <i>J</i> = 7.2 Hz), 1.50 (t, 3H, <i>J</i> = 7.2 Hz); HRMS for C<sub>20</sub>H<sub>21</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 434.1962, found 434.1965. </div><div class="NLM_p"><b>Ethyl </b><b>5-Isopropyl-4-(3-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxyl</b><b>ate (9):  </b>clear film; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.88 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.33 (s, 1H), 7.95 (s, 1H), 7.92−7.88 (m, 1H), 7.81 (s, 1H), 7.73−7.69 (m, 2H), 4.35 (q, 2H, <i>J</i> = 7.0 Hz), 3.89−3.78 (m, 4H), 1.55 (d, 6H, <i>J</i> = 7.2 Hz), 1.39 (t, 3H, <i>J</i> = 7.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub> with 1 drop CD<sub>3</sub>OD) δ 165.6, 163.7, 150.9, 150.4, 141.2, 138.5, 134.0, 130.4, 128.2, 126.7, 123.8, 121.6, 116.8, 110.7, 63.9, 60.9, 26.5, 24.7, 21.8, 14.0; HRMS for C<sub>20</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 398.1828, found 398.1821. </div><div class="NLM_p"><b>Ethyl </b><b>5-Isopropyl-4-(3-(methoxycarbamoyl)-4-methylphenylamino)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-</b><b>carboxylate (10):  </b>clear film; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.68 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.08 (s, 1H), 7.69 (s, 1H), 7.43−7.38 (m, 3H), 4.34 (q, 2H, <i>J</i> = 7.0 Hz), 3.98 (hep, 1H, <i>J</i> = 7.1 Hz), 3.84 (s, 3H), 2.45 (s, 3H), 1.51 (d, 6H, <i>J</i> = 7.1 Hz), 1.38 (t, 3H, <i>J</i> = 7.0 Hz); HRMS for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 412.1947, found 412.1984. </div><div class="NLM_p"><b>Ethyl </b><b>4-(4-Bromo-3-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-</b><b>carboxylate (11):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.76 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.95 (s, 1H), 7.68 (d, 1H, <i>J</i> = 8.6 Hz), 7.61 (s, 1H), 7.41 (s, 1H), 7.33 (d, 1H, <i>J</i> = 6.9 Hz), 4.31 (q, 2H, <i>J</i> = 7.1 Hz), 4.12 (hep, 1H, <i>J</i> = 7.0 Hz), 3.85 (s, 3H), 1.47 (d, 6H, <i>J</i> = 7.0 Hz), 1.40 (t, 3H, <i>J</i> = 7.1 Hz); HRMS for C<sub>20</sub>H<sub>22</sub>BrN<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 476.0933, found 476.0930. </div><div class="NLM_p"><b>Ethyl </b><b>4-(4-Fluoro-3-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-c</b><b>arboxylate (12):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.80 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.35 (bs, 1H), 8.14−8.12 (m, 2H), 8.06 (s, 1H), 7.95 (s, 1H), 7.43 (bs, 1H), 7.21 (t, 1H, <i>J</i> = 10.1 Hz), 4.35 (q, 2H, <i>J</i> = 7.1 Hz), 4.13 (hep, 1H, <i>J</i> = 7.2 Hz), 3.92 (s, 3H), 1.57 (d, 6H, <i>J</i> = 7.2 Hz), 1.40 (t, 3H, <i>J</i> = 7.1 Hz); HRMS for C<sub>20</sub>H<sub>22</sub>FN<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 416.1734, found 416.1737. </div><div class="NLM_p"><b>Ethyl </b><b>4-(2-Fluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-c</b><b>arboxylate (13):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.77 min (column A, purity 96%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.09 (bs, 1H), 8.81 (bs, 1H), 8.07 (s, 1H), 8.04 (s, 1H), 7.75−7.73 (m, 1H), 7.60−7.56 (m, 1H), 7.25 (t, 1H, <i>J</i> = 10.5 Hz), 4.35 (q, 2H, <i>J</i> = 7.1 Hz), 4.17−4.11 (m, 1H), 3.93 (s, 3H), 1.55 (d, 6H, <i>J</i> = 7.3 Hz), 1.40 (t, 3H, <i>J</i> = 7.1 Hz); HRMS for C<sub>20</sub>H<sub>22</sub>FN<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 416.1734, found 416.1737.</div><div class="NLM_p"><b>Ethyl </b><b>4-(2,4-Difluoro-5-(ethoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6</b><b>-carboxylate (15):</b> colorless oil; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.80 min (column A, purity 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.21 (bs, 1H), 9.08 (bs, 1H), 8.07 (s, 1H), 8.01 (s, 1H), 7.48 (s, 1H), 7.04 (t, 1H, <i>J</i> = 10.4 Hz), 4.38−4.31 (m, 2H), 4.19−4.08 (m, 3H), 1.55 (d, 6H, <i>J</i> = 7.2 Hz), 1.41−1.33 (m, 6H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 164.4, 160.9, 156.2 (dd, <i>J</i> = 242, 11 Hz), 155.7 (dd, <i>J</i> = 242, 11 Hz), 153.4, 147.8, 126.8 (d, <i>J</i> = 15 Hz), 126.5, 123.5, 123.2, 115.7 (d, <i>J</i> = 15 Hz), 115.4, 112.4, 104.4 (dd, <i>J</i> = 32, 26 Hz), 72.7, 60.5, 25.5, 22.7 (2C), 14.3, 13.5; HRMS for C<sub>21</sub>H<sub>23</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 448.1796, found 448.1782. </div><div class="NLM_p"><b>Ethyl </b><b>4-(2,4-Difluoro-5-(isopropoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazi</b><b>ne-6-carboxylate (16):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.84 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (bs, 1H), 8.12 (s, 1H), 7.85 (s, 1H), 7.49 (s, 1H), 7.38 (t, 1H, <i>J</i> = 10.5 Hz), 7.13 (t, 1H, <i>J</i> = 7.3 Hz), 4.83−4.49 (m, 1H), 4.18 (q, 1H, <i>J</i> = 7.0 Hz), 4.09 (hep, 1H, <i>J</i> = 7.2 Hz), 1.39−1.33 (m, 9H), 1.16 (d, 6H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.6, 160.7, 155.5 (dd, <i>J</i> = 245, 10 Hz), 154.0 (dd, <i>J</i> = 240, 10 Hz), 149.0, 141.4, 139.0, 132.3 (d, <i>J</i> = 15 Hz), 124.2, 118.1, 117.0 (d, <i>J</i> = 15 Hz), 115.6, 112.0, 104.4 (t, <i>J</i> = 30 Hz), 76.8, 59.7, 24.2, 22.8, 22.1, 21.1, 20.6, 14.3; HRMS for C<sub>22</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 462.1953, found 462.1964. </div><div class="NLM_p"><b>Ethyl </b><b>4-(2,4-Difluoro-5-(isobutoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin</b><b>e-6-carboxylate (17):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.78 min (column B, purity 96%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.21 (bs, 1H), 9.11 (bs, 1H), 8.07 (s, 1H), 8.01 (s, 1H), 7.49 (s, 1H), 7.02 (t, 1H, <i>J</i> = 8.0 Hz), 4.37−4.31 (m, 2H), 4.15 (hep, 1H, <i>J</i> = 7.2 Hz), 3.87−3.63 (m, 2H), 2.06−2.01 (m, 1H), 1.58−1.52 (m, 6H), 1.33 (t, 3H, <i>J</i> = 7.0 Hz), 1.06 (d, 6H, <i>J</i> = 6.9 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 164.4, 160.7, 156.1 (dd, <i>J</i> = 247, 12 Hz), 155.5 (dd, <i>J</i> = 247, 12 Hz), 153.4, 147.8, 127.0, 126.5, 123.7 (d, <i>J</i> = 13 Hz), 123.2, 115.9 (d, <i>J</i> = 13 Hz), 115.4, 112.4, 104.3 (t, <i>J</i> = 28 Hz), 83.6, 60.5, 27.4, 25.5, 22.7 (2C), 19.2 (2C), 14.4; HRMS for C<sub>23</sub>H<sub>27</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 476.2109, found 476.2099. </div><div class="NLM_p"><b>Ethyl </b><b>4-(5-((Cyclopropylmethoxy)carbamoyl)-2,4-difluorophenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][</b><b>1,2,4]-triazine-6-carboxylate (18):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.81 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.19−9.16 (m, 2H), 8.07 (s, 1H), 8.01 (s, 1H), 7.49 (s, 1H), 7.02 (t, 1H, <i>J</i> = 10.0 Hz), 4.34 (q, 2H, <i>J</i> = 7.1 Hz), 4.19−4.11 (m, 1H), 3.90 (d, 2H, <i>J</i> = 7.1 Hz), 1.55 (d, 6H, <i>J</i> = 7.7 Hz), 1.40 (t, 3H, <i>J</i> = 7.1 Hz), 1.29−1.18 (m, 1H), 0.68−0.61 (m, 2H), 0.39−0.33 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 164.4, 160.6, 156.4 (dd, <i>J</i> = 250, 14 Hz), 155.1 (dd, <i>J</i> = 250, 14 Hz), 153.4, 147.8, 127.0, 126.5, 123.5 (d, <i>J</i> = 11 Hz), 123.1, 115.4 (d, <i>J</i> = 17 Hz), 115.1, 112.2, 104.1 (t, <i>J</i> = 28 Hz), 81.5, 60.4, 25.4, 22.7 (2C), 14.3, 9.1, 3.1 (2C); HRMS for C<sub>23</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 474.1953, found 474.1956. </div><div class="NLM_p"><b>4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin</b><b>e-6-carboxylic Acid (19).</b> A mixture of compound <b>14</b> (6.0 g, 14 mmol) and 1 N NaOH (140 mL) in THF (140 mL) was heated to 60 °C for 27 h and then cooled to room temperature. The reaction mixture was acidified to pH 4 with 1 N HCl, and the volatiles were removed in vacuo. The precipitate was filtered, washed with diethyl ether, and dried under high vacuum overnight to give <b>19</b> (5.5 g, 98%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.33 min (column A, purity 95%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.28 (bs, 1H), 11.57 (s, 1H), 10.54 (s, 1H), 7.88 (s, 1H), 7.51−7.47 (m, 1H), 7.45 (t, 1H, <i>J</i> = 10.5 Hz), 7.22−7.18 (m, 1H), 4.46 (hep, 1H, <i>J</i> = 7.1 Hz), 3.70 (s, 3H), 1.34 (d, 6H, <i>J</i> = 7.1 Hz); MS (ESI) <i>m</i>/<i>z</i> 406 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>5-(6-(Azidocarbonyl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-ylamino)-2,4-difluoro-</b><b><i>N</i></b><b>-met</b><b>hoxybenzamide (20).</b> A solution of compound <b>19</b> (0.41 g, 0.94 mmol) in anhydrous 1,4-dioxane (10 mL) was treated with triethylamine (0.20 mL, 1.4 mmol) and diphenylphosphoryl azide (0.39 g, 1.4 mmol). The reaction mixture was heated to 40 °C for 1.5 h and then cooled to room temperature and concentrated under reduced <a name="jm004801204001" id="jm004801204001"></a> pressure. The residue was passed through a silica gel pad eluting with 25% EtOAc/hexanes to give <b>20</b> (0.42 g, 99%) as a pale yellow oil, which was used directly in the next step without further purification:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.86 min (column A, purity 90%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.40 (bs, 1H), 9.10 (bs, 1H), 8.11 (s, 1H), 8.00 (s, 1H), 7.78 (s, 1H,), 7.54 (t, 1H, <i>J</i> = 10.3 Hz), 4.15 (hep, 1H, <i>J</i> = 7.2 Hz), 3.91 (s, 3H), 1.60 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 406 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Ethyl </b><b>4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcar-bamate (21). Representative Procedure for the Preparation of C6-Carbamate </b><b>Derivatives. </b>A mixture of compound <b>20</b> (50 mg, 0.12 mmol) and EtOH (53 mg, 1.2 mmol) in DMF (1.2 mL) was heated to 85 °C for 2 h. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, and purified by flash chromatography (SiO<sub>2</sub>, 25−40% EtOAc/hexanes gradient elution) to give <b>21 </b>(32 mg, 62%) as an amorphous solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.09 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.01−7.97 (m, 1H), 7.62−7.58 (m, 2H), 7.02 (t, 1H, <i>J</i> = 10.1 Hz), 4.10 (q, 2H, <i>J</i> = 7.0 Hz), 3.72 (s, 3H), 3.58 (hep, 1H, <i>J</i> = 7.2 Hz), 1.35 (d, 6H, <i>J</i> = 7.2 Hz), 1.20 (q, 3H, <i>J</i> = 7.0 Hz); HRMS for C<sub>20</sub>H<sub>22</sub>F<sub>2</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 449.1749, found 449.1753. </div><div class="NLM_p"><b>Benzyl </b><b>4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcar-bamate (22):</b> amorphous solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.70 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (m, 1H), 7.71 (s, 1H), 7.40−7.18 (m, 6H), 7.12 (t, 1H, <i>J</i> = 10.0 Hz), 5.19 (s, 2H), 3.81 (s, 3H), 3.65 (hep, 1H, <i>J</i> = 7.2 Hz), 1.42 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 511 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(Piperidin-1-yl)propyl </b><b>4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcarbamate, Hydrochloride Salt (23):</b> amorphous solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.28 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.05−7.99 (m, 1H), 7.62−7.58 (m, 2H), 7.22 (t, 1H, <i>J</i> = 10.1 Hz), 4.28−4.23 (m, 2H), 3.85 (s, 3H), 3.69−3.62 (m, 2H), 3.26−3.23 (m, 2H), 2.98−2.91 (m, 2H), 2.20−2.11 (m, 2H), 2.10−1.91 (m, 2H), 1.89−1.74 (m, 4H), 1.59−1.50 (m, 1H), 1.47 (d, 6H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 163.7, 162.2, 161.5, 158.0, 156.4 (dd, <i>J</i> = 251, 12 Hz), 155.1 (dd, <i>J</i> = 251, 12 Hz), 151.8, 145.5, 127.0 (d, <i>J</i> = 15 Hz), 124.4, 123.5, 115.1 (d, <i>J</i> = 15 Hz), 113.8, 104.4 (t, <i>J</i> = 28 Hz), 64.8, 61.9, 54.4, 53.4, 37.0, 34.9, 31.7, 25.7, 23.8, 23.3, 22.7, 22.0; HRMS for C<sub>26</sub>H<sub>33</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd 546.2640, found 546.2616. </div><div class="NLM_p"><b>3-(Methylsulfonyl)propyl </b><b>4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcarbamate (24):</b> amorphous solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.51 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (s, 1H), 7.68−7.55 (m, 3H), 7.50−7.41 (m, 1H), 4.18−4.10 (m, 2H), 3.69 (s, 3H), 3.67−3.60 (m, 2H), 3.26−3.19 (m, 2H), 3.00 (s, 3H), 2.09−1.98 (m, 2H), 1.32 (d, 6H, <i>J</i> = 7.2 Hz); HRMS for C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>6</sub>O<sub>6</sub>S (M + H)<sup>+</sup> calcd 541.1637, found 541.1635. </div><div class="NLM_p"><b>(Tetrahydrofuran-2-yl)methyl </b><b>4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcarbamate (25):</b> amorphous solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.91 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (bs, 1H), 8.84 (bs, 1H), 7.68−7.40 (m, 4H), 4.18−3.97 (m, 2H), 3.71 (s, 3H), 3.71−3.57 (m, 3H), 1.97−1.81 (m, 3H), 1.67−1.60 (m, 1H), 1.32 (d, 6H, <i>J</i> = 6.9 Hz); HRMS for C<sub>23</sub>H<sub>26</sub>F<sub>2</sub>N<sub>6</sub>O<sub>5</sub> (M + H)<sup>+</sup> calcd 505.1936, found 505.1931. </div><div class="NLM_p"><b>Methylpiperidin-4-yl </b><b>4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-</b><b>6-ylcarbamate, Hydrochloride Salt (26):</b> amorphous solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.03 min (column A, purity 94%); <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.38 (bs, 1H), 7.83 (s, 1H), 7.76 (s, 1H), 7.39−7.11 (m, 4H), 4.98−4.89 (m, 2H), 3.83 (s, 3H), 3.63−3.54 (m, 1H), 3.29−3.18 (m, 1H), 3.10−2.99 (m, 2H), 2.72 (s, 3H), 2.30−2.23 (m, 2H), 2.10−2.01 (m, 2H), 1.49 (bs, 6H); MS (ESI) <i>m</i>/<i>z</i> 518 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carboxylic Acid (27).</b> A solution of ester <b>5</b> (4.0 g, 16 mmol) in THF/water (100/10 mL) was treated with 1 N NaOH (82 mL) and the resulting mixture was heated to 60 °C for 8 h, cooled to room temperature, and concentrated under reduced pressure to remove the THF. The remaining solution was acidified with 1 N HCl to pH 3. The precipitate was filtered, washed with water, and dried under high vacuum overnight to give <b>27</b> (3.4 g, 95%) as a white solid, which was used directly in the next step without further purification:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.30 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (bs, 1H), 11.63 (bs, 1H), 7.86 (s, 1H), 7.83 (s, 1H), 4.21 (hep, 1H, <i>J</i> = 7.1 Hz), 1.31 (d, 6H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.0, 154.6, 139.8, 134.4, 124.2, 117.1, 113.6, 23,7, 21.4 (2C); HRMS for C<sub>10</sub>H<sub>11</sub>N<sub>3</sub>O<sub>3</sub> (M − H)<sup>-</sup> calcd 220.0800, found 220.0728. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-methyloxazol-2-yl)-pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (29). </b>A mixture of acid <b>27</b> (0.44 g, 2.0 mmol), 1-aminoacetone HCl salt<sup><a onclick="showRef(event, 'jm0501275b00041'); return false;" href="javascript:void(0);" class="ref jm0501275b00041">41</a></sup> (0.27 g, 2.5 mmol), BOP reagent (1.1 g, 2.5 mmol), and triethylamine (0.68 mL, 4.9 mmol) in DMF (5 mL) was stirred at 50 °C for 2 h. The reaction mixture was partitioned between ethyl acetate (10 mL) and water (5 mL). The ethyl acetate layer was washed with brine, dried (MgSO<sub>4</sub>), and concentrated under reduced pressure. The residue was then purified by flash chromatography (SiO<sub>2</sub>; 100% ethyl acetate) to afford 4-hydroxy-5-isopropyl-<i>N</i>-(2-oxopropyl)pyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (0.34 g, 61%) as a pale yellow solid, which was used directly in the next step. </div><div class="NLM_p">The above carboxamide (55 mg, 0.21 mmol) was stirred with POCl<sub>3</sub> (2 mL) at 120 °C for 6 h. The excess POCl<sub>3</sub> was removed in vacuo and the residue was partitioned between dichloromethane (10 mL) and saturated aqueous NaHCO<sub>3</sub> solution (10 mL). The organic layer was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The residue was purified by flash chromatography (SiO<sub>2</sub>, 50% ethyl acetate/hexane) to afford chloroimidate <b>28</b> (31 mg, 0.11 mmol, 55%) as a pale yellow oil:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.87 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (s, 1H), 8.12 (s, 1H), 6.90 (s, 1H), 4.33 (hep, 1H, <i>J</i> = 7.2 Hz), 2.41 (s, 3H), 1.46 (d, 6H, <i>J</i> = 7.2 Hz). </div><div class="NLM_p">A solution of <b>28</b> (31 mg, 0.11 mmol) and 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (24 mg, 0.12 mmol) in MeCN (3 mL) was stirred at room temperature for 18 h. The solvent was removed under reduced pressure and the residue was purified by preparative HPLC to afford <b>29</b> (42 mg, 86%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.71 min (column A, purity 97%); <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.80 (s, 1H), 7.71−7.66 (m, 1H), 7.49 (s, 1H), 7.14 (t, 1H, <i>J</i> = 10.1 Hz), 6.86 (s, 1H), 4.04 (hep, 1H, <i>J</i> = 7.2 Hz), 3.24 (s, 3H), 2.33 (s, 3H), 1.35 (d, 6H, <i>J</i> = 7.0 Hz); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 160.9, 157.1, 156.5 (dd, <i>J</i> = 248, 10 Hz), 155.5 (dd, <i>J</i> = 250, 10 Hz), 152.8, 148.1, 147.1, 146.8, 126.8, 123.8, 122.9, 119.6, 115.0 (d, <i>J</i> = 12 Hz), 113.3, 112.1, 105.5 (dd, <i>J</i> = 29, 27 Hz), 64.8, 25.4, 23.0 (2C), 10.9; HRMS for C<sub>21</sub>H<sub>20</sub>F<sub>2</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 443.1643, found 443.1648. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-yl</b><b>amino)-</b><b><i>N</i></b><b>-methoxybenzamide (31).</b> To a solution of acid <b>27</b> (0.20 g, 0.90 mmol), <i>N</i>-hydroxylbenzotriazole (24 mg, 0.018 mmol), and diisopropylethylamine (0.58 g, 4.5 mmol) in DMF (9 mL) was added benzotriazol-1-yl-<i>N</i>,<i>N</i>,<i>N</i>‘,<i>N</i>‘-tetramethyluronium tetrafluoroborate (0.29 g, 0.90 mmol) at room temperature. <i>N</i>-Hydroxylacetamidine was added to the reaction and the resulting mixture was stirred for 14 h. The reaction mixture was quenched with water (7 mL) and extracted with EtOAc (3 × 10 mL). The EtOAc layers were washed with 10% aqueous LiCl (2 × 5 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give the desired intermediate, which was used directly in the next step without further purification:  MS (ESI) <i>m</i>/<i>z</i> 278 (M + H)<sup>+</sup>. </div><div class="NLM_p">The above intermediate was dissolved in DMF (9 mL) and heated to 140 °C for 3 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (30 mL), and washed with 10% aqueous LiCl (3 × 50 mL). The organics were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and triturated with 10% <a name="jm004801204002" id="jm004801204002"></a> MeOH in Et<sub>2</sub>O to give <b>30</b> (0.13 g, 0.51 mmol, 57%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.59 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.79 (bs, 1 H), 8.25 (s, 1H), 7.92 (s, 1H), 4.18 (hep, 1H, <i>J</i> = 7.2 Hz), 2.50 (s, 3H), 1.37 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 260 (M + H)<sup>+</sup>. </div><div class="NLM_p">Intermediate <b>30</b> (65 mg, 0.25 mmol) was treated with POCl<sub>3</sub> (2 mL) at 120 °C for 6 h. The excess POCl<sub>3</sub> was removed under reduced pressure and the residue was coevaporated with toluene. The residue was then dissolved in MeCN (3 mL) and treated with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (51 mg, 0.25 mmol). The reaction mixture was stirred at room temperature for 18 h. The solvent was removed under reduced pressure and the residue was purified by preparative HPLC to afford <b>31 </b>(73 mg, 68%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.11 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.24 (s, 1H), 7.86−7.81 (m, 1H), 7.68 (s, 1H), 7.32 (t, 1H, <i>J</i> = 10.5 Hz), 4.11−4.07 (m, 1H), 3.78 (s, 3H), 2.40 (s, 3H), 1.47 (d, 6H, <i>J</i> = 6.6 Hz); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 171.8, 166.7, 159.8, 156.6 (dd, <i>J</i> = 250, 10 Hz), 154.5 (dd, <i>J</i> = 245, 10 Hz), 140.9, 138.7, 132.3, 131.5, 124.5, 122.1, 117.8, 115.3 (d, <i>J</i> = 15 Hz), 113.7, 105.2 (t, <i>J</i> = 28 Hz), 63.0, 24.4, 20.8 (2C), 11.0; HRMS for C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 444.1596, found 444.1590. </div><div class="NLM_p"><b>5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carbonitrile (32).</b> A mixture of acid <b>27</b> (0.39 g, 1.8 mmol), concentrated NH<sub>4</sub>OH (2 mL), EDCI (0.44 g, 2.3 mmol), and HOBt (0.26 g, 1.9 mmol) in DMF (8 mL) was stirred at room temperature for 4 h. The reaction mixture was diluted with water (10 mL) and extracted with EtOAc (3 × 20 mL). The EtOAc layer was dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated under reduced pressure, and triturated with diethyl ether to give 5-isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamide (0.36 g, 92%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.60 min (column A, purity 90%); MS (ESI) <i>m</i>/<i>z</i> 221 (M + H)<sup>+</sup>. </div><div class="NLM_p">The above amide (60 mg, 0.27 mmol) was dissolved in POCl<sub>3</sub> (1 mL), heated to 60 °C under N<sub>2</sub> for 1 h, and then cooled to room temperature. The POCl<sub>3</sub> was removed under reduced pressure and coevaporated with toluene. The residue was dissolved in EtOAc (5 mL) and washed with saturated aqueous NaHCO<sub>3</sub>. The organics were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and triturated with 10% MeOH in diethyl ether to afford compound <b>32</b> (50 mg, 88%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.45 min (column A, purity 90%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.56 (s, 1H), 7.23 (s, 1H), 4.21 (hep, 1H, <i>J</i> = 7.2 Hz), 1.31 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 201 (M − H)<sup>-</sup>. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-methyl-1,2,4-oxadiazol-3-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-yl</b><b>amino)-</b><b><i>N</i></b><b>-methoxybenzamide (34).</b> A mixture of compound <b>32</b> (70 mg, 0.35 mmol), hydroxylamine hydrochloride (37 mg, 1.0 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.23 g, 1.7 mmol) in EtOH (4 mL) was heated to reflux for 28 h and then cooled to room temperature. Water (4 mL) was added to the reaction and the mixture was extracted with EtOAc (3 × 10 mL). The combined EtOAc layers were washed with brine (1 × 10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to give <i>N</i>‘-hydroxy-5-isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-<i>f</i>][1,2,4]triazine-6-carboxamidine, which was used directly in the next step without further purification:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.38 min (column A, purity 90%); MS (ESI) <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>. </div><div class="NLM_p">The above amidine was dissolved in pyridine (2 mL) and treated with acetyl chloride (0.5 mL). The reaction mixture was heated to reflux for 7 h, cooled to room temperature, diluted with water (4 mL), and extracted with EtOAc (3 × 10 mL). The organic layers were washed with 1 N NaOH (1 × 5 mL) and 1 N HCl (2 × 5 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and purified by flash chromatography (SiO<sub>2</sub>, 5−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient elution) to give <b>33</b> (10 mg, 0.039 mmol, 11%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.25 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 1H), 7.91 (s, 1H), 4.11 (hep, 1H, <i>J</i> = 7.2 Hz), 2.47 (s, 3H), 1.37 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 260 (M + H)<sup>+</sup>.</div><div class="NLM_p">Compound <b>33</b> (10 mg, 0.039 mmol) was dissolved in POCl<sub>3</sub> (1 mL) and the resulting mixture was heated at 120 °C for 5 h. The excess POCl<sub>3</sub> was removed under reduced pressure and the residue was coevaporated with toluene. The residue was then dissolved in MeCN and treated with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (8.0 mg, 0.040 mmol) and the mixture was stirred at room temperature for 14 h. The solvent was removed under reduced pressure and the residue was purified by preparative HPLC to afford <b>34</b> (5.2 mg, 30%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.49 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1H), 7.88 (s, 1H), 7.58 (s, 1H), 7.48 (t, 1H, <i>J</i> = 10.4 Hz), 7.31 (m, 1H), 5.5 (bs, 1 H), 4.25 (hep, 1H, <i>J</i> = 7.2 Hz), 3.71 (s, 3H), 2.65 (s, 3H), 1.39 (d, 6H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 178.5, 163.4, 160.4, 155.0 (dd, <i>J</i> = 250, 10 Hz), 154.5 (dd, <i>J</i> = 245, 10 Hz), 140.9, 138.7, 132.3, 131.5, 123.0 (d, <i>J</i> = 10 Hz), 122.1, 117.8, 115.3 (d, <i>J</i> = 15 Hz), 113.7, 105.5 (t, <i>J</i> = 30 Hz), 63.0, 26.4, 22.3 (2C), 14.5; HRMS for C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 444.1596, found 444.1580. </div><div class="NLM_p"><b>5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazine-6-carbohydrazide (35).</b> A mixture of ester <b>5 </b>(20.0 g, 80.3 mmol), hydrazine (80 mL), and EtOH (20 mL) was heated to 90 °C for 4 h, cooled to room temperature, and concentrated under reduced pressure. The residue was triturated with 10% MeOH/Et<sub>2</sub>O to give <b>35</b> (17.9 g, 95%) as an off-white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 0.72 min (column A, purity 95%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (bs, 1H), 7.78 (s, 1H), 7.76 (s, 1H), 4.36−4.11 (bs, 3H), 4.08 (hep, 1H, <i>J</i> = 7.2 Hz), 1.30 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 236 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-yl</b><b>amino)-</b><b><i>N</i></b><b>-methoxybenzamide (37).</b><b>Representative Procedure for the Preparation of </b><b>Chloroimidate 36 and Subsequent Coupling to 5-Amino-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide. </b>A mixture of hydrazide <b>35</b> (0.10 g, 0.43 mmol) and the corresponding carboxylic acid (acetic acid, 0.2 mL) in POCl<sub>3</sub> (2 mL) was heated to 100 °C for 1 h and then at 120 °C for 3 h under N<sub>2</sub>. The reaction mixture was cooled to room temperature. The POCl<sub>3</sub> was removed under reduced pressure and coevaporated with toluene. The residue was dissolved in EtOAc (5 mL) and washed with cold saturated aqueous NaHCO<sub>3</sub>. The EtOAc layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and passed through a short silica gel pad to give 4-chloro-5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine (<b>36</b>), which was used directly in the next step without further purification. </div><div class="NLM_p">4-Chloro-5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolo[2,1-<i>f</i>][1,2,4]triazine (<b>36</b>, 33 mg, 0.11 mmol) was treated with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (24 mg, 0.12 mmol) in DMF (3 mL) and the mixture was stirred at 50 °C for 6 h. The solvent was removed in vacuo and the residue was purified by preparative HPLC to afford <b>37</b> (30 mg, 60%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.58 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.25 (s, 1H), 7.96−7.92 (m, 1H), 7.78 (s, 1H), 7.41 (t, 1H, <i>J</i> = 10.0 Hz), 4.08 (hep, 1H, <i>J</i> = 7.1 Hz), 3.85 (s, 3H), 2.65 (s, 3H), 1.54 (d, 6H, <i>J</i> = 7.1 Hz); HRMS for C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 444.1596, found 444.1599. </div><div class="NLM_p"><b>5-(6-(5-Ethyl-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-ylamino)-2,4-dif</b><b>luoro-</b><b><i>N</i></b><b>-methoxybenzamide (39):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.69 min (column A, purity 96%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.98 (s, 1H), 7.76−7.73 (m, 1H), 7.58 (s, 1H), 7.25 (t, 1H, <i>J</i> = 10.1 Hz), 4.24 (hep, 1H, <i>J</i> = 7.1 Hz), 3.85 (s, 3H), 3.00 (q, 2H, <i>J</i> = 7.5 Hz), 1.49 (d, 6H, <i>J</i> = 7.1 Hz), 1.44 (t, 3H, <i>J</i> = 7.5 Hz); HRMS for C<sub>21</sub>H<sub>21</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 458.1698, found 458.1699. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-isopropyl-1,3,4-oxadiazol-2-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4</b><b>-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (40):  </b>off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.76 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.26−9.21 (m, 2H), 8.07 (s, 1H), 8.06 (s, 1H), 7.53−7.51 (m, 1H), 7.06 (t, 1H, <i>J</i> = 10.3 Hz), 4.26−4.22 (m, 1H), 3.94 (s, 3H), 3.32−3.25 (m, 1H), 1.57 (d, 6H, <i>J</i> = 7.3 Hz), 1.46 (d, 6H, <i>J</i> = 7.1 Hz); HRMS for C<sub>22</sub>H<sub>23</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 472.1888, found 472.1890. </div><div class="NLM_p"><a name="jm004801204003" id="jm004801204003"></a><b>2,4-Difluoro-5-(6-(5-isobutyl-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-</b><b>ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (41):  </b>off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.87 min (column A, purity 95%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.95 (s, 1H), 7.74−7.72 (m, 1H), 7.57 (s, 1H), 7.24 (t, 1H, <i>J</i> = 10.1 Hz), 4.26−4.22 (m, 1H), 3.84 (s, 3H), 2.86 (d, 2H, <i>J</i> = 7.1 Hz), 2.28−2.21 (m, 1H), 1.49 (d, 6H, <i>J</i> = 7.1 Hz), 1.08 (d, 6H, <i>J</i> = 6.7 Hz); HRMS for C<sub>23</sub>H<sub>25</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 486.1202, found 486.1204. </div><div class="NLM_p"><b>5-(6-(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-ylamino)</b><b>-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide (42):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.57 min (column B, purity 98%); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27−9.22 (m, 2H), 8.03−8.01 (m, 2H), 7.58−7.50 (m, 1H), 7.05 (t, 1H, <i>J</i> = 10.1 Hz), 4.28−4.21 (m, 1H), 3.93 (s, 3H), 2.26−2.22 (m, 1H), 1.55 (d, 6H, <i>J</i> = 7.1 Hz), 1.24−1.18 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 167.8, 160.8, 160.5, 156.2 (dd, <i>J</i> = 250, 14 Hz), 155.7 (dd, <i>J</i> = 254, 14 Hz), 152.9, 147.5, 127.0, 123.7 (d, <i>J</i> = 41 Hz), 119.9 (2C), 115.6 (d, <i>J</i> = 15 Hz), 112.8, 109.0, 104.5 (dd, <i>J</i> = 30, 27 Hz), 64.8, 43.5, 25.9, 22.8, 8.6 (2C), 6.4; HRMS for C<sub>22</sub>H<sub>21</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 470.1752, found 470.1756. </div><div class="NLM_p"><b>5-(6-(5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-</b><b>ylamino)-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide</b><b>(43):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.50 min (column B, purity 98%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.31−9.26 (m, 1H), 9.13 (bs, 1H), 8.07−7.93 (m, 2H), 7.46 (bs, 1H), 6.97 (t, 1H, <i>J</i> = 10.2 Hz), 4.21−4.17 (m, 1H), 3.85 (s, 3H), 2.77 (d, 2H, <i>J</i> = 7.1 Hz), 1.49 (d, 6H, <i>J</i> = 7.1 Hz), 1.17−1.09 (m, 1H), 0.61−0.56 (m, 2H), 0.31−0.27 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.2, 161.5, 161.2, 160.1, 156.5 (dd, <i>J</i> = 250, 10 Hz), 154.5 (dd, <i>J</i> = 245, 10 Hz), 153.5, 147.5, 129.9, 127.0, 124.5 (d, <i>J</i> = 10 Hz), 119.9, 117.8, 116.3 (d, <i>J</i> = 15 Hz), 106.9, 105.1 (t, <i>J</i> = 30 Hz), 63.7, 29.5, 25.1, 22.5, 21.4, 8.5, 4.8 (2C); HRMS for C<sub>23</sub>H<sub>23</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 484.1908, found 484.1904. </div><div class="NLM_p"><b>5-(6-(5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-yla</b><b>mino)-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide (44):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.78 min (column B, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13 (s, 1H), 7.73−7.68 (m, 1H), 7.59 (s, 1H), 7.23 (t, 1H, <i>J</i> = 10.4 Hz), 7.13 (t, 1H, <i>J</i> = 50 Hz), 4.11−4.05 (m, 1H), 3.73 (s, 3H), 1.42 (d, 6H, <i>J</i> = 7.1 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.9, 160.7, 157.7, 155.8 (dd, <i>J</i> = 251, 14 Hz), 155.1 (dd, <i>J</i> = 251, 14 Hz), 141.4, 139.5, 131.9 (d, <i>J</i> = 15 Hz), 130.5, 124.6, 122.4, 118.6 (d, <i>J</i> = 15 Hz), 116.7, 107.0 (t, <i>J</i> = 238 Hz), 106.0 (t, <i>J</i> = 30 Hz), 105.5, 63.7, 25.2, 21.3, 21.1; HRMS for C<sub>20</sub>H<sub>17</sub>F<sub>4</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 480.1407, found 480.1410. Anal. (C<sub>20</sub>H<sub>17</sub>F<sub>4</sub>N<sub>7</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)-pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]</b><b>triazin-4-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (45):</b> off-white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.81 min (column B, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.09 (s, 1H), 7.71−7.67 (m, 1H), 7.56 (s, 1H), 7.24 (t, 1H, <i>J</i> = 10.1 Hz), 4.35 (hep, 1H, <i>J</i> = 7.2 Hz), 3.80 (s, 3H), 1.51 (d, 6H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.7, 160.5, 160.1, 156.0 (dd, <i>J</i> = 255, 17 Hz), 155.6 (dd, <i>J</i> = 255, 17 Hz), 153.5, 153.1, 143.3, 130.5, 122.8, 122.2, 118.6 (d, <i>J</i> = 20 Hz), 118.0 (q, <i>J</i> = 274 Hz), 116.7, 116.3, 106.0 (t, <i>J</i> = 28 Hz), 63.7, 25.3, 21.3 (2C); HRMS for C<sub>20</sub>H<sub>16</sub>F<sub>5</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 498.1313, found 498.1297. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-(2,2,2-trifluoroethyl)-1,3,4-oxadiazol-2-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2</b><b>,4]triazin-4-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (46):</b> pale yellow oil; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.71 min (column A, purity 99%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17−9.14 (m, 2H), 8.03−7.97 (m, 2H), 7.45 (bs, 1H), 7.00 (t, 1H, <i>J</i> = 10.3 Hz), 4.19−4.14 (m, 1H), 3.86 (s, 3H), 3.79 (q, 2H, <i>J</i> = 9.6 Hz), 1.50 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 512 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>5-(6-(5-((Dimethylamino)methyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazi</b><b>n-4-ylamino)-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide, Trifluoroacetic Acid Salt (48):  </b>pale yellow oil; Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.23 min (column A, purity 90%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (s, 1H), 7.72−7.48 (m, 2H), 7.22 (t, 1H, <i>J</i> = 10.3 Hz), 4.82 (s, 2H), 4.37−4.28 (m, 1H), 3.82 (s, 3H), 3.31 (s, 3H), 3.11 (s, 3H), 1.51 (d, 6H, <i>J</i> = 7.1 Hz); MS (ESI) <i>m</i>/<i>z</i> 487 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-(methylsulfonylmethyl)-1,3,4-oxadiazol-2-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][</b><b>1,2,4]triazin-4-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (49):</b> white solid; Anal. RP-HPLC <i>t</i><sub>R</sub> = 2.75 min (column B, purity 96%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (s, 1H), 7.73−7.66 (m, 1H), 7.52 (s, 1H), 7.16 (t, 1H, <i>J</i> = 10.0 Hz), 4.83 (s, 2H), 3.93 (hep, 1H, <i>J</i> = 7.0 Hz), 3.67 (s, 3H), 3.04 (s, 3H), 1.34 (d, 6H, <i>J</i> = 7.0 Hz); HRMS for C<sub>21</sub>H<sub>21</sub>F<sub>2</sub>N<sub>7</sub>O<sub>5</sub>S (M + H)<sup>+</sup> calcd 522.1371, found 522.1369. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(1,3,4-oxadiazol-2-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-ylamino)-</b><b><i>N</i></b><b>-methoxybenzamide (38).</b> A solution of hydrazide <b>35</b> (48 mg, 0.20 mmol) and triethyl orthoformate (0.2 mL) in EtOH (2 mL) was heated to 120 °C for 7 h. The reaction mixture was cooled to room temperature, and the volatiles were removed under reduced pressure. The residue was triturated with Et<sub>2</sub>O to give 5-isopropyl-6-(1,3,4-oxadiazol-2-yl)pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (10 mg, 0.041 mmol, 20%), which was used directly in the next step without further purification:  Anal. RP-HPLC <i>t</i><sub>R</sub> 1.23 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (bs, 1H), 8.15 (s, 1H), 8.04 (s, 1H), 7.92 (s, 1H), 4.18 (hep, 1H, <i>J</i> = 7.2 Hz), 2.50 (s, 3H), 1.37 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 246 (M + H)<sup>+</sup>. </div><div class="NLM_p">The 5-isopropyl-6-(1,3,4-oxadiazol-2-yl)pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (10 mg, 0.041 mmol) was dissolved in POCl<sub>3</sub> (1 mL) and the reaction mixture was stirred at 120 °C for 5 h. The excess POCl<sub>3</sub> was removed under reduced pressure and the residue was coevaporated with toluene. The residue was dissolved in MeCN and treated with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (8.3 mg, 0.041 mmol). The reaction mixture was stirred at room temperature for 19 h, the solvent was removed under reduced pressure, and the residue was purified by preparative HPLC to afford <b>38</b> (9.8 mg, 56%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.43 min (column A, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.00 (s, 1H), 8.01 (s, 1H), 7.71−7.67 (m, 1H), 7.57 (s, 1H), 7.25 (t, 1H, <i>J</i> = 10.1 Hz), 4.33−4.27 (m, 1H), 3.85 (s, 3H), 1.50 (d, 6H, <i>J</i> = 7.1 Hz); HRMS for C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 430.1394, found 430.1399. </div><div class="NLM_p"><b>5-(6-(5-(Dimethylamino)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-yla</b><b>mino)-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide (47).</b> A solution of hydrazide <b>35</b> (92 mg, 0.39 mmol) and phosgene iminium chloride (76 mg, 0.47 mmol) in MeCN was heated to 80 °C for 6 h. The reaction mixture was cooled to room temperature and diluted with water (4 mL). The precipitate that formed after 5 min of stirring was filtered, washed with water, and dried overnight to give 6-(5-(dimethylamino)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-<i>f</i>][1,2,4]-triazin-4(3<i>H</i>)-one (91 mg, 0.32 mmol, 82%) as a colorless oil:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.35 min (column A, purity 97%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.79 (s, 1H), 7.48 (s, 1H), 3.92 (hep, 1H, <i>J</i> = 7.2 Hz), 3.07 (s, 3H), 3.05 (s, 3H), 1.27 (d, 6H, <i>J</i> = 7.2 Hz); MS (ESI) <i>m</i>/<i>z</i> 289 (M + H)<sup>+</sup>. </div><div class="NLM_p">A mixture of 6-(5-(dimethylamino)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-4(3<i>H</i>)-one (91 mg, 0.32 mmol) in POCl<sub>3</sub> (3 mL) was heated to 120 °C for 5 h. The excess POCl<sub>3</sub> was removed under reduced pressure and the residue was coevaporated with toluene. The residue was dissolved in MeCN (5 mL) and treated with 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide (63 mg, 0.31 mmol). The reaction mixture was stirred at room temperature for 16 h, the solvent was removed under reduced pressure, and the residue was purified by preparative HPLC to afford <b>47</b> (81 mg, 55%) as an off white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.50 min (column A, purity 99%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.78 (s, 1H), 7.59−7.55 (m, 1H), 7.39 (m, 1H), 7.07 (t, 1H, <i>J</i> = 10.1 Hz), 4.09−4.01 (m, 1H), 3.68 (s, 3H), 3.06 (s, 6H), 1.32 (d, 6H, <i>J</i> = 7.1 Hz); HRMS for C<sub>21</sub>H<sub>22</sub>F<sub>2</sub>N<sub>8</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 473.1805, found 473.1810. </div><div class="NLM_p"><b>5-(6-(5-(Difluoro(methylsulfonyl)methyl)-1,3,4-oxadiazol-2-yl)-5-isopropylpyrrolo[2,1-</b><b><i>f</i></b><b>][1,2</b><b>,4]triazin-4-ylamino)-2,4-difluoro-</b><b><i>N</i></b><b>-methoxybenzamide (50).</b> To a solution of <b>49</b> (0.89 g, 1.7 mmol) in THF (100 mL) at −78 °C was slowly added 1 N lithium bis(trimethylsilyl)amide in THF (6.9 mL, <a name="jm004801204004" id="jm004801204004"></a> 6.9 mmol). The reaction mixture was stirred for 10 min at −78 °C and then warmed to −40 °C. A solution of <i>N</i>-fluorobenzene sulfonamide (1.4 g, 4.3 mmol) in THF (10 mL) was added dropwise to the reaction mixture and the resulting solution was stirred for 1 h at −30 to −40 °C. The reaction was quenched by the addition of cold saturated aqueous NH<sub>4</sub>Cl solution (100 mL), and the mixture was extracted with EtOAc (3 × 100 mL). The EtOAc portions were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo, and the residue was purified by flash chromatography (SiO<sub>2</sub>, 0−2% MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient elution) to give <b>50</b> (0.63 g, 65%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.33 min (column B, purity 97%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.09−9.03 (m, 2H), 8.04 (s, 1H), 7.93 (s, 1H), 7.50 (bs, 1H), 6.91 (t, 1H, <i>J</i> = 10.3 Hz), 4.08−4.01 (m, 1H), 3.78 (s, 3H), 3.16 (s, 3H), 1.43 (d, 6H, <i>J</i> = 7.0 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> with one drop CD<sub>3</sub>OD) δ 164.4, 161.2, 155.6 (dd, <i>J</i> = 256, 14 Hz), 154.9 (dd, <i>J</i> = 256, 14 Hz), 153.2 (t, <i>J</i> = 30 Hz), 133.0, 127.5, 126.0 (2C), 121.5, 116.2, 116.1, 113.8 (t, <i>J</i> = 288 Hz), 105.4, 104.6 (t, <i>J</i> = 28 Hz), 63.6, 35.3, 25.5, 21.0 (2C); HRMS for C<sub>21</sub>H<sub>19</sub>F<sub>4</sub>N<sub>7</sub>O<sub>5</sub>S (M + H)<sup>+</sup> calcd 558.1165, found 558.1163. Anal. (C<sub>21</sub>H<sub>19</sub>F<sub>4</sub>N<sub>7</sub>O<sub>5</sub>S) C, H, N. </div><div class="NLM_p"><b>2,4-Difluoro-5-(5-isopropyl-6-(5-methyl-4</b><b><i>H</i></b><b>-1,2,4-triazol-3-yl)pyrrolo[2,1-</b><b><i>f</i></b><b>][1,2,4]triazin-4-y</b><b>lamino)-</b><b><i>N</i></b><b>-methoxybenzamide, Hydrochloride Salt (52).</b> A mixture of <b>35</b> (24 mg, 0.10 mmol) and acetamidine hydrochloride (14 mg, 0.15 mmol) in DMF (1 mL) was heated at 120 °C for 1 h. The reaction mixture was diluted with MeOH and purified by preparative HPLC to give <b>51</b> (22 mg, 0.086 mmol, 86%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 1.71 min (column B, purity 97%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (s, 1H), 7.90 (s, 1H), 4.21 (hep, 1H, <i>J</i> = 7.2 Hz), 2.40 (s, 3H), 1.35 (d, 6H, <i>J</i> = 7.1 Hz); MS (ESI) <i>m</i>/<i>z</i> 259 (M + H)<sup>+</sup>. </div><div class="NLM_p">The triazole <b>51 </b>(22 mg, 0.086 mmol) was treated with POCl<sub>3</sub> (1 mL) and the reaction mixture was stirred at 120 °C for 5 h. The excess POCl<sub>3</sub> was removed under reduced pressure and the residue was coevaporated with toluene. The residue was dissolved in 2-propanol and stirred with <i>N</i>-methoxyl-5-amino-2,4-difluorobenzamide (20 mg, 0.10 mmol) at 50 °C for 1 h. The solvent was removed in vacuo and the residue was purified by preparative HPLC. The product was converted to the hydrochloride salt by treatment with aqueous 1 N HCl followed by lyophilization to afford <b>52</b> (27 mg, 71%) as a white solid:  Anal. RP-HPLC <i>t</i><sub>R</sub> = 3.17 min (column B, purity 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.88 (s, 1H), 7.69−7.63 (m, 1H), 7.56 (s, 1H), 7.22 (t, 1H, <i>J</i> = 10.2 Hz), 4.10 (hep, 1H, <i>J</i> = 7.2 Hz), 3.82 (s, 3H), 2.74 (s, 3H), 1.43 (d, 6H, <i>J</i> = 7.2 Hz); HRMS for C<sub>20</sub>H<sub>20</sub>F<sub>2</sub>N<sub>8</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd 443.1742, found 443.1748. </div><div class="NLM_p"><b>In Vitro Kinase Assays.</b> The enzyme inhibition studies were carried out as previously described.<sup>23</sup> Recombinant proteins containing either the cytoplasmic domains of the human receptor tyrosine kinases (VEGFR-2, Flk-1, FGFR-1, PDGFR-β, IGF-1R, HER-1, HER-2) or the entire protein sequence for the serine/threonine kinases (PKC and CDK2) were expressed as n-terminal glutathione <i>S</i>-transferase (GST) fusion proteins using the baculovirus expression vector system in Sf9 cells. The resultant proteins were isolated by affinity chromatography using glutathione-Sepharose (Pharmacia Biotech). All enzymes were stored at −80 °C. The kinase assays were performed in 96-well microtiter plates using the synthetic polymer poly(Glu<sub>4</sub>/Tyr) (Sigma Chemicals) as a phosphoacceptor substrate. TCA precipitates were collected onto GF/C unifilter plates (Packard Instrument Co., Meriden, CT) using a Filtermate universal harvester (Packard Instrument Co.), and the filters were quantitated using a TopCount 96-well liquid scintillation counter (Perkin-Elmer Life Sciences). Procedures for assessing activity of the representative nonreceptor tyrosine kinase Lck and the serine-threonine kinases PKCα and CDK2 have been previously described.<sup>34,35</sup></div><div class="NLM_p">For the VEGFR-2, Flk-1, FGFR-1, and PDGFR-β kinase assays, compounds were dissolved in DMSO and diluted with water/10% DMSO to a final DMSO concentration of 2%. The VEGFR-2 kinase reactions consisted of 8 ng of GST-VEGFR-2 enzyme, 75 μg/mL substrate, 1 μM ATP, and 0.04 μCi [γ-<sup>33</sup>P]ATP in 50 μL total reaction volume (kinase buffer:  20 mM Tris, pH 7.0, 25 μg/mL BSA, 1.5 mM MnCl<sub>2</sub>, 0.5 mM dithiothreitol). The Flk-1 kinase reactions consisted of 10 ng of GST-Flk-1 enzyme, 75 μg/mL substrate, 1 μM ATP, and 0.04 μCi [γ-<sup>33</sup>P]ATP in 50 μL total reaction volume (kinase buffer:  20 mM Tris, pH 7.0, 25 μg/mL BSA, 4 mM MnCl<sub>2</sub>, 0.5 mM dithiothreitol). The FGFR-1 kinase reactions consisted of 10 ng of GST-FGFR-1 enzyme, 75 μg/mL substrate, 1 μM ATP, and 0.04 μCi [γ-<sup>33</sup>P]ATP in 50 μL total reaction volume (kinase buffer:  20 mM Tris, pH 7.0, 25 μg/mL BSA, 0.5 mM MnCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, and 0.5 mM dithiothreitol). The PDGFR-β kinase reactions consisted of 10 ng GST-PDGFR-β enzyme, 180 μg/mL substrate, 1 μM ATP, and 0.04 μCi [γ-<sup>33</sup>P]ATP in 50 μL total reaction volume (kinase buffer:  16 mM HEPES, pH 7.0, 80 μg/mL BSA, 4 mM MnCl<sub>2</sub>, 120 mM NaCl, and 0.5 mM dithiothreitol). In all cases, the reactions were incubated for 60 min at 27 °C and terminated with the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. </div><div class="NLM_p">For the IGF-1R kinase assay, reactions consisted of 125 ng of GST-IGF-1R enzyme, 25 ng substrate, and 25 μM of [γ-<sup>33</sup>P]ATP in a final reaction volume of 50 μL (kinase buffer:  20 mM MOPS, pH 7.0, 0.1 mg/mL BSA, 5 mM MnCl<sub>2</sub>, and 0.1 mM dithiothreitol). The reactions were incubated at 27 °C for 60 min. </div><div class="NLM_p">For HER-2, the entire cytoplasmic sequence was expressed without an affinity tag. The protein was partially purified by ion-exchange chromatography on DEAE-Sepharose (Pharmacia Biotech) and was eluted with a buffer containing 0.3 M NaCl. For both the HER-1 and HER-2 kinase assays, the reactions consisted of 10 ng of GST-HER-1 or 150 ng of partially purified HER-2 enzyme, 1.5 μM substrate, 1 μM ATP, and 0.15 μCi [γ-<sup>33</sup>P]ATP in a total reaction volume of 50 μL (kinase buffer:  50 mM Tris-HCl pH 7.7, 0.1 mg/mL BSA, 10 mM MnCl<sub>2</sub>, and 2 mM dithiothreitol). The reactions were incubated at 27 °C for 60 min and terminated by the addition of 10 μL of stop buffer (2.5 mg/mL BSA and 0.3 M EDTA), followed by 108 μL of a mixture of 3.5 mM ATP and 5% TCA. The percent inhibition from the kinase assays was determined by nonlinear regression analyses, and data were reported as the inhibitory concentration required to achieve 50% inhibition relative to control reactions (IC<sub>50</sub>). </div><div class="NLM_p">The apparent <i>K</i><i><sub>i</sub></i> value for <b>50</b> was determined by global fitting of background-corrected cpm data to a competitive model versus ATP using GraFit software, version 5 (Erithacus Software Ltd). </div><div class="NLM_p"><b>Cellular Proliferation Assays.</b> Primary human umbilical vein endothelial cells (HUVECs) were purchased from Clonetics (catalog # CC-2519) and not used beyond passage 3 for the mitogen-stimulated proliferation assays as previously described.<sup>23</sup> The concentrations of VEGF (Peprotech) and FGF (Clonetics) used in the mitogen-stimulated HUVEC assays were 8 and 80 ng/mL, respectively. The L2987 human lung carcinoma cells were not used beyond passage 20 for serum-stimulated proliferation assays. For compound assessment, cells were grown in 100 μL of minimal growth medium (Cellgro catalog # 10−040-CV) and 1.0% heat-inactivated fetal bovine serum (Cellgro catalog # 10−040-CV) in 96-well collagen IV coated plates (Bectin-Dickinson, catalog # 354429) at a density of 2 × 10<sup>3</sup> per well in a 37 °C/5% CO<sub>2</sub> environment. Twenty-four hours later, serum was adjusted to 10%, and test compounds at various dilutions were added to each well in a final volume of minimal growth media that contains 10% serum. Forty-eight hours later, 0.5 μCi of [<sup>3</sup>H]thymidine (Amersham catalog # TRK120) was added in a volume of 20 μL of minimal media for 24 h. Plates were washed once in PBS. Upon removal of PBS, Trypsin (Cellgro catalog numbers 21-031-CV and 25-054-CI, respectively) was added to cells which were subsequently harvested onto glass-fiber filters (Perkin-Elmer-Life-Sciences catalog # 1450−525) using an automated harvestor (Brandel Model# MWX RI-192TI). Incorporated tritium was quantified using a β-counter (Wallac Microbeta). Dose−response curves were generated to determine the IC<sub>50</sub> value, which is defined as the concentration of drug required to inhibit 50% of tritium incorporation when compared to untreated serum-stimulated cells. </div><div class="NLM_p"><a name="jm004801204005" id="jm004801204005"></a><b>Metabolic Stability. </b>The compound was incubated with human liver microsomes purchased from In Vitro Technologies (Baltimore, MD) and pooled from 10 individual donors. The rates of oxidative metabolism were measured under the following conditions:  compound (substrate) at 3 or 10 μM final concentration, final microsomal protein concentration of approximately 1 mg/mL, 1 mM NADPH, and 56 mM of pH 7.4 potassium phosphate buffer. Incubations were performed at 37 °C and were initiated by the addition of the substrate. Incubations were quenched by the addition of one volume of acetonitrile after 10 min. Samples were then analyzed for the parent compound by LC−MS. The rate of metabolism was calculated by determining the nanomoles of parent compound oxidized and dividing it by the time of incubation and the milligrams of protein. </div><div class="NLM_p"><b>Cytochrome P450 Assay.</b> The ability of compounds to inhibit the major human cytochrome P450s (CYPs) responsible for drug metabolism was evaluated in vitro using recombinant human CYP isoforms. The inhibition of cDNA-derived CYP enzymes prepared from baculovirus-infected insect cells was measured using either 3-cyano-7-ethoxycoumarin (CYP1A2, CYP2C19), 7-methoxy-4-trifluoromethylcoumarin (CYP2C9), or 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin (CYP2D6) as the substrates. CYP3A4 inhibition was evaluated with two substrates:  7-benzyloxy-4-trifluoromethylcoumarin (BFC) and resorufin benzyl ether (BzRes). A single concentration of each model substrate (at approximately the apparent <i>K</i><sub>m</sub>, with the exception of BFC, which was tested below the apparent <i>K</i><sub>m</sub>) and multiple concentrations of the test compounds, separated by approximately 1/2 log units, were tested in duplicate. Metabolism of the model substrates was assayed by the production of 7-hydroxy-3-cyanocoumarin, 3-[2-(<i>N</i>,<i>N</i>-diethylamino)ethyl]-7-hydroxy-4-methylcoumarin, 7-hydroxy-4-trifluoromethylcoumarin, or resorufin and measured via fluorescence detection. Assays were conducted in 96-well microtiter plates in the presence of an NADPH-generating system. Positive control samples were included in these studies. The positive control values were within the historical range for all the assays. The IC<sub>50</sub> values were calculated utilizing XLfit curve-fitting software. </div><div class="NLM_p"><b>Pharmacokinetic Parameters Obtained in Mice.</b> In these 4 h oral exposure studies, a single-dose of 50 mg/kg of compounds <b>24</b><b>−</b><b>26</b>, <b>37</b>, <b>44</b>, <b>49</b>, and <b>50</b> (10 mg/kg) was delivered as a solution in 70% PEG400/10% ethanol/20% water by oral gavage to fasted adult male Balb/C mice (<i>n </i>= 3 per compound). Three serum samples were collected from each mouse at 0.5, 1, and 4 h time points following oral dosing. The first two samples were obtained by retro-orbital bleed (∼100 μL/ 20−25 g mouse) and the third sample by cardiac puncture. The blood samples were allowed to clot on ice and centrifuged and then the serum was harvested. Plasma samples were stored at −20 °C prior to analysis. The plasma samples were analyzed for parent compound via HPLC-coupled tandem mass spectrometry (LC−MS/MS). </div><div class="NLM_p">To evaluate the oral bioavailability of compound <b>50</b> in male Balb/C mice, a single dose was delivered as a solution in 30% PEG 400/10% ethanol/60% water by either tail vein injection (iv, 5 mg/kg) or by oral gavage (po, 10 mg/kg). The mice were fasted overnight prior to dosing and fed 4 h post dose. A total of 18 mice were used in the study (<i>n </i>= 9 each for iv and po groups). Three serum samples were collected from each mouse, the first two samples by retro-orbital bleed (∼100 μL/ 20−25 g mouse) and the third sample by cardiac puncture. Blood samples were collected at 0.5, 0.5, 1, 3, 6, 8, 10, 12, and 24 h time points following iv dosing and at 0.25, 0.5, 1, 3, 6, 8, 10, 12, and 24 h following oral dosing. Blood samples were allowed to clot on ice and centrifuged, and then serum was harvested. Plasma samples were stored at −20 °C until analysis. Concentrations of parent compound were later determined by LC−MS/MS. Composite serum concentration−time profiles were constructed for pharmacokinetic analysis. </div><div class="NLM_p"><b>Serum Protein Binding of Compound 50. </b>The extent of protein binding of compound <b>50</b> was determined in mouse and human sera using the equilibrium dialysis method. All experiments were carried out using pooled serum (<i>n</i> = 10 for mice, <i>n</i> = 3 for human) obtained from Bioreclamation Inc. (Hicksville, NY). Compound <b>50</b> (1 mM) in acetonitrile was added to serum at a ratio of 1:100 to give a final concentration of 10 μM. Serum samples were dialyzed against 134 mM phosphate buffer (pH 7.4). The Micro-Equilibrium Dialyzer (500 μL chamber volume, Amika Corp., Holliston, MA) containing spiked serum was incubated in a shaking water bath maintained at 37 °C for 4 h. A 10 000 molecular weight cutoff dialysis membrane (Amika Corp., Holliston, MA) was used. All experiments were carried out in triplicate. Aliquots of buffer and serum were taken at 4 h, and analyzed by LC−MS/MS. Compound <b>50</b> was stable under these conditions over the 4 h incubation period in mouse and human serum. </div><div class="NLM_p">From each dialysis cell, the free and bound drug percentages were calculated as follows:<a class="ref internalNav" href="#jm0501275e00001" aria-label=""></a><span class="NLM_disp-formula" id="jm0501275e00001"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275e00001.gif" alt="" id="_i28" /></img></span></div><div class="NLM_p"><b>In Vivo Antitumor Activity in the Subcutaneously Implanted L2987 Xenograft Model in </b><b>Nude Mice. </b>Female Balb/C athymic (nu+/nu+) mice, 6−8 weeks old, were obtained from Sprague−Dawley Co. (Indianapolis, IN). Animals were provided with food and water ad libitum and housed five per cage. Mice were maintained in accordance with Bristol-Myers Squibb's Institutional Animal Care and Use Committee in accordance with the American Association for Accreditation of Laboratory Animal Care (AAALAC) guidelines for the humane treatment and care of laboratory mice. </div><div class="NLM_p">L2987 tumor fragments<sup><a onclick="showRef(event, 'jm0501275b00042'); return false;" href="javascript:void(0);" class="ref jm0501275b00042">42</a></sup> maintained by serial passage in vivo were implanted subcutaneously in the hind flank using an 18 g trocar. Approximately 2 weeks postimplant, when tumor sizes reached 100−150 mm<sup>3</sup>, oral dosing was initiated using gavage needles with either compound at the indicated concentrations or vehicle (7:1:2 PEG400/EtOH/H<sub>2</sub>O) in the control group. Tumor growth was assessed twice weekly by vernier caliper measurement. Group sizes were <i>n</i> = 8 or 9. </div><div class="NLM_p last">Treatments resulting in greater than 20% lethality and/or 20% body weight loss were considered toxic. Antitumor activity was determined by calculating the maximum percent tumor growth inhibition (TGI) of treated animals at the indicated time points using the formula<a class="ref internalNav" href="#jm0501275e00003" aria-label=""></a><span class="NLM_disp-formula" id="jm0501275e00003"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275e00003.gif" alt="" id="_i29" /></img></span> where <i>C</i><i><sub>t</sub></i> = the median tumor volume (mm<sup>3</sup>) of vehicle-treated control (C) mice at time t. <i>T</i><i><sub>t</sub></i> = median tumor volume of treated (T) mice at time <i>t</i>. <i>C</i><sub>0</sub> is the median tumor volume of control mice at time 0. Activity is defined as a continuous %TGI > 50% for at least one tumor volume doubling time after the start of drug treatment. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0501275/suppl_file/jm0501275si20050404_014025.pdf">jm0501275si20050404_014025.pdf (63.18 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm0501275" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoping Zheng</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ligang Qian</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Ellis</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen-wei Cai</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barri S. Wautlet</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Mortillo</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Jeyaseelan,</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Kukral</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aberra Fura</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amrita Kamath</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viral Vyas</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John S. Tokarski</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Hunt</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis J. Lombardo</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Fargnoli</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajeev S. Bhide</span> - <span class="hlFld-Affiliation affiliation">Departments of Oncology Chemistry, Discovery Biology, Metabolism and Pharmacokinetics, and Structural Biology and Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors wish to thank John Hynes for his seminal contributions on the hydroxamate-based pyrrolo[2,1-<i>f</i>][1,2,4]triazines; Amy Camuso, Steven Dzwonczyk, Kurt Gregor, Stephanie Kut, Aixin Li, and Chiang Yu for conducting the kinase selectivity assays; Hilary Gray for protein expression and purification; Mark Witmer for assistance with the enzyme kinetics; Victor Cardenas for informatics support; Brian Fink for helpful discussions; and the Discovery Analytical Sciences Department for obtaining high-resolution MS analyses. </p></div><div class="refs-header-label"><a name="jm004801204006" id="jm004801204006"></a></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="jm0501275b00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm0501275b00001_1"><span><span class="NLM_string-ref">(a) Folkman, J.; Shing, Y. Angiogenesis. <i>  J. Biol. Chem.</i><b>1992</b>, <i>267</i>, 10931−10934.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Folkman%2C+J.%3B+Shing%2C+Y.+Angiogenesis.+J.+Biol.+Chem.+1992%2C+267%2C+10931%E2%88%9210934.+%28a%29+Folkman%2C+J.%3B+Shing%2C+Y.+Angiogenesis.+J.+Biol.+Chem.1992%2C+267%2C+10931%E2%88%9210934."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00001_2"><span><span class="NLM_string-ref">(b) Griffioen, A. W.; Molema, G. Angiogenesis:  Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. <i>  Pharmacol. Rev.</i><b>2000</b>, <i>52</i>, 237−268.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=268&author=A.+W.+Griffioen&author=G.+Molema&author=+Angiogenesis&title=Potentials+for+pharmacologic+intervention+in+the+treatment+of+cancer%2C+cardiovascular+diseases%2C+and+chronic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00001_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26atitle%3DPotentials%2520for%2520pharmacologic%2520intervention%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520cardiovascular%2520diseases%252C%2520and%2520chronic%2520inflammation%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm0501275b00002_1"><span><span class="NLM_string-ref">Folkman, J.; Klagsbrun, M. Angiogenic factors. <i>  Science</i><b>1987</b>, <i>235</i>, 442−447.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=447&author=J.+Folkman&author=M+Klagsbrun&title=Angiogenic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenic%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm0501275b00003_1"><span><span class="NLM_string-ref">(a) Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. <i>  Nat. Med.</i><b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00003_2"><span><span class="NLM_string-ref">(b) Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. <i>  Nature</i><b>2000</b>, <i>407</i>, 249−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=257&author=P.+Carmeliet&author=R.+K+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00003_3"><span><span class="NLM_string-ref">(c) Folkman, J. Angiogenesis-dependent diseases. <i>  Semin. Oncol.</i><b>2001</b>, <i>28</i>, 536−542.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=542&author=J+Folkman&title=Angiogenesis-dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis-dependent%2520diseases%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00003_4"><span><span class="NLM_string-ref">(d) Fan, T.-P. D.; Jaggar, R.; Bicknell, R. Controlling the vasculature:  Angiogenesis, anti-angiogenesis and vascular targeting gene therapy. <i>  Trends Pharm. Sci.</i><b>1995</b>, <i>16</i>, 57−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=66&author=T.-P.+D.+Fan&author=R.+Jaggar&author=R+Bicknell&title=Controlling+the+vasculature%3A%E2%80%89+Angiogenesis%2C+anti-angiogenesis+and+vascular+targeting+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.-P.%2BD.%26atitle%3DControlling%2520the%2520vasculature%253A%25E2%2580%2589%2520Angiogenesis%252C%2520anti-angiogenesis%2520and%2520vascular%2520targeting%2520gene%2520therapy%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm0501275b00004_1"><span><span class="NLM_string-ref">(a) Koch, A. E. Angiogenesis as a target in rheumatoid arthritis. <i>  Ann. </i><i>Rheum. Dis.</i><b>2003</b>, <i>62</i>, ii60-ii67.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=i60&author=A.+E+Koch&title=Angiogenesis+as+a+target+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE%26atitle%3DAngiogenesis%2520as%2520a%2520target%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2003%26volume%3D62%26spage%3Di60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00004_2"><span><span class="NLM_string-ref">(b) Walsh, D. A. Angiogenesis and arthritis. <i>  Rheumatol.</i><b>1999</b>, <i>38</i>, 103−112.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=112&author=D.+A+Walsh&title=Angiogenesis+and+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA%26atitle%3DAngiogenesis%2520and%2520arthritis%26jtitle%3DRheumatol.%26date%3D1999%26volume%3D38%26spage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00004_3"><span><span class="NLM_string-ref">(c) Koch, A. E. Angiogenesis:  Implications for rheumatoid arthritis. <i>  Arthritis Rheum.</i><b>1998</b>, <i>41</i>, 951−962.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=962&author=A.+E.+Koch&author=+Angiogenesis&title=Implications+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE.%26atitle%3DImplications%2520for%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1998%26volume%3D41%26spage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm0501275b00005_1"><span><span class="NLM_string-ref">(a) Folkman, J. Anti-angiogenesis:  New concept for therapy of solid tumors. <i>  Ann. Surg.</i><b>1972</b>, <i>175</i>, 409−416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1972&pages=416&author=J.+Folkman&author=+Anti&title=New+concept+for+therapy+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DNew%2520concept%2520for%2520therapy%2520of%2520solid%2520tumors%26jtitle%3DAnn.%2520Surg.%26date%3D1972%26volume%3D175%26spage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00005_2"><span><span class="NLM_string-ref">(b) Folkman, J. What is the evidence that tumors are angiogenesis dependent? <i>J. Natl. Cancer Inst.</i><b>1990</b>, <i>83</i>, 4−6.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1990&pages=6&author=J+Folkman&title=What+is+the+evidence+that+tumors+are+angiogenesis+dependent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DWhat%2520is%2520the%2520evidence%2520that%2520tumors%2520are%2520angiogenesis%2520dependent%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D83%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm0501275b00006_1"><span><span class="NLM_string-ref">(a) Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. <i>  J. Biol. Chem.</i><b>1996</b>, <i>271</i>, 603−606.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=606&author=K.+A+Thomas&title=Vascular+endothelial+growth+factor%2C+a+potent+and+selective+angiogenic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DK.%2BA%26atitle%3DVascular%2520endothelial%2520growth%2520factor%252C%2520a%2520potent%2520and%2520selective%2520angiogenic%2520agent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00006_2"><span><span class="NLM_string-ref">(b) Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. <i>  Endocr. Rev.</i><b>1997</b>, <i>18</i>, 4−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=25&author=N.+Ferrara&author=T+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00006_3"><span><span class="NLM_string-ref">(c) Ferrara, N. VEGF:  An update on biological and therapeutic aspects. <i>  Curr. Opin. Biotech</i>. <b>2000</b>, <i>11</i>, 617−624.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=624&author=N.+Ferrara&title=An+update+on+biological+and+therapeutic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DAn%2520update%2520on%2520biological%2520and%2520therapeutic%2520aspects%26jtitle%3DCurr.%2520Opin.%2520Biotech.%26date%3D2000%26volume%3D11%26spage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm0501275b00007_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapySuccesses and failures. <i>  Exp. Opin. Ther. Targets</i><b>2003</b>, <i>7</i>, 215−234.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=234&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapySuccesses+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapySuccesses%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26spage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm0501275b00008_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discov. Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm0501275b00009_1"><span><span class="NLM_string-ref">(a) Caponigro, F. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. <i>  Anti-Cancer Drugs</i><b>2004</b>, <i>15</i>, 311−320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=320&author=F+Caponigro&title=Rationale+and+clinical+validation+of+epidermal+growth+factor+receptor+as+a+target+in+the+treatment+of+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaponigro%26aufirst%3DF%26atitle%3DRationale%2520and%2520clinical%2520validation%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520as%2520a%2520target%2520in%2520the%2520treatment%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00009_2"><span><span class="NLM_string-ref">(b) Tiseo, M.; Loprevite, M.; Ardizzoni, A. Epidermal growth factor receptor inhibitors:  A new prospective in the treatment of lung cancer. <i>  Curr. Med. Chem.:  Anti-Cancer </i><i>Agents</i><b>2004</b>, <i>4</i>, 139−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Tiseo&author=M.+Loprevite&author=A.+Ardizzoni&title=Epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+A+new+prospective+in+the+treatment+of+lung+cancer.+Curr.+Med.+Chem.%3A%E2%80%89+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00009_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTiseo%26aufirst%3DM.%26btitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520A%2520new%2520prospective%2520in%2520the%2520treatment%2520of%2520lung%2520cancer.%2520Curr.%2520Med.%2520Chem.%253A%25E2%2580%2589%2520Anti-Cancer%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00010"><div class="reference"><div class="NLM_citation" id="jm0501275b00010_1"><span><span class="NLM_string-ref">(a) Zondor, S. D.; Medina, P. J. Bevacizumab:  An angiogenesis inhibitor with efficacy in colorectal and other malignancies. <i>  Annals of </i><i>Pharmacotherapy</i><b>2004</b>, <i>38</i>, 1258−1264.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=1264&author=S.+D.+Zondor&author=P.+J.+Medina&author=+Bevacizumab&title=An+angiogenesis+inhibitor+with+efficacy+in+colorectal+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZondor%26aufirst%3DS.%2BD.%26atitle%3DAn%2520angiogenesis%2520inhibitor%2520with%2520efficacy%2520in%2520colorectal%2520and%2520other%2520malignancies%26jtitle%3DAnnals%2520of%2520Pharmacotherapy%26date%3D2004%26volume%3D38%26spage%3D1264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00010_2"><span><span class="NLM_string-ref">(b) Ferrara, N.; Hillan, K. J.; Gerber, H.-P.; Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. <i>  Nat. Rev. Drug Disc</i>. <b>2004</b>, <i>3</i>, 391−400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=400&author=N.+Ferrara&author=K.+J.+Hillan&author=H.-P.+Gerber&author=W+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Disc.%26date%3D2004%26volume%3D3%26spage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00010_3"><span><span class="NLM_string-ref">(c) Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. <i>  New Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2335−2342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2342&author=H.+Hurwitz&author=L.+Fehrenbacher&author=W.+Novotny&author=T.+Cartwright&author=J.+Hainsworth&author=W.+Heim&author=J.+Berlin&author=A.+Baron&author=S.+Griffing&author=E.+Holmgren&author=N.+Ferrara&author=G.+Fyfe&author=B.+Rogers&author=R.+Ross&author=F+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm0501275b00011_1"><span><span class="NLM_string-ref">(a) Underiner, T. L.; Ruggeri, B.; Gingrich, D. E. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. <i>  Curr. Med. Chem. </i><b>2004</b>, <i>11</i>, 731−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=745&author=T.+L.+Underiner&author=B.+Ruggeri&author=D.+E+Gingrich&title=Development+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+kinase+inhibitors+as+anti-angiogenic+agents+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00011_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Fraley, M. E.; Hartman, G. D. Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents. <i>  Exp. Opin. Invest. Drugs </i><b>2002</b>, <i>11</i>, 737−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=745&author=M.+T.+Bilodeau&author=M.+E.+Fraley&author=G.+D+Hartman&title=Kinase+insert+domain-containing+receptor+kinase+inhibitors+as+anti-angiogenic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DKinase%2520insert%2520domain-containing%2520receptor%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00011_3"><span><span class="NLM_string-ref">(b) Sepp-Lorenzino, L.; Thomas, K. A. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. <i>  Exp. Opin. Investig. </i><i>Drugs </i><b>2002</b>, <i>11</i>, 1447−1465.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1465&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothelial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm0501275b00012_1"><span><span class="NLM_string-ref">(a) Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rösel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2189&author=J.+M.+Wood&author=G.+Bold&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=J.+Frei&author=F.+Hofmann&author=J.+Mestan&author=H.+Mett&author=T.+O%27Reilly&author=E.+Persohn&author=J.+R%C3%B6sel&author=C.+Schnell&author=D.+Stover&author=A.+Theuer&author=H.+Towbin&author=F.+Wenger&author=K.+Woods-Cook&author=A.+Menrad&author=G.+Siemeister&author=M.+Schirner&author=K.-H.+Thierauch&author=M.+R.+Schneider&author=J.+Drevs&author=G.+Martiny-Baron&author=F.+Totzke&author=D.+Marm%C3%A9&title=a+novel+and+potent+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases%2C+impairs+vascular+endothelial+growth+factor-induced+responses+and+tumor+growth+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3Da%2520novel%2520and%2520potent%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%252C%2520impairs%2520vascular%2520endothelial%2520growth%2520factor-induced%2520responses%2520and%2520tumor%2520growth%2520after%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00012_2"><span><span class="NLM_string-ref">(b) Bold, G.; Altmann, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Brüggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rösel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lässer, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altmann&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Br%C3%BCggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+R%C3%B6sel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+L%C3%A4sser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+anilinophthalazines+as+potent+and+orally+well+absorbed+inhibitors+of+the+VEGF+receptor+tyrosine+kinases+useful+as+antagonists+of+tumor-driven+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520anilinophthalazines%2520as%2520potent%2520and%2520orally%2520well%2520absorbed%2520inhibitors%2520of%2520the%2520VEGF%2520receptor%2520tyrosine%2520kinases%2520useful%2520as%2520antagonists%2520of%2520tumor-driven%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00012_3"><span><span class="NLM_string-ref">(c) Furet, P.; Bold, G.; Hofmann, F.; Manley, P.; Meyer, T.; Altmann, K.-H. Identification of a newchemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2967−2971.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2971&author=P.+Furet&author=G.+Bold&author=F.+Hofmann&author=P.+Manley&author=T.+Meyer&author=K.-H+Altmann&title=Identification+of+a+newchemical+class+of+potent+angiogenesis+inhibitors+based+on+conformational+considerations+and+database+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%2520newchemical%2520class%2520of%2520potent%2520angiogenesis%2520inhibitors%2520based%2520on%2520conformational%2520considerations%2520and%2520database%2520searching%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00012_4"><span><span class="NLM_string-ref">(d) Manley, P. W.; Furet, P.; Bold, G.; Brüggen, J.; Mestan, J.; Meyer, T.; Schnell, C. R.; Wood, J.; Haberey, M.; Huth, A.; Krüger, M.; Menrad, A.; Ottow, E.; Seidelmann, D.; Siemeister, G.; Thierauch, K.-H. Anthranilic acid amides:  A novel class of antiangiogenic VEGF receptor kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 5687−5693.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5693&author=P.+W.+Manley&author=P.+Furet&author=G.+Bold&author=J.+Br%C3%BCggen&author=J.+Mestan&author=T.+Meyer&author=C.+R.+Schnell&author=J.+Wood&author=M.+Haberey&author=A.+Huth&author=M.+Kr%C3%BCger&author=A.+Menrad&author=E.+Ottow&author=D.+Seidelmann&author=G.+Siemeister&author=K.-H+Thierauch&title=Anthranilic+acid+amides%3A%E2%80%89+A+novel+class+of+antiangiogenic+VEGF+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26atitle%3DAnthranilic%2520acid%2520amides%253A%25E2%2580%2589%2520A%2520novel%2520class%2520of%2520antiangiogenic%2520VEGF%2520receptor%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm0501275b00013_1"><span><span class="NLM_string-ref">(a) Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.; Fukuda, J. Y.; Chu, J.-Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T. C.; Tang, F.; Wei, J.; Tang, C. Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 1116−1119.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1119&author=L.+Sun&author=C.+Liang&author=S.+Shirazian&author=Y.+Zhou&author=T.+Miller&author=J.+Cui&author=J.+Y.+Fukuda&author=J.-Y.+Chu&author=A.+Nematalla&author=X.+Wang&author=H.+Chen&author=A.+Sistla&author=T.+C.+Luu&author=F.+Tang&author=J.+Wei&author=C+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00013_2"><span><span class="NLM_string-ref">(b) Abrams, T. J.; Murray, L. J.; Pesenti, E.; Walker Holway, V.; Colombo, T.; Lee, L. B.; Cherrington, J. M.; Pryer, N. K. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer. <i>  Mol. Cancer Ther.</i><b>2003</b>, <i>2</i>, 1011−1021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1021&author=T.+J.+Abrams&author=L.+J.+Murray&author=E.+Pesenti&author=V.+Walker+Holway&author=T.+Colombo&author=L.+B.+Lee&author=J.+M.+Cherrington&author=N.+K.+Pryer&author=+Preclinical&title=%E2%80%9Cstandard+of+care%E2%80%9D+therapeutic+agents+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26atitle%3D%25E2%2580%259Cstandard%2520of%2520care%25E2%2580%259D%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00013_3"><span><span class="NLM_string-ref">(c) Sun, L.; Tran, N.; Liang, C.; Hubbard, S.; Tang, F.; Lipson, K.; Schreck, R.; Zhou, Y.; McMahon, G.; Tang, C. Identification of substituted 3-[(4,5,6,7-tetrahydro-1<i>H</i>-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ tyrosine kinases. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 2655−2663.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2663&author=L.+Sun&author=N.+Tran&author=C.+Liang&author=S.+Hubbard&author=F.+Tang&author=K.+Lipson&author=R.+Schreck&author=Y.+Zhou&author=G.+McMahon&author=C+Tang&title=Identification+of+substituted+3-%5B%284%2C5%2C6%2C7-tetrahydro-1H-indol-2-yl%29methylene%5D-1%2C3-dihydroindol-2-ones+as+growth+factor+receptor+inhibitors+for+VEGF-R2+%28Flk-1%2FKDR%29%2C+FGF-R1%2C+and+PDGF-R%CE%B2+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520substituted%25203-%255B%25284%252C5%252C6%252C7-tetrahydro-1H-indol-2-yl%2529methylene%255D-1%252C3-dihydroindol-2-ones%2520as%2520growth%2520factor%2520receptor%2520inhibitors%2520for%2520VEGF-R2%2520%2528Flk-1%252FKDR%2529%252C%2520FGF-R1%252C%2520and%2520PDGF-R%25CE%25B2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00013_4"><span><span class="NLM_string-ref">(d) Fong, T. A. T.; Shawver, L. K.; Sun, L.; Tang, C.; App, H.; Powell, T. J.; Kim, Y. H.; Schreck, R.; Wang, X.; Risau, W.; Ullrich, A.; Hirth, K. P.; McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. <i>  Cancer Res.</i><b>1999</b>, <i>59</i>, 99−106.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=106&author=T.+A.+T.+Fong&author=L.+K.+Shawver&author=L.+Sun&author=C.+Tang&author=H.+App&author=T.+J.+Powell&author=Y.+H.+Kim&author=R.+Schreck&author=X.+Wang&author=W.+Risau&author=A.+Ullrich&author=K.+P.+Hirth&author=G.+McMahon&title=is+a+potent+and+selective+inhibitor+of+the+vascular+endothelial+growth+factor+receptor+%28Flk-1%2FKDR%29+that+inhibits+tyrosine+kinase+catalysis%2C+tumor+vascularization%2C+and+growth+of+multiple+tumor+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26atitle%3Dis%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528Flk-1%252FKDR%2529%2520that%2520inhibits%2520tyrosine%2520kinase%2520catalysis%252C%2520tumor%2520vascularization%252C%2520and%2520growth%2520of%2520multiple%2520tumor%2520types%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00013_5"><span><span class="NLM_string-ref">(e) Laird, A. D.; Vajkoczy, P.; Shawver, L. K.; Thurnher, A.; Liang, C.; Mohammadi, M.; Schlessinger, J.; Ullrich, A.; Hubbard, S. R.; Blake, R. A.; Fong, T. A. T.; Strawn, L. M.; Sun, L.; Tang, C.; Hawtin, R.; Tang, F.; Shenoy, N.; Hirth, K. P.; McMahon, G.; Cherrington, J. M. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 4152−4160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4160&author=A.+D.+Laird&author=P.+Vajkoczy&author=L.+K.+Shawver&author=A.+Thurnher&author=C.+Liang&author=M.+Mohammadi&author=J.+Schlessinger&author=A.+Ullrich&author=S.+R.+Hubbard&author=R.+A.+Blake&author=T.+A.+T.+Fong&author=L.+M.+Strawn&author=L.+Sun&author=C.+Tang&author=R.+Hawtin&author=F.+Tang&author=N.+Shenoy&author=K.+P.+Hirth&author=G.+McMahon&author=J.+M.+Cherrington&title=is+a+potent+antiangiogenic+and+antitumor+agent+that+induces+regression+of+established+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26atitle%3Dis%2520a%2520potent%2520antiangiogenic%2520and%2520antitumor%2520agent%2520that%2520induces%2520regression%2520of%2520established%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00013_6"><span><span class="NLM_string-ref">(f) Mendel, D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen, J. G.; Li, G.; Schreck, R. E.; Abrams, T. J.; Ngai, T. J.; Lee, L. B.; Murray, L. J.; Carver, J.; Chan, E.; Moss, K. G.; Haznedar, J. O.; Sukbuntherng, J.; Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian, S.; McMahon, G.; Cherrington, J. M. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors:  Determination of a pharmacokinetic/pharmacodynamic relationship. <i>  Clin. Cancer Res.</i><b>2003</b>, <i>9</i>, 327−337.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=337&author=D.+B.+Mendel&author=A.+D.+Laird&author=X.+Xin&author=S.+G.+Louie&author=J.+G.+Christensen&author=G.+Li&author=R.+E.+Schreck&author=T.+J.+Abrams&author=T.+J.+Ngai&author=L.+B.+Lee&author=L.+J.+Murray&author=J.+Carver&author=E.+Chan&author=K.+G.+Moss&author=J.+O.+Haznedar&author=J.+Sukbuntherng&author=R.+A.+Blake&author=L.+Sun&author=C.+Tang&author=T.+Miller&author=S.+Shirazian&author=G.+McMahon&author=J.+M+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors%3A%E2%80%89+Determination+of+a+pharmacokinetic%2Fpharmacodynamic+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%253A%25E2%2580%2589%2520Determination%2520of%2520a%2520pharmacokinetic%252Fpharmacodynamic%2520relationship%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm0501275b00014_1"><span><span class="NLM_string-ref">(a) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+Design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520Design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00014_2"><span><span class="NLM_string-ref">(b) McCarty, M. F.; Wey, J.; Stoeltzing, O.; Liu, W.; Fan, F.; Bucana, C.; Mansfield, P. F.; Ryan, A. J.; Ellis, L. M. ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer<i>. Mol. Cancer Ther.</i><b>2004</b>, <i>3</i>, 1041−1048.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1048&author=M.+F.+McCarty&author=J.+Wey&author=O.+Stoeltzing&author=W.+Liu&author=F.+Fan&author=C.+Bucana&author=P.+F.+Mansfield&author=A.+J.+Ryan&author=L.+M.+Ellis&title=a+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+additional+activity+against+epidermal+growth+factor+receptor+tyrosine+kinase%2C+inhibits+orthotopic+growth+and+angiogenesis+of+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarty%26aufirst%3DM.%2BF.%26atitle%3Da%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520additional%2520activity%2520against%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%252C%2520inhibits%2520orthotopic%2520growth%2520and%2520angiogenesis%2520of%2520gastric%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00014_3"><span><span class="NLM_string-ref">(c) Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P. A.; Lohmann, J.-J. M.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-van der Brempt, C. Design and structure−activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+A.+Pl%C3%A9&author=J.-J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+structure%E2%88%92activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm0501275b00015_1"><span><span class="NLM_string-ref">(a) Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+characterization+of+CP-547%2C632%2C+a+novel+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520characterization%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00015_2"><span><span class="NLM_string-ref">(b) Munchhof, M. J.; Beebe, J. S.; Casavant, J. M.; Cooper, B. A.; Doty, J. L.; Higdon, R. C.; Hillerman, S. M.; Soderstrom, C. I.; Knauth, E. A.; Marx, M. A.; Rossi, A. M. K.; Sobolov, S. B.; Sun, J. Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity. <i>  Bioorg. Med. Chem. </i><i>Lett. </i><b>2004</b>, <i>14</i>, 21−24.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=24&author=M.+J.+Munchhof&author=J.+S.+Beebe&author=J.+M.+Casavant&author=B.+A.+Cooper&author=J.+L.+Doty&author=R.+C.+Higdon&author=S.+M.+Hillerman&author=C.+I.+Soderstrom&author=E.+A.+Knauth&author=M.+A.+Marx&author=A.+M.+K.+Rossi&author=S.+B.+Sobolov&author=J+Sun&title=Design+and+SAR+of+thienopyrimidine+and+thienopyridine+inhibitors+of+VEGFR-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00015_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26atitle%3DDesign%2520and%2520SAR%2520of%2520thienopyrimidine%2520and%2520thienopyridine%2520inhibitors%2520of%2520VEGFR-2%2520kinase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm0501275b00016_1"><span><span class="NLM_string-ref">(a) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Aimone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  Structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5- 4007  ones and the identification of CEP-5214 and its dimethylglycine  ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Aimone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+Structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C1-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-+4007++ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine++ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C1-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-%25204007%2520%2520ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00016_2"><span><span class="NLM_string-ref">(b) Ruggeri, B.; Singh, J.; Gingrich, D.; Angeles, T.; Albom, M.; Chang, H.; Robinson, C.; Hunter, K.; Dobrzanski, P.; Jones-Bolin, S.; Aimone, L.; Klein-Szanto, A.; Herbert, J.-M.; Bono, F.; Schaeffer, P.; Casellas, P.; Bourie, B.; Pili, R.; Isaacs, J.; Ator, M.; Hudkins, R.; Vaught, J.; Mallamo, J.; Dionne C. CEP-7055:  A novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 5978−5991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5991&author=B.+Ruggeri&author=J.+Singh&author=D.+Gingrich&author=T.+Angeles&author=M.+Albom&author=H.+Chang&author=C.+Robinson&author=K.+Hunter&author=P.+Dobrzanski&author=S.+Jones-Bolin&author=L.+Aimone&author=A.+Klein-Szanto&author=J.-M.+Herbert&author=F.+Bono&author=P.+Schaeffer&author=P.+Casellas&author=B.+Bourie&author=R.+Pili&author=J.+Isaacs&author=M.+Ator&author=R.+Hudkins&author=J.+Vaught&author=J.+Mallamo&author=C.+Dionne&title=orally+active+pan+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases+with+potent+antiangiogenic+activity+and+antitumor+efficacy+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00016_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DB.%26atitle%3Dorally%2520active%2520pan%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%2520with%2520potent%2520antiangiogenic%2520activity%2520and%2520antitumor%2520efficacy%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm0501275b00017_1"><span><span class="NLM_string-ref">(a) Bilodeau, M. T.; Balitza, A. E.; Koester, T. J.; Manley, P. J.; Rodman, L. D.; Buser-Doepner, C.; Coll, K. E.; Fernandes, C.; Gibbs, J. B.; Heimbrook, D. C.; Huckle, W. R.; Kohl, N.; Lynch, J. J.; Mao, X.; McFall, R. C.; McLoughlin, D.; Miller-Stein, C. M.; Rickert, K. W.; Sepp-Lorenzino, L.; Shipman, J. M.; Subramanian, R.; Thomas, K. A.; Wong, B. K.; Yu, S.; Hartman, G. D. Potent <i>N</i>-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 6363−6372.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6372&author=M.+T.+Bilodeau&author=A.+E.+Balitza&author=T.+J.+Koester&author=P.+J.+Manley&author=L.+D.+Rodman&author=C.+Buser-Doepner&author=K.+E.+Coll&author=C.+Fernandes&author=J.+B.+Gibbs&author=D.+C.+Heimbrook&author=W.+R.+Huckle&author=N.+Kohl&author=J.+J.+Lynch&author=X.+Mao&author=R.+C.+McFall&author=D.+McLoughlin&author=C.+M.+Miller-Stein&author=K.+W.+Rickert&author=L.+Sepp-Lorenzino&author=J.+M.+Shipman&author=R.+Subramanian&author=K.+A.+Thomas&author=B.+K.+Wong&author=S.+Yu&author=G.+D.+Hartman&author=+Potent&title=vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors+with+excellent+pharmacokinetics+and+low+affinity+for+the+hERG+ion+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3Dvascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520with%2520excellent%2520pharmacokinetics%2520and%2520low%2520affinity%2520for%2520the%2520hERG%2520ion%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Rodman, L. D.; McGaughey, G. B.; Coll, K. E.; Koester, T. J.; Hoffman, W. F.; Hungate, R. W.; Kendall, R. L.; McFall, R. C.; Rickert, K. W.; Rutledge, R. Z.; Thomas, K. A. The discovery of <i>N</i>-(1,3-thiazol-2-yl)pyridine-2-amines as potent inhibitors of KDR kinase. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 2941−2945.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2945&author=M.+T.+Bilodeau&author=L.+D.+Rodman&author=G.+B.+McGaughey&author=K.+E.+Coll&author=T.+J.+Koester&author=W.+F.+Hoffman&author=R.+W.+Hungate&author=R.+L.+Kendall&author=R.+C.+McFall&author=K.+W.+Rickert&author=R.+Z.+Rutledge&author=K.+A+Thomas&title=The+discovery+of+N-%281%2C3-thiazol-2-yl%29pyridine-2-amines+as+potent+inhibitors+of+KDR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DThe%2520discovery%2520of%2520N-%25281%252C3-thiazol-2-yl%2529pyridine-2-amines%2520as%2520potent%2520inhibitors%2520of%2520KDR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_3"><span><span class="NLM_string-ref">(c) Fraley, M. E.; Arrington, K. L.; Buser, C. A.; Ciecko, P. A.; Coll, K. E.; Fernandes, C.; Hartman, G. D.; Hoffman, W. F.; Lynch, J. J.; McFall, R. C.; Rickert, K.; Singh, R.; Smith, S.; Thomas, K. A.; Wong, B. K. Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors:  Effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 351−355.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=355&author=M.+E.+Fraley&author=K.+L.+Arrington&author=C.+A.+Buser&author=P.+A.+Ciecko&author=K.+E.+Coll&author=C.+Fernandes&author=G.+D.+Hartman&author=W.+F.+Hoffman&author=J.+J.+Lynch&author=R.+C.+McFall&author=K.+Rickert&author=R.+Singh&author=S.+Smith&author=K.+A.+Thomas&author=B.+K+Wong&title=Optimization+of+the+indolyl+quinolinone+class+of+KDR+%28VEGFR-2%29+kinase+inhibitors%3A%E2%80%89+Effects+of+5-amido-+and+5-sulphonamido-indolyl+groups+on+pharmacokinetics+and+hERG+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DOptimization%2520of%2520the%2520indolyl%2520quinolinone%2520class%2520of%2520KDR%2520%2528VEGFR-2%2529%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Effects%2520of%25205-amido-%2520and%25205-sulphonamido-indolyl%2520groups%2520on%2520pharmacokinetics%2520and%2520hERG%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_4"><span><span class="NLM_string-ref">(d) Fraley, M. E.; Arrington, K. L.; Hambaugh, S. R.; Hoffman, W. F.; Cunningham, A. M.; Young, M. B.; Hungate, R. W.; Tebben, A. J.; Rutledge, R. Z.; Kendall, R. L.; Huckle, W. R.; McFall, R. C.; Coll, K. E.; Thomas, K. A. Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1<i>H</i>-indoles as a novel class of KDR kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2973−2976.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2976&author=M.+E.+Fraley&author=K.+L.+Arrington&author=S.+R.+Hambaugh&author=W.+F.+Hoffman&author=A.+M.+Cunningham&author=M.+B.+Young&author=R.+W.+Hungate&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+L.+Kendall&author=W.+R.+Huckle&author=R.+C.+McFall&author=K.+E.+Coll&author=K.+A+Thomas&title=Discovery+and+evaluation+of+3-%285-thien-3-ylpyridin-3-yl%29-1H-indoles+as+a+novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%25203-%25285-thien-3-ylpyridin-3-yl%2529-1H-indoles%2520as%2520a%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_5"><span><span class="NLM_string-ref">(e) Wu, Z.; Fraley, M. E.; Bilodeau, M. T.; Kaufman, M. L.; Tasber, E. S.; Balitza, A. E.; Hartman, G. D.; Coll, K. E.; Rickert, K.; Shipman, J.; Shi, B.; Sepp-Lorenzino, L.; Thomas, K. A. Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 909−912.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=912&author=Z.+Wu&author=M.+E.+Fraley&author=M.+T.+Bilodeau&author=M.+L.+Kaufman&author=E.+S.+Tasber&author=A.+E.+Balitza&author=G.+D.+Hartman&author=K.+E.+Coll&author=K.+Rickert&author=J.+Shipman&author=B.+Shi&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Design+and+synthesis+of+3%2C7-diarylimidazopyridines+as+inhibitors+of+the+VEGF-receptor+KDR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25203%252C7-diarylimidazopyridines%2520as%2520inhibitors%2520of%2520the%2520VEGF-receptor%2520KDR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_6"><span><span class="NLM_string-ref">(f) Bilodeau, M. T.; Cunningham, A. M.; Koester, T. J.; Ciecko, P. A.; Coll, K. E.; Huckle, W. R.; Hungate, R. W.; Kendall, R. L.; McFall, R. C.; Mao, X.; Rutledge, R. Z.; Thomas, K. A. Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of VEGF-receptor KDR. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2485−2488.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2488&author=M.+T.+Bilodeau&author=A.+M.+Cunningham&author=T.+J.+Koester&author=P.+A.+Ciecko&author=K.+E.+Coll&author=W.+R.+Huckle&author=R.+W.+Hungate&author=R.+L.+Kendall&author=R.+C.+McFall&author=X.+Mao&author=R.+Z.+Rutledge&author=K.+A+Thomas&title=Design+and+synthesis+of+1%2C5-diarylbenzimidazoles+as+inhibitors+of+VEGF-receptor+KDR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DDesign%2520and%2520synthesis%2520of%25201%252C5-diarylbenzimidazoles%2520as%2520inhibitors%2520of%2520VEGF-receptor%2520KDR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_7"><span><span class="NLM_string-ref">(g) Manley, P. J.; Balitza, A. E.; Bilodeau, M. T.; Coll, K. E.; Hartman, G. D.; McFall, R. C.; Rickert, K. W.; Rodman, L. D.; Thomas, K. A. 2,4-Disubstituted pyrimidines:  A novel class of KDR kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 1673−1677.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1677&author=P.+J.+Manley&author=A.+E.+Balitza&author=M.+T.+Bilodeau&author=K.+E.+Coll&author=G.+D.+Hartman&author=R.+C.+McFall&author=K.+W.+Rickert&author=L.+D.+Rodman&author=K.+A.+Thomas&author=A+Disubstituted&title=novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26atitle%3Dnovel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_8"><span><span class="NLM_string-ref">(h) Fraley, M. E.; Rubino, R. S.; Hoffman, W. F.; Hambaugh, S. R.; Arrington, K. L.; Hungate, R. W.; Bilodeau, M. T.; Tebben, A. J.; Rutledge, R. Z.; Kendall, R. L.; McFall, R. C.; Huckle, W. R.; Coll, K. E.; Thomas, K. A. Optimization of a pyrazolo[1,5-<i>a</i>]pyrimidine class of KDR kinase inhibitors:  Improvements in physical properties enhance cellular activity and pharmacokinetics. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3537−3541.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3541&author=M.+E.+Fraley&author=R.+S.+Rubino&author=W.+F.+Hoffman&author=S.+R.+Hambaugh&author=K.+L.+Arrington&author=R.+W.+Hungate&author=M.+T.+Bilodeau&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+L.+Kendall&author=R.+C.+McFall&author=W.+R.+Huckle&author=K.+E.+Coll&author=K.+A+Thomas&title=Optimization+of+a+pyrazolo%5B1%2C5-a%5Dpyrimidine+class+of+KDR+kinase+inhibitors%3A%E2%80%89+Improvements+in+physical+properties+enhance+cellular+activity+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DOptimization%2520of%2520a%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520class%2520of%2520KDR%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Improvements%2520in%2520physical%2520properties%2520enhance%2520cellular%2520activity%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00017_9"><span><span class="NLM_string-ref">(i) Fraley, M. E.; Hoffman, W. F.; Rubino, R. S.; Hungate, R. W.; Tebben, A. J.; Rutledge, R. Z.; McFall, R. C.; Huckle, W. R.; Kendall, R. L.; Coll, K. E.; Thomas, K. A. Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-<i>a</i>]pyrimidines:  A new class of KDR kinase inhibitors. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2767−2770.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2770&author=M.+E.+Fraley&author=W.+F.+Hoffman&author=R.+S.+Rubino&author=R.+W.+Hungate&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+C.+McFall&author=W.+R.+Huckle&author=R.+L.+Kendall&author=K.+E.+Coll&author=K.+A+Thomas&title=Synthesis+and+initial+SAR+studies+of+3%2C6-disubstituted+pyrazolo%5B1%2C5-a%5Dpyrimidines%3A%E2%80%89+A+new+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520initial%2520SAR%2520studies%2520of%25203%252C6-disubstituted%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%253A%25E2%2580%2589%2520A%2520new%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm0501275b00018_1"><span><span class="NLM_string-ref">(a) Baindur, N.; Chadha, N.; Brandt, B. M.; Asgari, D.; Patch, R. J.; Schalk-HiHi, C.; Carver, T. E.; Petrounia, I. P.; Baumann, C. A.; Ott, H.; Manthey, C.; Springer, B. A.; Player, M. R. 2-Hydroxy-4,6-diamino-[1,3,5]triazines:  A novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 1717−1720.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1720&author=N.+Baindur&author=N.+Chadha&author=B.+M.+Brandt&author=D.+Asgari&author=R.+J.+Patch&author=C.+Schalk-HiHi&author=T.+E.+Carver&author=I.+P.+Petrounia&author=C.+A.+Baumann&author=H.+Ott&author=C.+Manthey&author=B.+A.+Springer&author=M.+R.+Player&author=+Hydroxy&title=novel+class+of+VEGF-R2+%28KDR%29+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaindur%26aufirst%3DN.%26atitle%3Dnovel%2520class%2520of%2520VEGF-R2%2520%2528KDR%2529%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00018_2"><span><span class="NLM_string-ref">(b) Kuo, G.-H.; Wang, A.; Emanuel, S.; DeAngelis, A.; Zhang, R.; Connolly, P. J.; Murray, W. V.; Gruninger, R. H.; Sechler, J.; Fuentes-Pesquera, A.; Johnson, D.; Middleton, S. A.; Jolliffe, L.; Chen, X. Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 1886−1900.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1900&author=G.-H.+Kuo&author=A.+Wang&author=S.+Emanuel&author=A.+DeAngelis&author=R.+Zhang&author=P.+J.+Connolly&author=W.+V.+Murray&author=R.+H.+Gruninger&author=J.+Sechler&author=A.+Fuentes-Pesquera&author=D.+Johnson&author=S.+A.+Middleton&author=L.+Jolliffe&author=X+Chen&title=Synthesis+and+discovery+of+pyrazine-pyridine+biheteroaryl+as+a+novel+series+of+potent+vascular+endothelial+growth+factor+receptor-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00018_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520pyrazine-pyridine%2520biheteroaryl%2520as%2520a%2520novel%2520series%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm0501275b00019_1"><span><span class="NLM_string-ref">Cross, M. J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis:  Signalling pathways, biological responses and therapeutic inhibition. <i>  Trends Pharm. Sci.</i><b>2001</b>, <i>22</i>, 201−207.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=207&author=M.+J.+Cross&author=L+Claesson-Welsh&title=FGF+and+VEGF+function+in+angiogenesis%3A%E2%80%89+Signalling+pathways%2C+biological+responses+and+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%2BJ.%26atitle%3DFGF%2520and%2520VEGF%2520function%2520in%2520angiogenesis%253A%25E2%2580%2589%2520Signalling%2520pathways%252C%2520biological%2520responses%2520and%2520therapeutic%2520inhibition%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00020"><div class="reference"><div class="NLM_citation" id="jm0501275b00020_1"><span><span class="NLM_string-ref">Gerwins, P.; Sköldenberg, E.; Claesson-Welsh, L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. <i>  Crit. Rev. Onc. Hemat.</i><b>2000</b>, <i>34</i>, 185−194.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2000&pages=194&author=P.+Gerwins&author=E.+Sk%C3%B6ldenberg&author=L+Claesson-Welsh&title=Function+of+fibroblast+growth+factors+and+vascular+endothelial+growth+factors+and+their+receptors+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerwins%26aufirst%3DP.%26atitle%3DFunction%2520of%2520fibroblast%2520growth%2520factors%2520and%2520vascular%2520endothelial%2520growth%2520factors%2520and%2520their%2520receptors%2520in%2520angiogenesis%26jtitle%3DCrit.%2520Rev.%2520Onc.%2520Hemat.%26date%3D2000%26volume%3D34%26spage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm0501275b00021_1"><span><span class="NLM_string-ref">Manetti, F.; Botta, M. Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK). <i>  Curr. Pharm. Des.</i><b>2003</b>, <i>9</i>, 567−581.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=581&author=F.+Manetti&author=M+Botta&title=Small-molecule+inhibitors+of+fibroblast+growth+factor+receptor+%28FGFR%29+tyrosine+kinases+%28TK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520fibroblast%2520growth%2520factor%2520receptor%2520%2528FGFR%2529%2520tyrosine%2520kinases%2520%2528TK%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm0501275b00022_1"><span><span class="NLM_string-ref">Boehm, T.; Folkman, J.; Browder, T.; O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. <i>  Nature</i><b>1997</b>, <i>390</i>, 404−409.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=409&author=T.+Boehm&author=J.+Folkman&author=T.+Browder&author=M.+S+O%27Reilly&title=Antiangiogenic+therapy+of+experimental+cancer+does+not+induce+acquired+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DT.%26atitle%3DAntiangiogenic%2520therapy%2520of%2520experimental%2520cancer%2520does%2520not%2520induce%2520acquired%2520drug%2520resistance%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm0501275b00023_1"><span><span class="NLM_string-ref">(a) Hunt, J. T.; Mitt, T.; Borzilleri, R.; Gullo-Brown, J.; Fargnoli, J.; Fink, B.; Han, W.-C.; Mortillo, S.; Vite, G.; Wautlet, B.; Wong, T.; Zheng, X.; Bhide, R. Discovery of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus as a new kinase inhibitor template. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 4054−4059.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4059&author=J.+T.+Hunt&author=T.+Mitt&author=R.+Borzilleri&author=J.+Gullo-Brown&author=J.+Fargnoli&author=B.+Fink&author=W.-C.+Han&author=S.+Mortillo&author=G.+Vite&author=B.+Wautlet&author=T.+Wong&author=X.+Zheng&author=R+Bhide&title=Discovery+of+the+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+nucleus+as+a+new+kinase+inhibitor+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520the%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520nucleus%2520as%2520a%2520new%2520kinase%2520inhibitor%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm0501275b00024_1"><span><span class="NLM_string-ref">(a) Borzilleri, R. M.; Fargnoli, J.; Fura, A.; Gerhardt, T.; Hunt, J. T.; Mortillo, S.; Qian, L.; Tokarski, J.; Vyas, V.; Wautlet, B.; Zheng, P.; Bhide, R. S. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2005</b>, <i>15</i>, 1429−1433.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1433&author=R.+M.+Borzilleri&author=J.+Fargnoli&author=A.+Fura&author=T.+Gerhardt&author=J.+T.+Hunt&author=S.+Mortillo&author=L.+Qian&author=J.+Tokarski&author=V.+Vyas&author=B.+Wautlet&author=P.+Zheng&author=R.+S+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0501275b00024_2"><span><span class="NLM_string-ref">(b) Leftheris, K.; Ahmed, G.; Chan, R.; Dyckman, A. J.; Hussain, Z.; Ho, K.; Hynes, J., Jr.; Letourneau, J.; Li, W.; Lin, S.; Metzger, A.; Moriarty, K. J.; Riviello, C.; Shimshock, Y.; Wen, J.; Wityak, J.; Wrobleski, S. T.; Wu, H.; Wu, J.; Desai, M.; Gillooly, K. M.; Lin, T. H.; Loo, D.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Shuster, D. J.; Zhang, R.; Diller, D.; Doweyko, A.; Sack, J.; Baldwin, J.; Barrish, J.; Dodd, J.; Henderson, I.; Kanner, S.; Schieven, G. L.; Webb, M. The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 6283−6291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6291&author=K.+Leftheris&author=G.+Ahmed&author=R.+Chan&author=A.+J.+Dyckman&author=Z.+Hussain&author=K.+Ho&author=J.+Hynes&author=+Jr&author=W.+Li&author=S.+Lin&author=A.+Metzger&author=K.+J.+Moriarty&author=C.+Riviello&author=Y.+Shimshock&author=J.+Wen&author=J.+Wityak&author=S.+T.+Wrobleski&author=H.+Wu&author=J.+Wu&author=M.+Desai&author=K.+M.+Gillooly&author=T.+H.+Lin&author=D.+Loo&author=K.+W.+McIntyre&author=S.+Pitt&author=D.+R.+Shen&author=D.+J.+Shuster&author=R.+Zhang&author=D.+Diller&author=A.+Doweyko&author=J.+Sack&author=J.+Baldwin&author=J.+Barrish&author=J.+Dodd&author=I.+Henderson&author=S.+Kanner&author=G.+L.+Schieven&author=M+Webb&title=The+Discovery+of+Orally+Active+Triaminotriazine+Aniline+Amides+as+Inhibitors+of+p38+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00024_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DThe%2520Discovery%2520of%2520Orally%2520Active%2520Triaminotriazine%2520Aniline%2520Amides%2520as%2520Inhibitors%2520of%2520p38%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm0501275b00025_1"><span><span class="NLM_string-ref">Patil, S. A.; Otter, B. A.; Klein, R. S. Synthesis of pyrrolo[2,1-<i>f</i>][1,2,4]triazine congeners of nucleic acid purines via the <i>N</i>-amination of 2-substituted pyrroles. <i>  J. Heterocycl. Chem.</i><b>1994</b>, <i>31</i>, 781−786.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=786&author=S.+A.+Patil&author=B.+A.+Otter&author=R.+S+Klein&title=Synthesis+of+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+congeners+of+nucleic+acid+purines+via+the+N-amination+of+2-substituted+pyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520of%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520congeners%2520of%2520nucleic%2520acid%2520purines%2520via%2520the%2520N-amination%2520of%25202-substituted%2520pyrroles%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1994%26volume%3D31%26spage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm0501275b00026_1"><span><span class="NLM_string-ref">Suzuki, M.; Miyoshi, M.; Matsumoto, K. A convenient synthesis of 3-substituted pyrrole-2,4-dicarboxylic acid esters. <i>  J. Org. Chem.</i><b>1974</b>, <i>39</i>, 1980.</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00927a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1974&pages=1980&author=M.+Suzuki&author=M.+Miyoshi&author=K+Matsumoto&title=A+convenient+synthesis+of+3-substituted+pyrrole-2%2C4-dicarboxylic+acid+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00026_1&amp;dbid=16384&amp;doi=10.1021%2Fjo00927a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00927a056%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthesis%2520of%25203-substituted%2520pyrrole-2%252C4-dicarboxylic%2520acid%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1974%26volume%3D39%26spage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm0501275b00027_1"><span><span class="NLM_string-ref">Belley, M.; Scheigetz, J.; Dube, P.; Dolman, S. Synthesis of <i>N</i>-aminoindole ureas from ethyl 1-amino-6-(trifluoromethyl)-1<i>H</i>-indole-3-carboxylate. <i>  Synlett</i><b>2001</b>, <i>2</i>, 222−225.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=225&author=M.+Belley&author=J.+Scheigetz&author=P.+Dube&author=S+Dolman&title=Synthesis+of+N-aminoindole+ureas+from+ethyl+1-amino-6-%28trifluoromethyl%29-1H-indole-3-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelley%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520N-aminoindole%2520ureas%2520from%2520ethyl%25201-amino-6-%2528trifluoromethyl%2529-1H-indole-3-carboxylate%26jtitle%3DSynlett%26date%3D2001%26volume%3D2%26spage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm0501275b00028_1"><span><span class="NLM_string-ref">Gangloff, A. R.; Litvak, J.; Shelton, E. J.; Sperandio, D.; Wang, V. R.; Rice, K. D. Synthesis of 3,5-disubstituted 1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst. <i>  Tetrahedron </i><i>Lett.</i><b>2001</b>, <i>42</i>, 1441−1443.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1443&author=A.+R.+Gangloff&author=J.+Litvak&author=E.+J.+Shelton&author=D.+Sperandio&author=V.+R.+Wang&author=K.+D+Rice&title=Synthesis+of+3%2C5-disubstituted+1%2C2%2C4-oxadiazoles+using+tetrabutylammonium+fluoride+as+a+mild+and+efficient+catalyst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangloff%26aufirst%3DA.%2BR.%26atitle%3DSynthesis%2520of%25203%252C5-disubstituted%25201%252C2%252C4-oxadiazoles%2520using%2520tetrabutylammonium%2520fluoride%2520as%2520a%2520mild%2520and%2520efficient%2520catalyst%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm0501275b00029_1"><span><span class="NLM_string-ref">Diana, G. D.; Volkots, D. L.; Nitz, T. J.; Bailey, T. R.; Long, M. A.; Vescio, N.; Aldous, S.; Pevear, D. C.; Dutko, F. J. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity<i>. J. Med. Chem.</i><b>1994</b>, <i>37</i>, 2421−2436.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2436&author=G.+D.+Diana&author=D.+L.+Volkots&author=T.+J.+Nitz&author=T.+R.+Bailey&author=M.+A.+Long&author=N.+Vescio&author=S.+Aldous&author=D.+C.+Pevear&author=F.+J+Dutko&title=Oxadiazoles+as+ester+bioisosteric+replacements+in+compounds+related+to+disoxaril.+Antirhinovirus+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26atitle%3DOxadiazoles%2520as%2520ester%2520bioisosteric%2520replacements%2520in%2520compounds%2520related%2520to%2520disoxaril.%2520Antirhinovirus%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00030"><div class="reference"><div class="NLM_citation" id="jm0501275b00030_1"><span><span class="NLM_string-ref">Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; MacLeod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor.<i>J. Med. </i><i>Chem.</i><b>1990</b>, <i>33</i>, 1128−1138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1138&author=J.+Saunders&author=M.+Cassidy&author=S.+B.+Freedman&author=E.+A.+Harley&author=L.+L.+Iversen&author=C.+Kneen&author=A.+M.+MacLeod&author=K.+J.+Merchant&author=R.+J.+Snow&author=R+Baker&title=Novel+quinuclidine-based+ligands+for+the+muscarinic+cholinergic+receptor.J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DNovel%2520quinuclidine-based%2520ligands%2520for%2520the%2520muscarinic%2520cholinergic%2520receptor.J%26jtitle%3DMed.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm0501275b00031_1"><span><span class="NLM_string-ref">Francis, J. E.; Gorczyca, L. A.; Mazzenga, G. C.; Meckler, H. A convenient synthesis of 3,5-disubstituted-1,2,4-triazoles<i>. Tetrahedron Lett.</i><b>1987</b>, <i>28</i>, 5133−5136.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1987&pages=5136&author=J.+E.+Francis&author=L.+A.+Gorczyca&author=G.+C.+Mazzenga&author=H+Meckler&title=A+convenient+synthesis+of+3%2C5-disubstituted-1%2C2%2C4-triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26atitle%3DA%2520convenient%2520synthesis%2520of%25203%252C5-disubstituted-1%252C2%252C4-triazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1987%26volume%3D28%26spage%3D5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm0501275b00032_1"><span><span class="NLM_string-ref">Kuo, S.-C.; Wu, C.-H.; Huang, L.-J.; Yamamoto, K.; Yoshina, S. Synthesis and antimicrobial activity of methyl 5-nitro-3,4-diphenylfuran-2-carboxylate and related compounds. <i>  Chem. </i><i>Pharm. Bull.</i><b>1981</b>, <i>29</i>, 635−645.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=645&author=S.-C.+Kuo&author=C.-H.+Wu&author=L.-J.+Huang&author=K.+Yamamoto&author=S+Yoshina&title=Synthesis+and+antimicrobial+activity+of+methyl+5-nitro-3%2C4-diphenylfuran-2-carboxylate+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.-C.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520activity%2520of%2520methyl%25205-nitro-3%252C4-diphenylfuran-2-carboxylate%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1981%26volume%3D29%26spage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm0501275b00033_1"><span><span class="NLM_string-ref">Hervens, F.; Viehe, H. G. Heterocycles from compounds containing two nucleophilic centers and phosgeneimmonium salts. <i>  Angew. Chem., Int. Ed. </i><i>Engl.</i><b>1973</b>, <i>12</i>, 405−406.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1973&pages=406&author=F.+Hervens&author=H.+G+Viehe&title=Heterocycles+from+compounds+containing+two+nucleophilic+centers+and+phosgeneimmonium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHervens%26aufirst%3DF.%26atitle%3DHeterocycles%2520from%2520compounds%2520containing%2520two%2520nucleophilic%2520centers%2520and%2520phosgeneimmonium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1973%26volume%3D12%26spage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm0501275b00034_1"><span><span class="NLM_string-ref">Chen, P.; Doweyko, A. M.; Norris, D.; Gu, H. H.; Spergel, S. H.; Das, J.; Moquin, R. V.; Lin, J.; Wityak, J.; Iwanowicz, E. J.; McIntyre, K. W.; Shuster, D. J.; Behnia, K.; Chong, S.; de Fex, H.; Pang, S.; Pitt, S.; Shen, D. R.; Thrall, S.; Stanley, P.; Kocy, O. R.; Witmer, M. R.; Kanner, S. B.; Schieven, G. L.; Barrish, J. C. Imidazoquinoxaline Src-family kinase p56<sup>Lck</sup> inhibitors:  SAR, QSAR, and the discovery of (S)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo-[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity. <i>  J. Med. </i><i>Chem</i>. <b>2004</b>, <i>47</i>, 4517−4529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4529&author=P.+Chen&author=A.+M.+Doweyko&author=D.+Norris&author=H.+H.+Gu&author=S.+H.+Spergel&author=J.+Das&author=R.+V.+Moquin&author=J.+Lin&author=J.+Wityak&author=E.+J.+Iwanowicz&author=K.+W.+McIntyre&author=D.+J.+Shuster&author=K.+Behnia&author=S.+Chong&author=H.+de+Fex&author=S.+Pang&author=S.+Pitt&author=D.+R.+Shen&author=S.+Thrall&author=P.+Stanley&author=O.+R.+Kocy&author=M.+R.+Witmer&author=S.+B.+Kanner&author=G.+L.+Schieven&author=J.+C+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A%E2%80%89+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%25E2%2580%2589%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm0501275b00035_1"><span><span class="NLM_string-ref">Kim, K. S.; Kimball, S. D.; Misra, R. N.; Rawlins, D. B.; Hunt, J. T.; Xiao, H.-Y.; Lu, S.; Qian, L.; Han, W.-C.; Shan, W.; Mitt, T.; Cai, Z.-W.; Poss, M. A.; Zhu, H.; Sack, J. S.; Tokarski, J. S.; Chang, C. Y.; Pavletich, N.; Kamath, A.; Humphreys, W. G.; Marathe, P.; Bursuker, I.; Kellar, O. K. A.; Roongta, U.; Batorsky, R.; Mulheron, J. G.; Bol, D.; Fairchild, C. R.; Lee, F. Y.; Webster, K. R. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2:  Synthesis, X-ray crystallographic analysis, and biological activities. <i>  J. Med. Chem</i>. <b>2002</b>, <i>45</i>, 3905−3927.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3927&author=K.+S.+Kim&author=S.+D.+Kimball&author=R.+N.+Misra&author=D.+B.+Rawlins&author=J.+T.+Hunt&author=H.-Y.+Xiao&author=S.+Lu&author=L.+Qian&author=W.-C.+Han&author=W.+Shan&author=T.+Mitt&author=Z.-W.+Cai&author=M.+A.+Poss&author=H.+Zhu&author=J.+S.+Sack&author=J.+S.+Tokarski&author=C.+Y.+Chang&author=N.+Pavletich&author=A.+Kamath&author=W.+G.+Humphreys&author=P.+Marathe&author=I.+Bursuker&author=O.+K.+A.+Kellar&author=U.+Roongta&author=R.+Batorsky&author=J.+G.+Mulheron&author=D.+Bol&author=C.+R.+Fairchild&author=F.+Y.+Lee&author=K.+R+Webster&title=Discovery+of+aminothiazole+inhibitors+of+cyclin-dependent+kinase+2%3A%E2%80%89+Synthesis%2C+X-ray+crystallographic+analysis%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520aminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202%253A%25E2%2580%2589%2520Synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm0501275b00036_1"><span><span class="NLM_string-ref">The drug concentrations obtained during a mouse coarse oral PK study using a single 50 mg/kg dose of compound <b>13</b> were 1.8 μM at 1 h and 0.23 μM at 4 h.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+drug+concentrations+obtained+during+a+mouse+coarse+oral+PK+study+using+a+single+50+mg%2Fkg+dose+of+compound+13+were+1.8+%CE%BCM+at+1+h+and+0.23+%CE%BCM+at+4+h.+The+drug+concentrations+obtained+during+a+mouse+coarse+oral+PK+study+using+a+single+50+mg%2Fkg+dose+of+compound+13+were+1.8+%CE%BCM+at+1+h+and+0.23+%CE%BCM+at+4+h."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm0501275b00037_1"><span><span class="NLM_string-ref">McTigue, M. A.; Wickersham, J. A.; Pinko, C.; Showalter, R. E.; Parast, C. V.; Tempczyk-Russell, A.; Gehring, M. R.; Mroczkowski, B.; Kan, C.-C.; Villafranca, J. E.; Appelt, K.  4008  Crystalstructure of the kinase domain of human vascular endothelial  growth factor receptor 2:  A key enzyme in angiogenesis. <i>  Structure</i><b>1999</b>, <i>7</i>, 319−330.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=330&author=M.+A.+McTigue&author=J.+A.+Wickersham&author=C.+Pinko&author=R.+E.+Showalter&author=C.+V.+Parast&author=A.+Tempczyk-Russell&author=M.+R.+Gehring&author=B.+Mroczkowski&author=C.-C.+Kan&author=J.+E.+Villafranca&author=K.+Appelt&title=Crystalstructure+of+the+kinase+domain+of+human+vascular+endothelial++growth+factor+receptor+2%3A%E2%80%89+A+key+enzyme+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26atitle%3DCrystalstructure%2520of%2520the%2520kinase%2520domain%2520of%2520human%2520vascular%2520endothelial%2520%2520growth%2520factor%2520receptor%25202%253A%25E2%2580%2589%2520A%2520key%2520enzyme%2520in%2520angiogenesis%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm0501275b00038_1"><span><span class="NLM_string-ref">Version 3.5, Schrodinger, LLC:  New York, 2005.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Version+3.5%2C+Schrodinger%2C+LLC%3A%E2%80%89+New+York%2C+2005.+Version+3.5%2C+Schrodinger%2C+LLC%3A%E2%80%89+New+York%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm0501275b00039_1"><span><span class="NLM_string-ref">Hagler, A. T.; Ewig, C. S. On the use of quantum energy surfaces in the derivation of molecular force fields. <i>  Comput.</i><i> Phys. Comm</i>. <b>1994</b>, <i>84</i>, 131−155.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1994&pages=155&author=A.+T.+Hagler&author=C.+S+Ewig&title=On+the+use+of+quantum+energy+surfaces+in+the+derivation+of+molecular+force+fields"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DOn%2520the%2520use%2520of%2520quantum%2520energy%2520surfaces%2520in%2520the%2520derivation%2520of%2520molecular%2520force%2520fields%26jtitle%3DComput.%2520Phys.%2520Comm.%26date%3D1994%26volume%3D84%26spage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00040"><div class="reference"><div class="NLM_citation" id="jm0501275b00040_1"><span><span class="NLM_string-ref">Kuramoto, Y.; Ohshita, Y.; Yoshida, J.; Yazaki, A.; Shiro, M.; Koike, T. A novel antibacterial 8-chloroquinolone with a distorted orientation of the <i>N</i>1-(5-amino-2,4-difluorophenyl) group. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 1905−1917.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1917&author=Y.+Kuramoto&author=Y.+Ohshita&author=J.+Yoshida&author=A.+Yazaki&author=M.+Shiro&author=T+Koike&title=A+novel+antibacterial+8-chloroquinolone+with+a+distorted+orientation+of+the+N1-%285-amino-2%2C4-difluorophenyl%29+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuramoto%26aufirst%3DY.%26atitle%3DA%2520novel%2520antibacterial%25208-chloroquinolone%2520with%2520a%2520distorted%2520orientation%2520of%2520the%2520N1-%25285-amino-2%252C4-difluorophenyl%2529%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm0501275b00041_1"><span><span class="NLM_string-ref">Armarego, W. L. F.; Taguchi, H.; Cotton, R. G. H.; Battiston, S.; Leong, L. Lipophilic 5,6,7,8-tetrahydropterin substrates for phenylalanine hydroxylase (monkey brain), tryptophan hydroxylase (rat brain), and tyrosine hydroxylase (rat brain). <i>  Eur. J. Med. Chem.</i><b>1987</b>, <i>22</i>, 283−291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=291&author=W.+L.+F.+Armarego&author=H.+Taguchi&author=R.+G.+H.+Cotton&author=S.+Battiston&author=L.+Leong&author=+Lipophilic&title=substrates+for+phenylalanine+hydroxylase+%28monkey+brain%29%2C+tryptophan+hydroxylase+%28rat+brain%29%2C+and+tyrosine+hydroxylase+%28rat+brain%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26atitle%3Dsubstrates%2520for%2520phenylalanine%2520hydroxylase%2520%2528monkey%2520brain%2529%252C%2520tryptophan%2520hydroxylase%2520%2528rat%2520brain%2529%252C%2520and%2520tyrosine%2520hydroxylase%2520%2528rat%2520brain%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0501275b00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0501275b00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm0501275b00042_1"><span><span class="NLM_string-ref">Francisco, J. A.; Gawlak, S. L.; Siegall, C. B. Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1<i>. J. </i><i>Biol. Chem.</i><b>1997</b>, <i>272</i>, 24165−24169.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=24169&author=J.+A.+Francisco&author=S.+L.+Gawlak&author=C.+B.+Siegall&author=+Construction&title=and+characterization+of+BD1-G28-5+sFv%2C+a+single-chain+anti-CD40+immunotoxin+containing+the+ribosome-inactivating+protein+bryodin+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26atitle%3Dand%2520characterization%2520of%2520BD1-G28-5%2520sFv%252C%2520a%2520single-chain%2520anti-CD40%2520immunotoxin%2520containing%2520the%2520ribosome-inactivating%2520protein%2520bryodin%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D24169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm0501275b00001':['jm0501275b00001_1','jm0501275b00001_2'],'jm0501275b00002':['jm0501275b00002_1'],'jm0501275b00003':['jm0501275b00003_1','jm0501275b00003_2','jm0501275b00003_3','jm0501275b00003_4'],'jm0501275b00004':['jm0501275b00004_1','jm0501275b00004_2','jm0501275b00004_3'],'jm0501275b00005':['jm0501275b00005_1','jm0501275b00005_2'],'jm0501275b00006':['jm0501275b00006_1','jm0501275b00006_2','jm0501275b00006_3'],'jm0501275b00007':['jm0501275b00007_1'],'jm0501275b00008':['jm0501275b00008_1'],'jm0501275b00009':['jm0501275b00009_1','jm0501275b00009_2'],'jm0501275b00010':['jm0501275b00010_1','jm0501275b00010_2','jm0501275b00010_3'],'jm0501275b00011':['jm0501275b00011_1','jm0501275b00011_2','jm0501275b00011_3'],'jm0501275b00012':['jm0501275b00012_1','jm0501275b00012_2','jm0501275b00012_3','jm0501275b00012_4'],'jm0501275b00013':['jm0501275b00013_1','jm0501275b00013_2','jm0501275b00013_3','jm0501275b00013_4','jm0501275b00013_5','jm0501275b00013_6'],'jm0501275b00014':['jm0501275b00014_1','jm0501275b00014_2','jm0501275b00014_3'],'jm0501275b00015':['jm0501275b00015_1','jm0501275b00015_2'],'jm0501275b00016':['jm0501275b00016_1','jm0501275b00016_2'],'jm0501275b00017':['jm0501275b00017_1','jm0501275b00017_2','jm0501275b00017_3','jm0501275b00017_4','jm0501275b00017_5','jm0501275b00017_6','jm0501275b00017_7','jm0501275b00017_8','jm0501275b00017_9'],'jm0501275b00018':['jm0501275b00018_1','jm0501275b00018_2'],'jm0501275b00019':['jm0501275b00019_1'],'jm0501275b00020':['jm0501275b00020_1'],'jm0501275b00021':['jm0501275b00021_1'],'jm0501275b00022':['jm0501275b00022_1'],'jm0501275b00023':['jm0501275b00023_1'],'jm0501275b00024':['jm0501275b00024_1','jm0501275b00024_2'],'jm0501275b00025':['jm0501275b00025_1'],'jm0501275b00026':['jm0501275b00026_1'],'jm0501275b00027':['jm0501275b00027_1'],'jm0501275b00028':['jm0501275b00028_1'],'jm0501275b00029':['jm0501275b00029_1'],'jm0501275b00030':['jm0501275b00030_1'],'jm0501275b00031':['jm0501275b00031_1'],'jm0501275b00032':['jm0501275b00032_1'],'jm0501275b00033':['jm0501275b00033_1'],'jm0501275b00034':['jm0501275b00034_1'],'jm0501275b00035':['jm0501275b00035_1'],'jm0501275b00036':['jm0501275b00036_1'],'jm0501275b00037':['jm0501275b00037_1'],'jm0501275b00038':['jm0501275b00038_1'],'jm0501275b00039':['jm0501275b00039_1'],'jm0501275b00040':['jm0501275b00040_1'],'jm0501275b00041':['jm0501275b00041_1'],'jm0501275b00042':['jm0501275b00042_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul C.  Lobben</span>, <span class="hlFld-ContribAuthor ">Evan  Barlow</span>, <span class="hlFld-ContribAuthor ">James S.  Bergum</span>, <span class="hlFld-ContribAuthor ">Alan  Braem</span>, <span class="hlFld-ContribAuthor ">Shih-Ying  Chang</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Kopp</span>, <span class="hlFld-ContribAuthor ">Chiajen  Lai</span>, <span class="hlFld-ContribAuthor ">Thomas L.  LaPorte</span>, <span class="hlFld-ContribAuthor ">David K.  Leahy</span>, <span class="hlFld-ContribAuthor ">Jale  Müslehiddinoğlu</span>, <span class="hlFld-ContribAuthor ">Fernando  Quiroz</span>, <span class="hlFld-ContribAuthor ">Dimitri  Skliar</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Sushil  Srivastava</span>, <span class="hlFld-ContribAuthor ">Daniel  Wasser</span>, <span class="hlFld-ContribAuthor ">John  Wasylyk</span>, <span class="hlFld-ContribAuthor ">Robert  Wethman</span>, and <span class="hlFld-ContribAuthor ">Zhongmin  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (8)
                                     , 900-907. <a href="https://doi.org/10.1021/op500126u" title="DOI URL">https://doi.org/10.1021/op500126u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op500126u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop500126u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DControl%252BStrategy%252Bfor%252Bthe%252BManufacture%252Bof%252BBrivanib%252BAlaninate%25252C%252Ba%252BNovel%252BPyrrolotriazine%252BVEGFR%25252FFGFR%252BInhibitor%26aulast%3DLobben%26aufirst%3DPaul%2BC.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D15042014%26date%3D29052014%26date%3D21082015%26date%3D15052014%26volume%3D19%26issue%3D8%26spage%3D900%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaan A.  Pesti</span>, <span class="hlFld-ContribAuthor ">Thomas  LaPorte</span>, <span class="hlFld-ContribAuthor ">John E.  Thornton</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Frederic  Buono</span>, <span class="hlFld-ContribAuthor ">Gerard  Crispino</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Paul  Lobben</span>, and <span class="hlFld-ContribAuthor ">Christos G.  Papaioannou</span>  . </span><span class="cited-content_cbyCitation_article-title">Commercial Synthesis of a Pyrrolotriazine–Fluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (1)
                                     , 89-102. <a href="https://doi.org/10.1021/op400242j" title="DOI URL">https://doi.org/10.1021/op400242j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400242j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400242j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCommercial%252BSynthesis%252Bof%252Ba%252BPyrrolotriazine%2525E2%252580%252593Fluoroindole%252BIntermediate%252Bto%252BBrivanib%252BAlaninate%25253A%252BProcess%252BDevelopment%252BDirected%252Btoward%252BImpurity%252BControl%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D01092013%26date%3D10122013%26date%3D17012014%26date%3D02122013%26volume%3D18%26issue%3D1%26spage%3D89%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Weiping  Zhu</span>, <span class="hlFld-ContribAuthor ">Xianwen  Cao</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Shaoying  Tan</span>, <span class="hlFld-ContribAuthor ">Dong  Kuang</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, and <span class="hlFld-ContribAuthor ">Xuhong  Qian</span>  . </span><span class="cited-content_cbyCitation_article-title">Acenaphtho[1,2-b]pyrrole-Based Selective Fibroblast Growth Factor Receptors 1 (FGFR1) Inhibitors: Design, Synthesis, and Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (11)
                                     , 3732-3745. <a href="https://doi.org/10.1021/jm200258t" title="DOI URL">https://doi.org/10.1021/jm200258t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200258t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200258t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcenaphtho%25255B1%25252C2-b%25255Dpyrrole-Based%252BSelective%252BFibroblast%252BGrowth%252BFactor%252BReceptors%252B1%252B%252528FGFR1%252529%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%26aulast%3DChen%26aufirst%3DZhuo%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D16122010%26date%3D13052011%26date%3D09062011%26date%3D25042011%26volume%3D54%26issue%3D11%26spage%3D3732%26epage%3D3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunsong  Tong</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Bouska</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">Joel  Leverson</span>, <span class="hlFld-ContribAuthor ">Xuesong  Liu</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Marcotte</span>, <span class="hlFld-ContribAuthor ">Amanda M.  Olson</span>, <span class="hlFld-ContribAuthor ">Donald J.  Osterling</span>, <span class="hlFld-ContribAuthor ">Magdalena  Przytulinska</span>, <span class="hlFld-ContribAuthor ">Luis E.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Nirupama  Soni</span>, <span class="hlFld-ContribAuthor ">Jason  Stavropoulos</span>, <span class="hlFld-ContribAuthor ">Sheela  Thomas</span>, <span class="hlFld-ContribAuthor ">Cherrie K.  Donawho</span>, <span class="hlFld-ContribAuthor ">David J.  Frost</span>, <span class="hlFld-ContribAuthor ">Yan  Luo</span>, <span class="hlFld-ContribAuthor ">Vincent L.  Giranda</span> and <span class="hlFld-ContribAuthor ">Thomas D.  Penning</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6803-6813. <a href="https://doi.org/10.1021/jm900697r" title="DOI URL">https://doi.org/10.1021/jm900697r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900697r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900697r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252Ba%252BNew%252BGeneration%252Bof%252BOrally%252BEfficacious%252BBenzimidazole-Based%252BPoly%252528ADP-ribose%252529%252BPolymerase-1%252B%252528PARP-1%252529%252BInhibitors%252Bas%252BAnticancer%252BAgents%26aulast%3DTong%26aufirst%3DYunsong%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D22052009%26date%3D21102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6803%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashvinikumar V.  Gavai</span>, <span class="hlFld-ContribAuthor ">Brian E.  Fink</span>, <span class="hlFld-ContribAuthor ">David J.  Fairfax</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Martin</span>, <span class="hlFld-ContribAuthor ">Lana M.  Rossiter</span>, <span class="hlFld-ContribAuthor ">Christian L.  Holst</span>, <span class="hlFld-ContribAuthor ">Soong-Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Leavitt</span>, <span class="hlFld-ContribAuthor ">Harold  Mastalerz</span>, <span class="hlFld-ContribAuthor ">Wen-Ching  Han</span>, <span class="hlFld-ContribAuthor ">Derek  Norris</span>, <span class="hlFld-ContribAuthor ">Bindu  Goyal</span>, <span class="hlFld-ContribAuthor ">Shankar  Swaminathan</span>, <span class="hlFld-ContribAuthor ">Bharat  Patel</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Dolatrai M.  Vyas</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Chiang  Yu</span>, <span class="hlFld-ContribAuthor ">Simone  Oppenheimer</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Francis Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Tai W.  Wong</span> and <span class="hlFld-ContribAuthor ">Gregory D.  Vite</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid, (3S)-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6527-6530. <a href="https://doi.org/10.1021/jm9010065" title="DOI URL">https://doi.org/10.1021/jm9010065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9010065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9010065%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BEvaluation%252Bof%252B%25255B4-%25255B%25255B1-%2525283-fluorophenyl%252529methyl%25255D-1H-indazol-5-ylamino%25255D-5-methylpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-6-yl%25255Dcarbamic%252BAcid%25252C%252B%2525283S%252529-3-Morpholinylmethyl%252BEster%252B%252528BMS-599626%252529%25252C%252Ba%252BSelective%252Band%252BOrally%252BEfficacious%252BInhibitor%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B1%252Band%252B2%252BKinases%26aulast%3DGavai%26aufirst%3DAshvinikumar%2BV.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D08072009%26date%3D12102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6527%26epage%3D6530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Roza  Kazemi</span>, <span class="hlFld-ContribAuthor ">Ramadevi  Sanam</span>, <span class="hlFld-ContribAuthor ">Ravikumar  Muttineni</span>, <span class="hlFld-ContribAuthor ">Jagarlapudi A. R. P.  Sarma</span>, <span class="hlFld-ContribAuthor ">Raveendra  Dayam</span> and <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (12)
                                     , 3367-3377. <a href="https://doi.org/10.1021/jm7013875" title="DOI URL">https://doi.org/10.1021/jm7013875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSmall-Molecule%252BInhibitors%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor-2%25253A%252BCombined%252BLigand%252Band%252BTarget-Based%252BApproach%26aulast%3DGundla%26aufirst%3DRambabu%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D26%252006%25202008%26date%3D24%252005%25202008%26date%3D05%252011%25202007%26volume%3D51%26issue%3D12%26spage%3D3367%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-wei  Cai</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Stephanie  Barbosa</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zheng</span>, <span class="hlFld-ContribAuthor ">Lawrence  Wu</span>, <span class="hlFld-ContribAuthor ">Junying  Fan</span>, <span class="hlFld-ContribAuthor ">Zhongping  Shi</span>, <span class="hlFld-ContribAuthor ">Barri S.  Wautlet</span>, <span class="hlFld-ContribAuthor ">Steve  Mortillo</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan, Sr.</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Kukral</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">George  Derbin</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span> and <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1976-1980. <a href="https://doi.org/10.1021/jm7013309" title="DOI URL">https://doi.org/10.1021/jm7013309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBrivanib%252BAlaninate%252B%252528%252528S%252529-%252528%252528R%252529-1-%2525284-%2525284-Fluoro-2-methyl-1H-indol-5-yloxy%252529-5-methylpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-6-yloxy%252529propan-2-yl%2525292-aminopropanoate%252529%25252C%252BA%252BNovel%252BProdrug%252Bof%252BDual%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor-1%252BKinase%252BInhibitor%252B%252528BMS-540215%252529%26aulast%3DCai%26aufirst%3DZhen-wei%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D21%252002%25202008%26date%3D23%252010%25202007%26volume%3D51%26issue%3D6%26spage%3D1976%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Hynes, Jr.</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">Steven B.  Kanner</span>, <span class="hlFld-ContribAuthor ">Herinder  Lonial</span>, <span class="hlFld-ContribAuthor ">Derek  Loo</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">XiaoXia  Yang</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Kamelia  Behnia</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Matthew  Pokross</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span> and <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (1)
                                     , 4-16. <a href="https://doi.org/10.1021/jm7009414" title="DOI URL">https://doi.org/10.1021/jm7009414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7009414%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAnti-inflammatory%252BProperties%252Bof%252BOrally%252BActive%252B4-%252528Phenylamino%252529-pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bp38%2525CE%2525B1%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DHynes%26aufirst%3DJohn%26date%3D2008%26date%3D2007%26date%3D2007%26date%3D2%252011%25202007%26date%3D31%252007%25202007%26date%3D26%252010%25202007%26date%3D12%252012%25202007%26date%3D10%25201%25202008%26volume%3D51%26issue%3D1%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaurav S.  Rai</span>, <span class="hlFld-ContribAuthor ">Jayesh J.  Maru</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (12)
                                     , 1517-1522. <a href="https://doi.org/10.1007/s10593-020-02844-9" title="DOI URL">https://doi.org/10.1007/s10593-020-02844-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02844-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02844-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthetic%252Bstrategies%252Bfor%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%25253A%252Bthe%252Bparent%252Bmoiety%252Bof%252Bantiviral%252Bdrug%252Bremdesivir%26aulast%3DRai%26aufirst%3DGaurav%2BS.%26date%3D2020%26date%3D2021%26volume%3D56%26issue%3D12%26spage%3D1517%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna  Volynets</span>, <span class="hlFld-ContribAuthor ">Sergiy  Lukashov</span>, <span class="hlFld-ContribAuthor ">Iryna  Borysenko</span>, <span class="hlFld-ContribAuthor ">Andrii  Gryshchenko</span>, <span class="hlFld-ContribAuthor ">Sergiy  Starosyla</span>, <span class="hlFld-ContribAuthor ">Volodymyr  Bdzhola</span>, <span class="hlFld-ContribAuthor ">Tetiana  Ruban</span>, <span class="hlFld-ContribAuthor ">Anna  Iatsyshyna</span>, <span class="hlFld-ContribAuthor ">Lyubov  Lukash</span>, <span class="hlFld-ContribAuthor ">Yaroslav  Bilokin</span>, <span class="hlFld-ContribAuthor ">Sergiy  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of protein kinase fibroblast growth factor receptor 1 (FGFR1) inhibitors among the derivatives of 5-(5,6-dimethoxybenzimidazol-1-yl)-3-hydroxythiophene-2-carboxylic acid. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2019,</strong> <em>150 </em>
                                    (10)
                                     , 1801-1808. <a href="https://doi.org/10.1007/s00706-019-02493-5" title="DOI URL">https://doi.org/10.1007/s00706-019-02493-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-019-02493-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-019-02493-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DIdentification%252Bof%252Bprotein%252Bkinase%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B1%252B%252528FGFR1%252529%252Binhibitors%252Bamong%252Bthe%252Bderivatives%252Bof%252B5-%2525285%25252C6-dimethoxybenzimidazol-1-yl%252529-3-hydroxythiophene-2-carboxylic%252Bacid%26aulast%3DVolynets%26aufirst%3DGalyna%26date%3D2019%26date%3D2019%26volume%3D150%26issue%3D10%26spage%3D1801%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Hao  Qiang</span>, <span class="hlFld-ContribAuthor ">Dandan  Huang</span>, <span class="hlFld-ContribAuthor ">Xinzhou  Bi</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 814-831. <a href="https://doi.org/10.1016/j.ejmech.2018.09.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bwith%252Bimproved%252Banticancer%252Befficacy%252Bas%252Bdual%252Binhibitors%252Bof%252Bc-Met%25252FVEGFR-2%26aulast%3DShi%26aufirst%3DWei%26date%3D2018%26volume%3D158%26spage%3D814%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 328-375. <a href="https://doi.org/10.1016/j.ejmech.2017.08.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bon%252Bthe%252Brecent%252Bdevelopments%252Bof%252B1%25252C2%25252C4-triazine%252Bderivatives%252Bas%252Banticancer%252Bcompounds%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D328%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, <span class="hlFld-ContribAuthor ">David A.  Favor</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4238-4246. <a href="https://doi.org/10.1016/j.bmcl.2017.07.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazines%25253A%252BFrom%252BC-nucleosides%252Bto%252Bkinases%252Band%252Bback%252Bagain%25252C%252Bthe%252Bremarkable%252Bjourney%252Bof%252Ba%252Bversatile%252Bnitrogen%252Bheterocycle%26aulast%3DOtt%26aufirst%3DGregory%2BR.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4238%26epage%3D4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjeet  Kumar</span>, <span class="hlFld-ContribAuthor ">Praveen  Singh</span>, <span class="hlFld-ContribAuthor ">Simon  Parsons</span>, <span class="hlFld-ContribAuthor ">Ashish K.  Tewari</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental and Theoretical Study for the Assessment of the Conformational Analysis of Pyrazolone Derivatives: Employing Quantitative Analysis for Intermolecular Interactions. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (22)
                                     , 6331-6337. <a href="https://doi.org/10.1002/slct.201700764" title="DOI URL">https://doi.org/10.1002/slct.201700764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700764%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DExperimental%252Band%252BTheoretical%252BStudy%252Bfor%252Bthe%252BAssessment%252Bof%252Bthe%252BConformational%252BAnalysis%252Bof%252BPyrazolone%252BDerivatives%25253A%252BEmploying%252BQuantitative%252BAnalysis%252Bfor%252BIntermolecular%252BInteractions%26aulast%3DKumar%26aufirst%3DRanjeet%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D22%26spage%3D6331%26epage%3D6337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Qu</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>, <span class="hlFld-ContribAuthor ">J. S.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2)
                                     , 111-132. <a href="https://doi.org/10.1080/1062936X.2017.1284898" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1284898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1284898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1284898%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DSAR%252Band%252BQSAR%252Bstudy%252Bon%252Bthe%252Bbioactivities%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DQu%26aufirst%3DD.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D2%26spage%3D111%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shada J  Alabed</span>, <span class="hlFld-ContribAuthor ">Mohammad  Khanfar</span>, <span class="hlFld-ContribAuthor ">Mutasem O  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided discovery of new FGFR-1 inhibitors followed by
              in vitro
              validation. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (15)
                                     , 1841-1869. <a href="https://doi.org/10.4155/fmc-2016-0056" title="DOI URL">https://doi.org/10.4155/fmc-2016-0056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0056%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DComputer-aided%252Bdiscovery%252Bof%252Bnew%252BFGFR-1%252Binhibitors%252Bfollowed%252Bby%252Bin%252Bvitro%252Bvalidation%26aulast%3DAlabed%26aufirst%3DShada%2BJ%26date%3D2016%26volume%3D8%26issue%3D15%26spage%3D1841%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Jingwei  Shao</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Sufen  Cao</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2594-2599. <a href="https://doi.org/10.1016/j.bmcl.2016.04.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolylaminoquinazoline%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Bpan-fibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DFan%26aufirst%3DJun%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2594%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han Kiat  Ho</span>, <span class="hlFld-ContribAuthor ">Angie Hui Ling  Yeo</span>, <span class="hlFld-ContribAuthor ">Tse Siang  Kang</span>, <span class="hlFld-ContribAuthor ">Boon Tin  Chua</span>. </span><span class="cited-content_cbyCitation_article-title">Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (1)
                                     , 51-62. <a href="https://doi.org/10.1016/j.drudis.2013.07.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.07.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.07.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCurrent%252Bstrategies%252Bfor%252Binhibiting%252BFGFR%252Bactivities%252Bin%252Bclinical%252Bapplications%25253A%252Bopportunities%25252C%252Bchallenges%252Band%252Btoxicological%252Bconsiderations%26aulast%3DHo%26aufirst%3DHan%2BKiat%26date%3D2014%26volume%3D19%26issue%3D1%26spage%3D51%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gijs  Koopmanschap</span>, <span class="hlFld-ContribAuthor ">Eelco  Ruijter</span>, <span class="hlFld-ContribAuthor ">Romano VA  Orru</span>. </span><span class="cited-content_cbyCitation_article-title">Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 544-598. <a href="https://doi.org/10.3762/bjoc.10.50" title="DOI URL">https://doi.org/10.3762/bjoc.10.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.50%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIsocyanide-based%252Bmulticomponent%252Breactions%252Btowards%252Bcyclic%252Bconstrained%252Bpeptidomimetics%26aulast%3DKoopmanschap%26aufirst%3DGijs%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D544%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SHINICHIRO  MASEKI</span>, <span class="hlFld-ContribAuthor ">KEI  IJICHI</span>, <span class="hlFld-ContribAuthor ">HAYAO  NAKANISHI</span>, <span class="hlFld-ContribAuthor ">YASUHISA  HASEGAWA</span>, <span class="hlFld-ContribAuthor ">TETSUYA  OGAWA</span>, <span class="hlFld-ContribAuthor ">SHINGO  MURAKAMI</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Clinical Oncology</span><span> <strong>2013,</strong> <em>1 </em>
                                    (5)
                                     , 918-924. <a href="https://doi.org/10.3892/mco.2013.159" title="DOI URL">https://doi.org/10.3892/mco.2013.159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/mco.2013.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fmco.2013.159%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Clinical%2520Oncology%26atitle%3DEfficacy%252Bof%252Bgemcitabine%252Band%252Bcetuximab%252Bcombination%252Btreatment%252Bin%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%26aulast%3DMASEKI%26aufirst%3DSHINICHIRO%26date%3D2013%26date%3D2013%26volume%3D1%26issue%3D5%26spage%3D918%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Shariq  Syed</span>, <span class="hlFld-ContribAuthor ">Yuan-Qing  Xia</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Mohammed  Jemal</span>, <span class="hlFld-ContribAuthor ">W. Griff  Humphreys</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Chiral Inversion of Brivanib and Its Relevance to Safety and Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (12)
                                     , 2374-2380. <a href="https://doi.org/10.1124/dmd.112.047340" title="DOI URL">https://doi.org/10.1124/dmd.112.047340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.047340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.047340%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolic%252BChiral%252BInversion%252Bof%252BBrivanib%252Band%252BIts%252BRelevance%252Bto%252BSafety%252Band%252BPharmacology%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2374%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer molecules targeting fibroblast growth factor receptors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (10)
                                     , 531-541. <a href="https://doi.org/10.1016/j.tips.2012.07.001" title="DOI URL">https://doi.org/10.1016/j.tips.2012.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DAnticancer%252Bmolecules%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2012%26volume%3D33%26issue%3D10%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Szuster-Ciesielska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Sztanke</span>, <span class="hlFld-ContribAuthor ">Martyna  Kandefer-Szerszeń</span>. </span><span class="cited-content_cbyCitation_article-title">A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A2A receptors in ethanol-activated liver stellate cells. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2012,</strong> <em>195 </em>
                                    (1)
                                     , 18-24. <a href="https://doi.org/10.1016/j.cbi.2011.10.004" title="DOI URL">https://doi.org/10.1016/j.cbi.2011.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2011.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2011.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DA%252Bnovel%252Bfused%252B1%25252C2%25252C4-triazine%252Baryl%252Bderivative%252Bas%252Bantioxidant%252Band%252Bnonselective%252Bantagonist%252Bof%252Badenosine%252BA2A%252Breceptors%252Bin%252Bethanol-activated%252Bliver%252Bstellate%252Bcells%26aulast%3DSzuster-Ciesielska%26aufirst%3DAgnieszka%26date%3D2012%26volume%3D195%26issue%3D1%26spage%3D18%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang Min  Park</span>, <span class="hlFld-ContribAuthor ">Dong Ju  Jeon</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis of novel pyrazole derivatives using tert-butansulfonamide as a chiral auxiliary. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2012,</strong> <em>10 </em>
                                    (13)
                                     , 2613. <a href="https://doi.org/10.1039/c2ob06495b" title="DOI URL">https://doi.org/10.1039/c2ob06495b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ob06495b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ob06495b%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DStereoselective%252Bsynthesis%252Bof%252Bnovel%252Bpyrazole%252Bderivatives%252Busing%252Btert-butansulfonamide%252Bas%252Ba%252Bchiral%252Bauxiliary%26aulast%3DPark%26aufirst%3DChang%2BMin%26date%3D2012%26volume%3D10%26issue%3D13%26spage%3D2613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Oxidative and Conjugative Enzymes Involved in the Biotransformation of Brivanib. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (1)
                                     , 219-226. <a href="https://doi.org/10.1124/dmd.111.042457" title="DOI URL">https://doi.org/10.1124/dmd.111.042457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.111.042457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.111.042457%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DIdentification%252Bof%252Bthe%252BOxidative%252Band%252BConjugative%252BEnzymes%252BInvolved%252Bin%252Bthe%252BBiotransformation%252Bof%252BBrivanib%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2011%26volume%3D40%26issue%3D1%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Gómez de la Oliva</span>, <span class="hlFld-ContribAuthor ">Pilar  Goya Laza</span>, <span class="hlFld-ContribAuthor ">Carmen  Ochoa de Ocariz</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Heterocycles: Triazines, Tetrazines and Other Polyaza Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 1777-1864. <a href="https://doi.org/10.1002/9783527637737.ch20" title="DOI URL">https://doi.org/10.1002/9783527637737.ch20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527637737.ch20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527637737.ch20%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BHeterocycles%25253A%252BTriazines%25252C%252BTetrazines%252Band%252BOther%252BPolyaza%252BSystems%26aulast%3DG%25C3%25B3mez%2Bde%2Bla%2BOliva%26aufirst%3DCristina%26date%3D2011%26date%3D2011%26spage%3D1777%26epage%3D1864%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DModern%252BHeterocyclic%252BChemistry%26aulast%3DAlvarez-Builla%26aufirst%3DJulio%26date%3D2011%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Kaczanowska</span>, <span class="hlFld-ContribAuthor ">Holger  Eickhoff</span>, <span class="hlFld-ContribAuthor ">Klaus  Albert</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Wiesmüller</span>, <span class="hlFld-ContribAuthor ">Arnaud-Pierre  Schaffner</span>. </span><span class="cited-content_cbyCitation_article-title">A simple, diversity oriented synthesis of highly substituted pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2011,</strong> <em>48 </em>
                                    (4)
                                     , 792-798. <a href="https://doi.org/10.1002/jhet.614" title="DOI URL">https://doi.org/10.1002/jhet.614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.614%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252Bsimple%25252C%252Bdiversity%252Boriented%252Bsynthesis%252Bof%252Bhighly%252Bsubstituted%252Bpyridines%26aulast%3DKaczanowska%26aufirst%3DKatarzyna%26date%3D2011%26date%3D2011%26volume%3D48%26issue%3D4%26spage%3D792%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Janet  Caceres-Cortes</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Christopher</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Alban  Allentoff</span>, <span class="hlFld-ContribAuthor ">Michael  Lago</span>, <span class="hlFld-ContribAuthor ">Scott B.  Tran</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism and Disposition of [
              14
              C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2011,</strong> <em>39 </em>
                                    (5)
                                     , 891-903. <a href="https://doi.org/10.1124/dmd.110.037341" title="DOI URL">https://doi.org/10.1124/dmd.110.037341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.110.037341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.110.037341%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Band%252BDisposition%252Bof%252B%25255B%252B14%252BC%25255DBrivanib%252BAlaninate%252Bafter%252BOral%252BAdministration%252Bto%252BRats%25252C%252BMonkeys%25252C%252Band%252BHumans%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2011%26date%3D2011%26volume%3D39%26issue%3D5%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine Y.  Shiang</span>, <span class="hlFld-ContribAuthor ">Yuan  Qi</span>, <span class="hlFld-ContribAuthor ">Bailiang  Wang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Lazar</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">W.  Fraser Symmans</span>, <span class="hlFld-ContribAuthor ">Gabriel N.  Hortobagyi</span>, <span class="hlFld-ContribAuthor ">Fabrice  Andre</span>, <span class="hlFld-ContribAuthor ">Lajos  Pusztai</span>. </span><span class="cited-content_cbyCitation_article-title">Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2010,</strong> <em>123 </em>
                                    (3)
                                     , 747-755. <a href="https://doi.org/10.1007/s10549-009-0677-6" title="DOI URL">https://doi.org/10.1007/s10549-009-0677-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-009-0677-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-009-0677-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DAmplification%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor-1%252Bin%252Bbreast%252Bcancer%252Band%252Bthe%252Beffects%252Bof%252Bbrivanib%252Balaninate%26aulast%3DShiang%26aufirst%3DChristine%2BY.%26date%3D2010%26date%3D2009%26volume%3D123%26issue%3D3%26spage%3D747%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bristi  Basu</span>, <span class="hlFld-ContribAuthor ">Tim  Eisen</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives in drug development for metastatic renal cell cancer. </span><span class="cited-content_cbyCitation_journal-name">Targeted Oncology</span><span> <strong>2010,</strong> <em>5 </em>
                                    (2)
                                     , 139-156. <a href="https://doi.org/10.1007/s11523-010-0149-2" title="DOI URL">https://doi.org/10.1007/s11523-010-0149-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11523-010-0149-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11523-010-0149-2%26sid%3Dliteratum%253Aachs%26jtitle%3DTargeted%2520Oncology%26atitle%3DPerspectives%252Bin%252Bdrug%252Bdevelopment%252Bfor%252Bmetastatic%252Brenal%252Bcell%252Bcancer%26aulast%3DBasu%26aufirst%3DBristi%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D2%26spage%3D139%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.A.  Pasha</span>, <span class="hlFld-ContribAuthor ">M.  Muddassar</span>, <span class="hlFld-ContribAuthor ">M.M.  Neaz</span>, <span class="hlFld-ContribAuthor ">Seung Joo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore and docking-based combined in-silico study of KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2009,</strong> <em>28 </em>
                                    (1)
                                     , 54-61. <a href="https://doi.org/10.1016/j.jmgm.2009.04.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2009.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2009.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Band%252Bdocking-based%252Bcombined%252Bin-silico%252Bstudy%252Bof%252BKDR%252Binhibitors%26aulast%3DPasha%26aufirst%3DF.A.%26date%3D2009%26volume%3D28%26issue%3D1%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">John E.  Leet</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Ravindra W.  Tejwani</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Donna D.  Wei</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-
              N
              -(2-methyl-1
              H
              -pyrrolo[2,3-
              b
              ]pyridin-5-yl)pyrrolo[2,1-
              f
              ][1,2,4]triazin-4-amine (BMS-645737): Identification of an Unusual
              N
              -Acetylglucosamine Conjugate in the Cynomolgus Monkey. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2008,</strong> <em>36 </em>
                                    (12)
                                     , 2475-2483. <a href="https://doi.org/10.1124/dmd.108.022624" title="DOI URL">https://doi.org/10.1124/dmd.108.022624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.108.022624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.108.022624%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Bof%252B5-Isopropyl-6-%2525285-methyl-1%25252C3%25252C4-oxadiazol-2-yl%252529-%252BN%252B-%2525282-methyl-1%252BH%252B-pyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridin-5-yl%252529pyrrolo%25255B2%25252C1-%252Bf%252B%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-amine%252B%252528BMS-645737%252529%25253A%252BIdentification%252Bof%252Ban%252BUnusual%252BN%252B-Acetylglucosamine%252BConjugate%252Bin%252Bthe%252BCynomolgus%252BMonkey%26aulast%3DJohnson%26aufirst%3DBenjamin%2BM.%26date%3D2008%26date%3D2008%26volume%3D36%26issue%3D12%26spage%3D2475%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Gretchen M.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Lyndon A.M.  Cornelius</span>, <span class="hlFld-ContribAuthor ">Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Xiao-Tao  Chen</span>, <span class="hlFld-ContribAuthor ">Robert J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">David K.  Williams</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Yongmi  An</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Veeraswamy  Manne</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (11)
                                     , 3224-3229. <a href="https://doi.org/10.1016/j.bmcl.2008.04.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Borally%252Bactive%252Bpyrrolopyridine-%252Band%252Baminopyridine-based%252BMet%252Bkinase%252Binhibitors%26aulast%3DCai%26aufirst%3DZhen-Wei%26date%3D2008%26volume%3D18%26issue%3D11%26spage%3D3224%26epage%3D3229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Réjean  Ruel</span>, <span class="hlFld-ContribAuthor ">Carl  Thibeault</span>, <span class="hlFld-ContribAuthor ">Alexandre  L’Heureux</span>, <span class="hlFld-ContribAuthor ">Alain  Martel</span>, <span class="hlFld-ContribAuthor ">Zhen-Wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">George  Derbin</span>, <span class="hlFld-ContribAuthor ">Barri  Wautlet</span>, <span class="hlFld-ContribAuthor ">Steven  Mortillo</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">Benjamin  Henley</span>, <span class="hlFld-ContribAuthor ">Ravindra  Tejwani</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">George L.  Trainor</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (9)
                                     , 2985-2989. <a href="https://doi.org/10.1016/j.bmcl.2008.03.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.03.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.03.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bpreclinical%252Bstudies%252Bof%252B5-isopropyl-6-%2525285-methyl-1%25252C3%25252C4-oxadiazol-2-yl%252529-N-%2525282-methyl-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridin-5-yl%252529pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-amine%252B%252528BMS-645737%252529%25252C%252Ban%252Bin%252Bvivo%252Bactive%252Bpotent%252BVEGFR-2%252Binhibitor%26aulast%3DRuel%26aufirst%3DR%25C3%25A9jean%26date%3D2008%26volume%3D18%26issue%3D9%26spage%3D2985%26epage%3D2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Tredup</span>, <span class="hlFld-ContribAuthor ">Gerald J.  Duke</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (8)
                                     , 2739-2744. <a href="https://doi.org/10.1016/j.bmcl.2008.02.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.02.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.02.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.02.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bnew%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazines%252Bas%252Bpotent%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DWrobleski%26aufirst%3DStephen%2BT.%26date%3D2008%26volume%3D18%26issue%3D8%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gretchen M.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Xiao-Tao  Chen</span>, <span class="hlFld-ContribAuthor ">David K.  Williams</span>, <span class="hlFld-ContribAuthor ">David S.  Nirschl</span>, <span class="hlFld-ContribAuthor ">Zhen-Wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Yongmi  An</span>, <span class="hlFld-ContribAuthor ">John  Sack</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Tram  Huynh</span>, <span class="hlFld-ContribAuthor ">Wayne  Vaccaro</span>, <span class="hlFld-ContribAuthor ">Michael  Poss</span>, <span class="hlFld-ContribAuthor ">Barri  Wautlet</span>, <span class="hlFld-ContribAuthor ">Johnni  Gullo-Brown</span>, <span class="hlFld-ContribAuthor ">Kristen  Kellar</span>, <span class="hlFld-ContribAuthor ">Veeraswamy  Manne</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Tai W.  Wong</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (6)
                                     , 1945-1951. <a href="https://doi.org/10.1016/j.bmcl.2008.01.121" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.01.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.01.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.01.121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-based%252Binhibitors%252Bof%252BMet%252Bkinase%26aulast%3DSchroeder%26aufirst%3DGretchen%2BM.%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D1945%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiazhong  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Qin</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Mancang  Liu</span>, <span class="hlFld-ContribAuthor ">Zhide  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Prediction of Inhibition Activity of Pyrazine–Pyridine Biheteroaryls as VEGFR-2 Inhibitors Based on Least Squares Support Vector Machines. </span><span class="cited-content_cbyCitation_journal-name">QSAR & Combinatorial Science</span><span> <strong>2008,</strong> <em>27 </em>
                                    (2)
                                     , 157-164. <a href="https://doi.org/10.1002/qsar.200630154" title="DOI URL">https://doi.org/10.1002/qsar.200630154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qsar.200630154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqsar.200630154%26sid%3Dliteratum%253Aachs%26jtitle%3DQSAR%2520%2526%2520Combinatorial%2520Science%26atitle%3DIn%252BSilico%252BPrediction%252Bof%252BInhibition%252BActivity%252Bof%252BPyrazine%2525E2%252580%252593Pyridine%252BBiheteroaryls%252Bas%252BVEGFR-2%252BInhibitors%252BBased%252Bon%252BLeast%252BSquares%252BSupport%252BVector%252BMachines%26aulast%3DLi%26aufirst%3DJiazhong%26date%3D2008%26volume%3D27%26issue%3D2%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Steven  Mortillo</span>, <span class="hlFld-ContribAuthor ">Barri  Wautlet</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Henley</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">John  Tokarski</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (4)
                                     , 1354-1358. <a href="https://doi.org/10.1016/j.bmcl.2008.01.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252BSAR%25252C%252Band%252BEvaluation%252Bof%252B4-%25255B2%25252C4-Difluoro-5-%252528cyclopropylcarbamoyl%252529phenylamino%25255Dpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-based%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DCai%26aufirst%3DZhen-wei%26date%3D2008%26volume%3D18%26issue%3D4%26spage%3D1354%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Ciapetti</span>, <span class="hlFld-ContribAuthor ">Bruno  Giethlen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Variations Based on Isosteric Replacements. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 290-342. <a href="https://doi.org/10.1016/B978-0-12-374194-3.00015-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-374194-3.00015-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-374194-3.00015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-374194-3.00015-9%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BVariations%252BBased%252Bon%252BIsosteric%252BReplacements%26aulast%3DCiapetti%26aufirst%3DPaola%26date%3D2008%26spage%3D290%26epage%3D342%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Ciapetti</span>, <span class="hlFld-ContribAuthor ">Bruno  Giethlen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Variations Based on Isosteric Replacements. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 181-241. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00008-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00008-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00008-0%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BVariations%252BBased%252Bon%252BIsosteric%252BReplacements%26aulast%3DCiapetti%26aufirst%3DPaola%26date%3D2008%26spage%3D181%26epage%3D241%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Suwiński</span>, <span class="hlFld-ContribAuthor ">W.  Szczepankiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,4-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 397-466. <a href="https://doi.org/10.1016/B978-008044992-0.00506-X" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.00506-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.00506-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.00506-X%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3%25252C4-Oxadiazoles%26aulast%3DSuwi%25C5%2584ski%26aufirst%3DJ.%26date%3D2008%26spage%3D397%26epage%3D466%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">T.  Constantieux</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems with One Bridgehead (Ring Junction) Nitrogen Atom: Two Extra Heteroatoms 0:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 629-644. <a href="https://doi.org/10.1016/B978-008044992-0.01014-2" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.01014-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.01014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.01014-2%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252Bwith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BTwo%252BExtra%252BHeteroatoms%252B0%25253A2%26aulast%3DRodriguez%26aufirst%3DJ.%26date%3D2008%26spage%3D629%26epage%3D644%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Mandracchia</span>, <span class="hlFld-ContribAuthor ">Antonio Palumbo  Piccionello</span>, <span class="hlFld-ContribAuthor ">Giovanna  Pitarresi</span>, <span class="hlFld-ContribAuthor ">Andrea  Pace</span>, <span class="hlFld-ContribAuthor ">Silvestre  Buscemi</span>, <span class="hlFld-ContribAuthor ">Gaetano  Giammona</span>. </span><span class="cited-content_cbyCitation_article-title">Fluoropolymer Based on a Polyaspartamide containing 1,2,4-Oxadiazole Units: A Potential Artificial Oxygen (O2) Carrier. </span><span class="cited-content_cbyCitation_journal-name">Macromolecular Bioscience</span><span> <strong>2007,</strong> <em>7 </em>
                                    (6)
                                     , 836-845. <a href="https://doi.org/10.1002/mabi.200600266" title="DOI URL">https://doi.org/10.1002/mabi.200600266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mabi.200600266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmabi.200600266%26sid%3Dliteratum%253Aachs%26jtitle%3DMacromolecular%2520Bioscience%26atitle%3DFluoropolymer%252BBased%252Bon%252Ba%252BPolyaspartamide%252Bcontaining%252B1%25252C2%25252C4-Oxadiazole%252BUnits%25253A%252BA%252BPotential%252BArtificial%252BOxygen%252B%252528O2%252529%252BCarrier%26aulast%3DMandracchia%26aufirst%3DDelia%26date%3D2007%26volume%3D7%26issue%3D6%26spage%3D836%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Yu</span>, <span class="hlFld-ContribAuthor ">Zhanli  Wang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Jufeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling and in silico screening for new KDR kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (8)
                                     , 2126-2133. <a href="https://doi.org/10.1016/j.bmcl.2007.01.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.01.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.01.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.01.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacophore%252Bmodeling%252Band%252Bin%252Bsilico%252Bscreening%252Bfor%252Bnew%252BKDR%252Bkinase%252Binhibitors%26aulast%3DYu%26aufirst%3DHui%26date%3D2007%26volume%3D17%26issue%3D8%26spage%3D2126%26epage%3D2133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Yu</span>, <span class="hlFld-ContribAuthor ">Zhanli  Wang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Jufeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Novel Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibitors: Pharmacophore Modeling, Virtual Screening and Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2007,</strong> <em>69 </em>
                                    (3)
                                     , 204-211. <a href="https://doi.org/10.1111/j.1747-0285.2007.00488.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2007.00488.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2007.00488.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2007.00488.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DThe%252BDiscovery%252Bof%252BNovel%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinases%252BInhibitors%25253A%252BPharmacophore%252BModeling%25252C%252BVirtual%252BScreening%252Band%252BDocking%252BStudies%26aulast%3DYu%26aufirst%3DHui%26date%3D2007%26volume%3D69%26issue%3D3%26spage%3D204%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pilar  Goya</span>, <span class="hlFld-ContribAuthor ">Cristina Gómez  de la Oliva</span>. </span><span class="cited-content_cbyCitation_article-title">Triazines, tetrazines and fused ring polyaza systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2007,</strong>,, 353-375. <a href="https://doi.org/10.1016/S0959-6380(07)80018-3" title="DOI URL">https://doi.org/10.1016/S0959-6380(07)80018-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(07)80018-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2807%2980018-3%26sid%3Dliteratum%253Aachs%26atitle%3DTriazines%25252C%252Btetrazines%252Band%252Bfused%252Bring%252Bpolyaza%252Bsystems%26aulast%3DGoya%26aufirst%3DPilar%26date%3D2007%26spage%3D353%26epage%3D375%26pub%3DElsevier%26atitle%3DA%252Bcritical%252Breview%252Bof%252Bthe%252B2005%252Bliterature%252Bpreceded%252Bby%252Btwo%252Bchapters%252Bon%252Bcurrent%252Bheterocyclic%252Btopics%26date%3D2007%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raveendra  Dayam</span>, <span class="hlFld-ContribAuthor ">Fedora  Grande</span>, <span class="hlFld-ContribAuthor ">Laith Q  Al-Mawsawi</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the design and discovery of small-molecule therapeutics targeting HER2/neu. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2007,</strong> <em>17 </em>
                                    (1)
                                     , 83-102. <a href="https://doi.org/10.1517/13543776.17.1.83" title="DOI URL">https://doi.org/10.1517/13543776.17.1.83</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.17.1.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.17.1.83%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdesign%252Band%252Bdiscovery%252Bof%252Bsmall-molecule%252Btherapeutics%252Btargeting%252BHER2%25252Fneu%26aulast%3DDayam%26aufirst%3DRaveendra%26date%3D2007%26date%3D2007%26volume%3D17%26issue%3D1%26spage%3D83%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long-Chih  Hwang</span>, <span class="hlFld-ContribAuthor ">Shin-Yi  Jane</span>, <span class="hlFld-ContribAuthor ">Hsing-Yi  Lai</span>, <span class="hlFld-ContribAuthor ">Chun-Hsien  Tu</span>, <span class="hlFld-ContribAuthor ">Gene-Hsiang  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Structure and Characterization of Allylic Derivatives of 6-Amino-3-methyl-1,2,4-triazolo[3,4-f][1,2,4]-triazin-8(7H)-one. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2006,</strong> <em>11 </em>
                                    (6)
                                     , 444-452. <a href="https://doi.org/10.3390/11060444" title="DOI URL">https://doi.org/10.3390/11060444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/11060444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2F11060444%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BMolecular%252BStructure%252Band%252BCharacterization%252Bof%252BAllylic%252BDerivatives%252Bof%252B6-Amino-3-methyl-1%25252C2%25252C4-triazolo%25255B3%25252C4-f%25255D%25255B1%25252C2%25252C4%25255D-triazin-8%2525287H%252529-one%26aulast%3DHwang%26aufirst%3DLong-Chih%26date%3D2006%26date%3D2006%26volume%3D11%26issue%3D6%26spage%3D444%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María  Sañudo</span>, <span class="hlFld-ContribAuthor ">Stefano  Marcaccini</span>, <span class="hlFld-ContribAuthor ">Sara  Basurto</span>, <span class="hlFld-ContribAuthor ">Tomás  Torroba</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-Hydroxy-6-oxo[1,2,4]triazin-1-yl Alaninamides, a New Class of Cyclic Dipeptidyl Ureas. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2006,</strong> <em>71 </em>
                                    (12)
                                     , 4578-4584. <a href="https://doi.org/10.1021/jo060434y" title="DOI URL">https://doi.org/10.1021/jo060434y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo060434y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo060434y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3-Hydroxy-6-oxo%25255B1%25252C2%25252C4%25255Dtriazin-1-yl%252BAlaninamides%25252C%252Ba%252BNew%252BClass%252Bof%252BCyclic%252BDipeptidyl%252BUreas%26aulast%3DSa%25C3%25B1udo%26aufirst%3DMar%25C3%25ADa%26date%3D2006%26volume%3D71%26issue%3D12%26spage%3D4578%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chukwuemeka  Isanbor</span>, <span class="hlFld-ContribAuthor ">David  O’Hagan</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine in medicinal chemistry: A review of anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2006,</strong> <em>127 </em>
                                    (3)
                                     , 303-319. <a href="https://doi.org/10.1016/j.jfluchem.2006.01.011" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2006.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2006.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2006.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DFluorine%252Bin%252Bmedicinal%252Bchemistry%25253A%252BA%252Breview%252Bof%252Banti-cancer%252Bagents%26aulast%3DIsanbor%26aufirst%3DChukwuemeka%26date%3D2006%26volume%3D127%26issue%3D3%26spage%3D303%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc D.  Ogan</span>, <span class="hlFld-ContribAuthor ">Scott Bach  Tran</span>, <span class="hlFld-ContribAuthor ">J. Kent  Rinehart</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of [13C4,15N2]pyrrolo[2,1-f][1,2,4]triazinone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2006,</strong> <em>49 </em>
                                    (2)
                                     , 139-145. <a href="https://doi.org/10.1002/jlcr.1030" title="DOI URL">https://doi.org/10.1002/jlcr.1030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.1030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.1030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DSynthesis%252Bof%252B%25255B13C4%25252C15N2%25255Dpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazinone%26aulast%3DOgan%26aufirst%3DMarc%2BD.%26date%3D2006%26date%3D2006%26volume%3D49%26issue%3D2%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nancy E.  Hynes</span>, <span class="hlFld-ContribAuthor ">Anne  Boulay</span>. </span><span class="cited-content_cbyCitation_article-title">The mTOR Pathway in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Mammary Gland Biology and Neoplasia</span><span> <strong>2006,</strong> <em>11 </em>
                                    (1)
                                     , 53-61. <a href="https://doi.org/10.1007/s10911-006-9012-6" title="DOI URL">https://doi.org/10.1007/s10911-006-9012-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10911-006-9012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10911-006-9012-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Mammary%2520Gland%2520Biology%2520and%2520Neoplasia%26atitle%3DThe%252BmTOR%252BPathway%252Bin%252BBreast%252BCancer%26aulast%3DHynes%26aufirst%3DNancy%2BE.%26date%3D2006%26date%3D2006%26volume%3D11%26issue%3D1%26spage%3D53%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275c00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275c00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275c00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Examples of VEGFR-2 Inhibitors Undergoing Clinical Trials </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275c00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275c00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275f00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00001.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Evolution of the hydroxamate series of VEGFR-2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275h00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00001.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) Ph<sub>2</sub>PO<sub>2</sub>NH<sub>2</sub> or Me<sub>3</sub>PhSO<sub>3</sub>NH<sub>2</sub>, NaH, DMF, 85%; (b) formamide, 165 °C, 90%; (c) POCl<sub>3</sub>, 110 °C, 3 h, 90%; (d) X = O:  K<sub>2</sub>CO<sub>3</sub>, DMF, 25 °C, 18 h, X = NH:  DMF, 25 °C, 12−18 h.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275h00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00002.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) 1 N NaOH, THF−H<sub>2</sub>O, 60 °C, 27 h, 98%; (b) DPPA, 1,4-dioxane, Et<sub>3</sub>N, 40 °C, 1 h, 99%; (c) R<sup>2</sup>OH, DMF, 85 °C, 2 h, 50−65%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275h00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00003.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) 1 N NaOH, THF−H<sub>2</sub>O, 60 °C, 98%; (b) 1-aminopropan-2-one, BOP reagent, Et<sub>3</sub>N, DMF, 50 °C, 2 h, 61%; (c) POCl<sub>3</sub>, 120 °C, 6 h; (d) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, MeCN, 25 °C, 18 h; (e) (1) <i>N</i>-hydroxyacetamidine, TBTU, cat. HOBt, <i>i</i>-Pr<sub>2</sub>NEt, DMF, 1.5 h, (2) DMF, 140 °C, 3 h, 57% overall.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275h00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00004.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) (1) NH<sub>2</sub>OH−HCl, K<sub>2</sub>CO<sub>3</sub>, EtOH reflux, 28 h, (2) AcCl, pyridine reflux, 7 h, 11% overall; (b) POCl<sub>3</sub>, 120 °C, 5 h; (c) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, MeCN, 25 °C, 14 h; 30% from <b>33</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275h00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275h00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) RCO<sub>2</sub>H, POCl<sub>3</sub>, 100 °C, 1 h then 120 °C, 3 h; (b) 5-amino-2,4-difluoro-<i>N</i>-methoxybenzamide, DMF, 50 °C, 1−6 h; (c) LiN[Si(CH<sub>3</sub>)<sub>3</sub>]<sub>2</sub>, (PhSO<sub>2</sub>)<sub>2</sub>NF, THF, −78 to −30 °C, 1 h, 65%; (d) acetamidine-HCl, DMF, 120 °C, 1 h, 86%; (e) POCl<sub>3</sub>, 120 °C, 5 h; (f) 71% overall yield from <b>51</b>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275h00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275h00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275f00002" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00002.jpeg" id="rightTab-_i23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Binding model of compound <b>50</b> in the ATP binding site of VEGFR-2 kinase. Carbon atoms of <b>50</b> are in green and carbon atoms of the protein are in gray. Potential hydrogen-bond interactions are indicated by magenta dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0501275f00003" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/medium/jm0501275f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00003.jpeg" id="rightTab-_i25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Antitumor activity of compound <b>50</b> against established L2987 human tumor xenografts implanted subcutaneously in athymic mice. Arrows indicate dosing (qd × 10).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-12/jm0501275/production/images/large/jm0501275f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0501275&amp;id=jm0501275f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004801204006" id="jm004801204006"></a></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm0501275b00001"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00001_1"><span><span class="NLM_string-ref">(a) Folkman, J.; Shing, Y. Angiogenesis. <i>  J. Biol. Chem.</i><b>1992</b>, <i>267</i>, 10931−10934.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Folkman%2C+J.%3B+Shing%2C+Y.+Angiogenesis.+J.+Biol.+Chem.+1992%2C+267%2C+10931%E2%88%9210934.+%28a%29+Folkman%2C+J.%3B+Shing%2C+Y.+Angiogenesis.+J.+Biol.+Chem.1992%2C+267%2C+10931%E2%88%9210934."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00001_2"><span><span class="NLM_string-ref">(b) Griffioen, A. W.; Molema, G. Angiogenesis:  Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. <i>  Pharmacol. Rev.</i><b>2000</b>, <i>52</i>, 237−268.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=268&author=A.+W.+Griffioen&author=G.+Molema&author=+Angiogenesis&title=Potentials+for+pharmacologic+intervention+in+the+treatment+of+cancer%2C+cardiovascular+diseases%2C+and+chronic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00001_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26atitle%3DPotentials%2520for%2520pharmacologic%2520intervention%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520cardiovascular%2520diseases%252C%2520and%2520chronic%2520inflammation%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00002"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00002_1"><span><span class="NLM_string-ref">Folkman, J.; Klagsbrun, M. Angiogenic factors. <i>  Science</i><b>1987</b>, <i>235</i>, 442−447.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1987&pages=447&author=J.+Folkman&author=M+Klagsbrun&title=Angiogenic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenic%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D235%26spage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00003"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00003_1"><span><span class="NLM_string-ref">(a) Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. <i>  Nat. Med.</i><b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00003_2"><span><span class="NLM_string-ref">(b) Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. <i>  Nature</i><b>2000</b>, <i>407</i>, 249−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=257&author=P.+Carmeliet&author=R.+K+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00003_3"><span><span class="NLM_string-ref">(c) Folkman, J. Angiogenesis-dependent diseases. <i>  Semin. Oncol.</i><b>2001</b>, <i>28</i>, 536−542.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=542&author=J+Folkman&title=Angiogenesis-dependent+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis-dependent%2520diseases%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00003_4"><span><span class="NLM_string-ref">(d) Fan, T.-P. D.; Jaggar, R.; Bicknell, R. Controlling the vasculature:  Angiogenesis, anti-angiogenesis and vascular targeting gene therapy. <i>  Trends Pharm. Sci.</i><b>1995</b>, <i>16</i>, 57−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=66&author=T.-P.+D.+Fan&author=R.+Jaggar&author=R+Bicknell&title=Controlling+the+vasculature%3A%E2%80%89+Angiogenesis%2C+anti-angiogenesis+and+vascular+targeting+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00003_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.-P.%2BD.%26atitle%3DControlling%2520the%2520vasculature%253A%25E2%2580%2589%2520Angiogenesis%252C%2520anti-angiogenesis%2520and%2520vascular%2520targeting%2520gene%2520therapy%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00004"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00004_1"><span><span class="NLM_string-ref">(a) Koch, A. E. Angiogenesis as a target in rheumatoid arthritis. <i>  Ann. </i><i>Rheum. Dis.</i><b>2003</b>, <i>62</i>, ii60-ii67.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=i60&author=A.+E+Koch&title=Angiogenesis+as+a+target+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE%26atitle%3DAngiogenesis%2520as%2520a%2520target%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2003%26volume%3D62%26spage%3Di60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00004_2"><span><span class="NLM_string-ref">(b) Walsh, D. A. Angiogenesis and arthritis. <i>  Rheumatol.</i><b>1999</b>, <i>38</i>, 103−112.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=112&author=D.+A+Walsh&title=Angiogenesis+and+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA%26atitle%3DAngiogenesis%2520and%2520arthritis%26jtitle%3DRheumatol.%26date%3D1999%26volume%3D38%26spage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00004_3"><span><span class="NLM_string-ref">(c) Koch, A. E. Angiogenesis:  Implications for rheumatoid arthritis. <i>  Arthritis Rheum.</i><b>1998</b>, <i>41</i>, 951−962.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=962&author=A.+E.+Koch&author=+Angiogenesis&title=Implications+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00004_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DA.%2BE.%26atitle%3DImplications%2520for%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1998%26volume%3D41%26spage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00005"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00005_1"><span><span class="NLM_string-ref">(a) Folkman, J. Anti-angiogenesis:  New concept for therapy of solid tumors. <i>  Ann. Surg.</i><b>1972</b>, <i>175</i>, 409−416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1972&pages=416&author=J.+Folkman&author=+Anti&title=New+concept+for+therapy+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DNew%2520concept%2520for%2520therapy%2520of%2520solid%2520tumors%26jtitle%3DAnn.%2520Surg.%26date%3D1972%26volume%3D175%26spage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00005_2"><span><span class="NLM_string-ref">(b) Folkman, J. What is the evidence that tumors are angiogenesis dependent? <i>J. Natl. Cancer Inst.</i><b>1990</b>, <i>83</i>, 4−6.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1990&pages=6&author=J+Folkman&title=What+is+the+evidence+that+tumors+are+angiogenesis+dependent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DWhat%2520is%2520the%2520evidence%2520that%2520tumors%2520are%2520angiogenesis%2520dependent%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D83%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00006"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00006_1"><span><span class="NLM_string-ref">(a) Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. <i>  J. Biol. Chem.</i><b>1996</b>, <i>271</i>, 603−606.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=606&author=K.+A+Thomas&title=Vascular+endothelial+growth+factor%2C+a+potent+and+selective+angiogenic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DK.%2BA%26atitle%3DVascular%2520endothelial%2520growth%2520factor%252C%2520a%2520potent%2520and%2520selective%2520angiogenic%2520agent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00006_2"><span><span class="NLM_string-ref">(b) Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. <i>  Endocr. Rev.</i><b>1997</b>, <i>18</i>, 4−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=25&author=N.+Ferrara&author=T+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocr.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00006_3"><span><span class="NLM_string-ref">(c) Ferrara, N. VEGF:  An update on biological and therapeutic aspects. <i>  Curr. Opin. Biotech</i>. <b>2000</b>, <i>11</i>, 617−624.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=624&author=N.+Ferrara&title=An+update+on+biological+and+therapeutic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00006_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DAn%2520update%2520on%2520biological%2520and%2520therapeutic%2520aspects%26jtitle%3DCurr.%2520Opin.%2520Biotech.%26date%3D2000%26volume%3D11%26spage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00007"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00007_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapySuccesses and failures. <i>  Exp. Opin. Ther. Targets</i><b>2003</b>, <i>7</i>, 215−234.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=234&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapySuccesses+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapySuccesses%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26spage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00008"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00008_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discov. Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00009"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00009_1"><span><span class="NLM_string-ref">(a) Caponigro, F. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. <i>  Anti-Cancer Drugs</i><b>2004</b>, <i>15</i>, 311−320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=320&author=F+Caponigro&title=Rationale+and+clinical+validation+of+epidermal+growth+factor+receptor+as+a+target+in+the+treatment+of+head+and+neck+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaponigro%26aufirst%3DF%26atitle%3DRationale%2520and%2520clinical%2520validation%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520as%2520a%2520target%2520in%2520the%2520treatment%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00009_2"><span><span class="NLM_string-ref">(b) Tiseo, M.; Loprevite, M.; Ardizzoni, A. Epidermal growth factor receptor inhibitors:  A new prospective in the treatment of lung cancer. <i>  Curr. Med. Chem.:  Anti-Cancer </i><i>Agents</i><b>2004</b>, <i>4</i>, 139−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Tiseo&author=M.+Loprevite&author=A.+Ardizzoni&title=Epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+A+new+prospective+in+the+treatment+of+lung+cancer.+Curr.+Med.+Chem.%3A%E2%80%89+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00009_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTiseo%26aufirst%3DM.%26btitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520A%2520new%2520prospective%2520in%2520the%2520treatment%2520of%2520lung%2520cancer.%2520Curr.%2520Med.%2520Chem.%253A%25E2%2580%2589%2520Anti-Cancer%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm0501275b00010_1"><span><span class="NLM_string-ref">(a) Zondor, S. D.; Medina, P. J. Bevacizumab:  An angiogenesis inhibitor with efficacy in colorectal and other malignancies. <i>  Annals of </i><i>Pharmacotherapy</i><b>2004</b>, <i>38</i>, 1258−1264.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=1264&author=S.+D.+Zondor&author=P.+J.+Medina&author=+Bevacizumab&title=An+angiogenesis+inhibitor+with+efficacy+in+colorectal+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZondor%26aufirst%3DS.%2BD.%26atitle%3DAn%2520angiogenesis%2520inhibitor%2520with%2520efficacy%2520in%2520colorectal%2520and%2520other%2520malignancies%26jtitle%3DAnnals%2520of%2520Pharmacotherapy%26date%3D2004%26volume%3D38%26spage%3D1264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00010_2"><span><span class="NLM_string-ref">(b) Ferrara, N.; Hillan, K. J.; Gerber, H.-P.; Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. <i>  Nat. Rev. Drug Disc</i>. <b>2004</b>, <i>3</i>, 391−400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=400&author=N.+Ferrara&author=K.+J.+Hillan&author=H.-P.+Gerber&author=W+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Disc.%26date%3D2004%26volume%3D3%26spage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00010_3"><span><span class="NLM_string-ref">(c) Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. <i>  New Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2335−2342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2342&author=H.+Hurwitz&author=L.+Fehrenbacher&author=W.+Novotny&author=T.+Cartwright&author=J.+Hainsworth&author=W.+Heim&author=J.+Berlin&author=A.+Baron&author=S.+Griffing&author=E.+Holmgren&author=N.+Ferrara&author=G.+Fyfe&author=B.+Rogers&author=R.+Ross&author=F+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00011"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00011_1"><span><span class="NLM_string-ref">(a) Underiner, T. L.; Ruggeri, B.; Gingrich, D. E. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. <i>  Curr. Med. Chem. </i><b>2004</b>, <i>11</i>, 731−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=745&author=T.+L.+Underiner&author=B.+Ruggeri&author=D.+E+Gingrich&title=Development+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+kinase+inhibitors+as+anti-angiogenic+agents+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00011_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Fraley, M. E.; Hartman, G. D. Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents. <i>  Exp. Opin. Invest. Drugs </i><b>2002</b>, <i>11</i>, 737−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=745&author=M.+T.+Bilodeau&author=M.+E.+Fraley&author=G.+D+Hartman&title=Kinase+insert+domain-containing+receptor+kinase+inhibitors+as+anti-angiogenic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DKinase%2520insert%2520domain-containing%2520receptor%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00011_3"><span><span class="NLM_string-ref">(b) Sepp-Lorenzino, L.; Thomas, K. A. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. <i>  Exp. Opin. Investig. </i><i>Drugs </i><b>2002</b>, <i>11</i>, 1447−1465.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1465&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothelial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00012"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00012_1"><span><span class="NLM_string-ref">(a) Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rösel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2189&author=J.+M.+Wood&author=G.+Bold&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=J.+Frei&author=F.+Hofmann&author=J.+Mestan&author=H.+Mett&author=T.+O%27Reilly&author=E.+Persohn&author=J.+R%C3%B6sel&author=C.+Schnell&author=D.+Stover&author=A.+Theuer&author=H.+Towbin&author=F.+Wenger&author=K.+Woods-Cook&author=A.+Menrad&author=G.+Siemeister&author=M.+Schirner&author=K.-H.+Thierauch&author=M.+R.+Schneider&author=J.+Drevs&author=G.+Martiny-Baron&author=F.+Totzke&author=D.+Marm%C3%A9&title=a+novel+and+potent+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases%2C+impairs+vascular+endothelial+growth+factor-induced+responses+and+tumor+growth+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3Da%2520novel%2520and%2520potent%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%252C%2520impairs%2520vascular%2520endothelial%2520growth%2520factor-induced%2520responses%2520and%2520tumor%2520growth%2520after%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00012_2"><span><span class="NLM_string-ref">(b) Bold, G.; Altmann, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Brüggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rösel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lässer, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altmann&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Br%C3%BCggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+R%C3%B6sel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+L%C3%A4sser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+anilinophthalazines+as+potent+and+orally+well+absorbed+inhibitors+of+the+VEGF+receptor+tyrosine+kinases+useful+as+antagonists+of+tumor-driven+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520anilinophthalazines%2520as%2520potent%2520and%2520orally%2520well%2520absorbed%2520inhibitors%2520of%2520the%2520VEGF%2520receptor%2520tyrosine%2520kinases%2520useful%2520as%2520antagonists%2520of%2520tumor-driven%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00012_3"><span><span class="NLM_string-ref">(c) Furet, P.; Bold, G.; Hofmann, F.; Manley, P.; Meyer, T.; Altmann, K.-H. Identification of a newchemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2967−2971.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2971&author=P.+Furet&author=G.+Bold&author=F.+Hofmann&author=P.+Manley&author=T.+Meyer&author=K.-H+Altmann&title=Identification+of+a+newchemical+class+of+potent+angiogenesis+inhibitors+based+on+conformational+considerations+and+database+searching"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%2520newchemical%2520class%2520of%2520potent%2520angiogenesis%2520inhibitors%2520based%2520on%2520conformational%2520considerations%2520and%2520database%2520searching%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00012_4"><span><span class="NLM_string-ref">(d) Manley, P. W.; Furet, P.; Bold, G.; Brüggen, J.; Mestan, J.; Meyer, T.; Schnell, C. R.; Wood, J.; Haberey, M.; Huth, A.; Krüger, M.; Menrad, A.; Ottow, E.; Seidelmann, D.; Siemeister, G.; Thierauch, K.-H. Anthranilic acid amides:  A novel class of antiangiogenic VEGF receptor kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 5687−5693.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5693&author=P.+W.+Manley&author=P.+Furet&author=G.+Bold&author=J.+Br%C3%BCggen&author=J.+Mestan&author=T.+Meyer&author=C.+R.+Schnell&author=J.+Wood&author=M.+Haberey&author=A.+Huth&author=M.+Kr%C3%BCger&author=A.+Menrad&author=E.+Ottow&author=D.+Seidelmann&author=G.+Siemeister&author=K.-H+Thierauch&title=Anthranilic+acid+amides%3A%E2%80%89+A+novel+class+of+antiangiogenic+VEGF+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00012_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26atitle%3DAnthranilic%2520acid%2520amides%253A%25E2%2580%2589%2520A%2520novel%2520class%2520of%2520antiangiogenic%2520VEGF%2520receptor%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00013"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00013_1"><span><span class="NLM_string-ref">(a) Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.; Fukuda, J. Y.; Chu, J.-Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T. C.; Tang, F.; Wei, J.; Tang, C. Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 1116−1119.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1119&author=L.+Sun&author=C.+Liang&author=S.+Shirazian&author=Y.+Zhou&author=T.+Miller&author=J.+Cui&author=J.+Y.+Fukuda&author=J.-Y.+Chu&author=A.+Nematalla&author=X.+Wang&author=H.+Chen&author=A.+Sistla&author=T.+C.+Luu&author=F.+Tang&author=J.+Wei&author=C+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00013_2"><span><span class="NLM_string-ref">(b) Abrams, T. J.; Murray, L. J.; Pesenti, E.; Walker Holway, V.; Colombo, T.; Lee, L. B.; Cherrington, J. M.; Pryer, N. K. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer. <i>  Mol. Cancer Ther.</i><b>2003</b>, <i>2</i>, 1011−1021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1021&author=T.+J.+Abrams&author=L.+J.+Murray&author=E.+Pesenti&author=V.+Walker+Holway&author=T.+Colombo&author=L.+B.+Lee&author=J.+M.+Cherrington&author=N.+K.+Pryer&author=+Preclinical&title=%E2%80%9Cstandard+of+care%E2%80%9D+therapeutic+agents+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26atitle%3D%25E2%2580%259Cstandard%2520of%2520care%25E2%2580%259D%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00013_3"><span><span class="NLM_string-ref">(c) Sun, L.; Tran, N.; Liang, C.; Hubbard, S.; Tang, F.; Lipson, K.; Schreck, R.; Zhou, Y.; McMahon, G.; Tang, C. Identification of substituted 3-[(4,5,6,7-tetrahydro-1<i>H</i>-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ tyrosine kinases. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 2655−2663.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2663&author=L.+Sun&author=N.+Tran&author=C.+Liang&author=S.+Hubbard&author=F.+Tang&author=K.+Lipson&author=R.+Schreck&author=Y.+Zhou&author=G.+McMahon&author=C+Tang&title=Identification+of+substituted+3-%5B%284%2C5%2C6%2C7-tetrahydro-1H-indol-2-yl%29methylene%5D-1%2C3-dihydroindol-2-ones+as+growth+factor+receptor+inhibitors+for+VEGF-R2+%28Flk-1%2FKDR%29%2C+FGF-R1%2C+and+PDGF-R%CE%B2+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520substituted%25203-%255B%25284%252C5%252C6%252C7-tetrahydro-1H-indol-2-yl%2529methylene%255D-1%252C3-dihydroindol-2-ones%2520as%2520growth%2520factor%2520receptor%2520inhibitors%2520for%2520VEGF-R2%2520%2528Flk-1%252FKDR%2529%252C%2520FGF-R1%252C%2520and%2520PDGF-R%25CE%25B2%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00013_4"><span><span class="NLM_string-ref">(d) Fong, T. A. T.; Shawver, L. K.; Sun, L.; Tang, C.; App, H.; Powell, T. J.; Kim, Y. H.; Schreck, R.; Wang, X.; Risau, W.; Ullrich, A.; Hirth, K. P.; McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. <i>  Cancer Res.</i><b>1999</b>, <i>59</i>, 99−106.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=106&author=T.+A.+T.+Fong&author=L.+K.+Shawver&author=L.+Sun&author=C.+Tang&author=H.+App&author=T.+J.+Powell&author=Y.+H.+Kim&author=R.+Schreck&author=X.+Wang&author=W.+Risau&author=A.+Ullrich&author=K.+P.+Hirth&author=G.+McMahon&title=is+a+potent+and+selective+inhibitor+of+the+vascular+endothelial+growth+factor+receptor+%28Flk-1%2FKDR%29+that+inhibits+tyrosine+kinase+catalysis%2C+tumor+vascularization%2C+and+growth+of+multiple+tumor+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26atitle%3Dis%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528Flk-1%252FKDR%2529%2520that%2520inhibits%2520tyrosine%2520kinase%2520catalysis%252C%2520tumor%2520vascularization%252C%2520and%2520growth%2520of%2520multiple%2520tumor%2520types%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00013_5"><span><span class="NLM_string-ref">(e) Laird, A. D.; Vajkoczy, P.; Shawver, L. K.; Thurnher, A.; Liang, C.; Mohammadi, M.; Schlessinger, J.; Ullrich, A.; Hubbard, S. R.; Blake, R. A.; Fong, T. A. T.; Strawn, L. M.; Sun, L.; Tang, C.; Hawtin, R.; Tang, F.; Shenoy, N.; Hirth, K. P.; McMahon, G.; Cherrington, J. M. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 4152−4160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4160&author=A.+D.+Laird&author=P.+Vajkoczy&author=L.+K.+Shawver&author=A.+Thurnher&author=C.+Liang&author=M.+Mohammadi&author=J.+Schlessinger&author=A.+Ullrich&author=S.+R.+Hubbard&author=R.+A.+Blake&author=T.+A.+T.+Fong&author=L.+M.+Strawn&author=L.+Sun&author=C.+Tang&author=R.+Hawtin&author=F.+Tang&author=N.+Shenoy&author=K.+P.+Hirth&author=G.+McMahon&author=J.+M.+Cherrington&title=is+a+potent+antiangiogenic+and+antitumor+agent+that+induces+regression+of+established+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26atitle%3Dis%2520a%2520potent%2520antiangiogenic%2520and%2520antitumor%2520agent%2520that%2520induces%2520regression%2520of%2520established%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00013_6"><span><span class="NLM_string-ref">(f) Mendel, D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen, J. G.; Li, G.; Schreck, R. E.; Abrams, T. J.; Ngai, T. J.; Lee, L. B.; Murray, L. J.; Carver, J.; Chan, E.; Moss, K. G.; Haznedar, J. O.; Sukbuntherng, J.; Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian, S.; McMahon, G.; Cherrington, J. M. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors:  Determination of a pharmacokinetic/pharmacodynamic relationship. <i>  Clin. Cancer Res.</i><b>2003</b>, <i>9</i>, 327−337.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=337&author=D.+B.+Mendel&author=A.+D.+Laird&author=X.+Xin&author=S.+G.+Louie&author=J.+G.+Christensen&author=G.+Li&author=R.+E.+Schreck&author=T.+J.+Abrams&author=T.+J.+Ngai&author=L.+B.+Lee&author=L.+J.+Murray&author=J.+Carver&author=E.+Chan&author=K.+G.+Moss&author=J.+O.+Haznedar&author=J.+Sukbuntherng&author=R.+A.+Blake&author=L.+Sun&author=C.+Tang&author=T.+Miller&author=S.+Shirazian&author=G.+McMahon&author=J.+M+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors%3A%E2%80%89+Determination+of+a+pharmacokinetic%2Fpharmacodynamic+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00013_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%253A%25E2%2580%2589%2520Determination%2520of%2520a%2520pharmacokinetic%252Fpharmacodynamic%2520relationship%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00014"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00014_1"><span><span class="NLM_string-ref">(a) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+Design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520Design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00014_2"><span><span class="NLM_string-ref">(b) McCarty, M. F.; Wey, J.; Stoeltzing, O.; Liu, W.; Fan, F.; Bucana, C.; Mansfield, P. F.; Ryan, A. J.; Ellis, L. M. ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer<i>. Mol. Cancer Ther.</i><b>2004</b>, <i>3</i>, 1041−1048.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1048&author=M.+F.+McCarty&author=J.+Wey&author=O.+Stoeltzing&author=W.+Liu&author=F.+Fan&author=C.+Bucana&author=P.+F.+Mansfield&author=A.+J.+Ryan&author=L.+M.+Ellis&title=a+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+additional+activity+against+epidermal+growth+factor+receptor+tyrosine+kinase%2C+inhibits+orthotopic+growth+and+angiogenesis+of+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarty%26aufirst%3DM.%2BF.%26atitle%3Da%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520additional%2520activity%2520against%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%252C%2520inhibits%2520orthotopic%2520growth%2520and%2520angiogenesis%2520of%2520gastric%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00014_3"><span><span class="NLM_string-ref">(c) Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P. A.; Lohmann, J.-J. M.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-van der Brempt, C. Design and structure−activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+A.+Pl%C3%A9&author=J.-J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+structure%E2%88%92activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00014_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00015"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00015_1"><span><span class="NLM_string-ref">(a) Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+characterization+of+CP-547%2C632%2C+a+novel+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520characterization%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00015_2"><span><span class="NLM_string-ref">(b) Munchhof, M. J.; Beebe, J. S.; Casavant, J. M.; Cooper, B. A.; Doty, J. L.; Higdon, R. C.; Hillerman, S. M.; Soderstrom, C. I.; Knauth, E. A.; Marx, M. A.; Rossi, A. M. K.; Sobolov, S. B.; Sun, J. Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity. <i>  Bioorg. Med. Chem. </i><i>Lett. </i><b>2004</b>, <i>14</i>, 21−24.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=24&author=M.+J.+Munchhof&author=J.+S.+Beebe&author=J.+M.+Casavant&author=B.+A.+Cooper&author=J.+L.+Doty&author=R.+C.+Higdon&author=S.+M.+Hillerman&author=C.+I.+Soderstrom&author=E.+A.+Knauth&author=M.+A.+Marx&author=A.+M.+K.+Rossi&author=S.+B.+Sobolov&author=J+Sun&title=Design+and+SAR+of+thienopyrimidine+and+thienopyridine+inhibitors+of+VEGFR-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00015_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26atitle%3DDesign%2520and%2520SAR%2520of%2520thienopyrimidine%2520and%2520thienopyridine%2520inhibitors%2520of%2520VEGFR-2%2520kinase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00016"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00016_1"><span><span class="NLM_string-ref">(a) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Aimone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  Structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5- 4007  ones and the identification of CEP-5214 and its dimethylglycine  ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Aimone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+Structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C1-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-+4007++ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine++ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C1-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-%25204007%2520%2520ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00016_2"><span><span class="NLM_string-ref">(b) Ruggeri, B.; Singh, J.; Gingrich, D.; Angeles, T.; Albom, M.; Chang, H.; Robinson, C.; Hunter, K.; Dobrzanski, P.; Jones-Bolin, S.; Aimone, L.; Klein-Szanto, A.; Herbert, J.-M.; Bono, F.; Schaeffer, P.; Casellas, P.; Bourie, B.; Pili, R.; Isaacs, J.; Ator, M.; Hudkins, R.; Vaught, J.; Mallamo, J.; Dionne C. CEP-7055:  A novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 5978−5991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5991&author=B.+Ruggeri&author=J.+Singh&author=D.+Gingrich&author=T.+Angeles&author=M.+Albom&author=H.+Chang&author=C.+Robinson&author=K.+Hunter&author=P.+Dobrzanski&author=S.+Jones-Bolin&author=L.+Aimone&author=A.+Klein-Szanto&author=J.-M.+Herbert&author=F.+Bono&author=P.+Schaeffer&author=P.+Casellas&author=B.+Bourie&author=R.+Pili&author=J.+Isaacs&author=M.+Ator&author=R.+Hudkins&author=J.+Vaught&author=J.+Mallamo&author=C.+Dionne&title=orally+active+pan+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases+with+potent+antiangiogenic+activity+and+antitumor+efficacy+in+preclinical+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00016_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DB.%26atitle%3Dorally%2520active%2520pan%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%2520with%2520potent%2520antiangiogenic%2520activity%2520and%2520antitumor%2520efficacy%2520in%2520preclinical%2520models%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00017"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00017_1"><span><span class="NLM_string-ref">(a) Bilodeau, M. T.; Balitza, A. E.; Koester, T. J.; Manley, P. J.; Rodman, L. D.; Buser-Doepner, C.; Coll, K. E.; Fernandes, C.; Gibbs, J. B.; Heimbrook, D. C.; Huckle, W. R.; Kohl, N.; Lynch, J. J.; Mao, X.; McFall, R. C.; McLoughlin, D.; Miller-Stein, C. M.; Rickert, K. W.; Sepp-Lorenzino, L.; Shipman, J. M.; Subramanian, R.; Thomas, K. A.; Wong, B. K.; Yu, S.; Hartman, G. D. Potent <i>N</i>-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 6363−6372.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6372&author=M.+T.+Bilodeau&author=A.+E.+Balitza&author=T.+J.+Koester&author=P.+J.+Manley&author=L.+D.+Rodman&author=C.+Buser-Doepner&author=K.+E.+Coll&author=C.+Fernandes&author=J.+B.+Gibbs&author=D.+C.+Heimbrook&author=W.+R.+Huckle&author=N.+Kohl&author=J.+J.+Lynch&author=X.+Mao&author=R.+C.+McFall&author=D.+McLoughlin&author=C.+M.+Miller-Stein&author=K.+W.+Rickert&author=L.+Sepp-Lorenzino&author=J.+M.+Shipman&author=R.+Subramanian&author=K.+A.+Thomas&author=B.+K.+Wong&author=S.+Yu&author=G.+D.+Hartman&author=+Potent&title=vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors+with+excellent+pharmacokinetics+and+low+affinity+for+the+hERG+ion+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3Dvascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520with%2520excellent%2520pharmacokinetics%2520and%2520low%2520affinity%2520for%2520the%2520hERG%2520ion%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Rodman, L. D.; McGaughey, G. B.; Coll, K. E.; Koester, T. J.; Hoffman, W. F.; Hungate, R. W.; Kendall, R. L.; McFall, R. C.; Rickert, K. W.; Rutledge, R. Z.; Thomas, K. A. The discovery of <i>N</i>-(1,3-thiazol-2-yl)pyridine-2-amines as potent inhibitors of KDR kinase. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 2941−2945.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2945&author=M.+T.+Bilodeau&author=L.+D.+Rodman&author=G.+B.+McGaughey&author=K.+E.+Coll&author=T.+J.+Koester&author=W.+F.+Hoffman&author=R.+W.+Hungate&author=R.+L.+Kendall&author=R.+C.+McFall&author=K.+W.+Rickert&author=R.+Z.+Rutledge&author=K.+A+Thomas&title=The+discovery+of+N-%281%2C3-thiazol-2-yl%29pyridine-2-amines+as+potent+inhibitors+of+KDR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DThe%2520discovery%2520of%2520N-%25281%252C3-thiazol-2-yl%2529pyridine-2-amines%2520as%2520potent%2520inhibitors%2520of%2520KDR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_3"><span><span class="NLM_string-ref">(c) Fraley, M. E.; Arrington, K. L.; Buser, C. A.; Ciecko, P. A.; Coll, K. E.; Fernandes, C.; Hartman, G. D.; Hoffman, W. F.; Lynch, J. J.; McFall, R. C.; Rickert, K.; Singh, R.; Smith, S.; Thomas, K. A.; Wong, B. K. Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors:  Effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 351−355.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=355&author=M.+E.+Fraley&author=K.+L.+Arrington&author=C.+A.+Buser&author=P.+A.+Ciecko&author=K.+E.+Coll&author=C.+Fernandes&author=G.+D.+Hartman&author=W.+F.+Hoffman&author=J.+J.+Lynch&author=R.+C.+McFall&author=K.+Rickert&author=R.+Singh&author=S.+Smith&author=K.+A.+Thomas&author=B.+K+Wong&title=Optimization+of+the+indolyl+quinolinone+class+of+KDR+%28VEGFR-2%29+kinase+inhibitors%3A%E2%80%89+Effects+of+5-amido-+and+5-sulphonamido-indolyl+groups+on+pharmacokinetics+and+hERG+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DOptimization%2520of%2520the%2520indolyl%2520quinolinone%2520class%2520of%2520KDR%2520%2528VEGFR-2%2529%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Effects%2520of%25205-amido-%2520and%25205-sulphonamido-indolyl%2520groups%2520on%2520pharmacokinetics%2520and%2520hERG%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_4"><span><span class="NLM_string-ref">(d) Fraley, M. E.; Arrington, K. L.; Hambaugh, S. R.; Hoffman, W. F.; Cunningham, A. M.; Young, M. B.; Hungate, R. W.; Tebben, A. J.; Rutledge, R. Z.; Kendall, R. L.; Huckle, W. R.; McFall, R. C.; Coll, K. E.; Thomas, K. A. Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1<i>H</i>-indoles as a novel class of KDR kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2973−2976.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2976&author=M.+E.+Fraley&author=K.+L.+Arrington&author=S.+R.+Hambaugh&author=W.+F.+Hoffman&author=A.+M.+Cunningham&author=M.+B.+Young&author=R.+W.+Hungate&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+L.+Kendall&author=W.+R.+Huckle&author=R.+C.+McFall&author=K.+E.+Coll&author=K.+A+Thomas&title=Discovery+and+evaluation+of+3-%285-thien-3-ylpyridin-3-yl%29-1H-indoles+as+a+novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%25203-%25285-thien-3-ylpyridin-3-yl%2529-1H-indoles%2520as%2520a%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_5"><span><span class="NLM_string-ref">(e) Wu, Z.; Fraley, M. E.; Bilodeau, M. T.; Kaufman, M. L.; Tasber, E. S.; Balitza, A. E.; Hartman, G. D.; Coll, K. E.; Rickert, K.; Shipman, J.; Shi, B.; Sepp-Lorenzino, L.; Thomas, K. A. Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 909−912.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=912&author=Z.+Wu&author=M.+E.+Fraley&author=M.+T.+Bilodeau&author=M.+L.+Kaufman&author=E.+S.+Tasber&author=A.+E.+Balitza&author=G.+D.+Hartman&author=K.+E.+Coll&author=K.+Rickert&author=J.+Shipman&author=B.+Shi&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Design+and+synthesis+of+3%2C7-diarylimidazopyridines+as+inhibitors+of+the+VEGF-receptor+KDR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25203%252C7-diarylimidazopyridines%2520as%2520inhibitors%2520of%2520the%2520VEGF-receptor%2520KDR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_6"><span><span class="NLM_string-ref">(f) Bilodeau, M. T.; Cunningham, A. M.; Koester, T. J.; Ciecko, P. A.; Coll, K. E.; Huckle, W. R.; Hungate, R. W.; Kendall, R. L.; McFall, R. C.; Mao, X.; Rutledge, R. Z.; Thomas, K. A. Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of VEGF-receptor KDR. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 2485−2488.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2488&author=M.+T.+Bilodeau&author=A.+M.+Cunningham&author=T.+J.+Koester&author=P.+A.+Ciecko&author=K.+E.+Coll&author=W.+R.+Huckle&author=R.+W.+Hungate&author=R.+L.+Kendall&author=R.+C.+McFall&author=X.+Mao&author=R.+Z.+Rutledge&author=K.+A+Thomas&title=Design+and+synthesis+of+1%2C5-diarylbenzimidazoles+as+inhibitors+of+VEGF-receptor+KDR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DDesign%2520and%2520synthesis%2520of%25201%252C5-diarylbenzimidazoles%2520as%2520inhibitors%2520of%2520VEGF-receptor%2520KDR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_7"><span><span class="NLM_string-ref">(g) Manley, P. J.; Balitza, A. E.; Bilodeau, M. T.; Coll, K. E.; Hartman, G. D.; McFall, R. C.; Rickert, K. W.; Rodman, L. D.; Thomas, K. A. 2,4-Disubstituted pyrimidines:  A novel class of KDR kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2003</b>, <i>13</i>, 1673−1677.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1677&author=P.+J.+Manley&author=A.+E.+Balitza&author=M.+T.+Bilodeau&author=K.+E.+Coll&author=G.+D.+Hartman&author=R.+C.+McFall&author=K.+W.+Rickert&author=L.+D.+Rodman&author=K.+A.+Thomas&author=A+Disubstituted&title=novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26atitle%3Dnovel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_8"><span><span class="NLM_string-ref">(h) Fraley, M. E.; Rubino, R. S.; Hoffman, W. F.; Hambaugh, S. R.; Arrington, K. L.; Hungate, R. W.; Bilodeau, M. T.; Tebben, A. J.; Rutledge, R. Z.; Kendall, R. L.; McFall, R. C.; Huckle, W. R.; Coll, K. E.; Thomas, K. A. Optimization of a pyrazolo[1,5-<i>a</i>]pyrimidine class of KDR kinase inhibitors:  Improvements in physical properties enhance cellular activity and pharmacokinetics. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 3537−3541.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3541&author=M.+E.+Fraley&author=R.+S.+Rubino&author=W.+F.+Hoffman&author=S.+R.+Hambaugh&author=K.+L.+Arrington&author=R.+W.+Hungate&author=M.+T.+Bilodeau&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+L.+Kendall&author=R.+C.+McFall&author=W.+R.+Huckle&author=K.+E.+Coll&author=K.+A+Thomas&title=Optimization+of+a+pyrazolo%5B1%2C5-a%5Dpyrimidine+class+of+KDR+kinase+inhibitors%3A%E2%80%89+Improvements+in+physical+properties+enhance+cellular+activity+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DOptimization%2520of%2520a%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520class%2520of%2520KDR%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520Improvements%2520in%2520physical%2520properties%2520enhance%2520cellular%2520activity%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00017_9"><span><span class="NLM_string-ref">(i) Fraley, M. E.; Hoffman, W. F.; Rubino, R. S.; Hungate, R. W.; Tebben, A. J.; Rutledge, R. Z.; McFall, R. C.; Huckle, W. R.; Kendall, R. L.; Coll, K. E.; Thomas, K. A. Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-<i>a</i>]pyrimidines:  A new class of KDR kinase inhibitors. <i>  Bioorg. </i><i>Med. Chem. Lett.</i><b>2002</b>, <i>12</i>, 2767−2770.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2770&author=M.+E.+Fraley&author=W.+F.+Hoffman&author=R.+S.+Rubino&author=R.+W.+Hungate&author=A.+J.+Tebben&author=R.+Z.+Rutledge&author=R.+C.+McFall&author=W.+R.+Huckle&author=R.+L.+Kendall&author=K.+E.+Coll&author=K.+A+Thomas&title=Synthesis+and+initial+SAR+studies+of+3%2C6-disubstituted+pyrazolo%5B1%2C5-a%5Dpyrimidines%3A%E2%80%89+A+new+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00017_9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520initial%2520SAR%2520studies%2520of%25203%252C6-disubstituted%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%253A%25E2%2580%2589%2520A%2520new%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00018"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00018_1"><span><span class="NLM_string-ref">(a) Baindur, N.; Chadha, N.; Brandt, B. M.; Asgari, D.; Patch, R. J.; Schalk-HiHi, C.; Carver, T. E.; Petrounia, I. P.; Baumann, C. A.; Ott, H.; Manthey, C.; Springer, B. A.; Player, M. R. 2-Hydroxy-4,6-diamino-[1,3,5]triazines:  A novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 1717−1720.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1720&author=N.+Baindur&author=N.+Chadha&author=B.+M.+Brandt&author=D.+Asgari&author=R.+J.+Patch&author=C.+Schalk-HiHi&author=T.+E.+Carver&author=I.+P.+Petrounia&author=C.+A.+Baumann&author=H.+Ott&author=C.+Manthey&author=B.+A.+Springer&author=M.+R.+Player&author=+Hydroxy&title=novel+class+of+VEGF-R2+%28KDR%29+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaindur%26aufirst%3DN.%26atitle%3Dnovel%2520class%2520of%2520VEGF-R2%2520%2528KDR%2529%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00018_2"><span><span class="NLM_string-ref">(b) Kuo, G.-H.; Wang, A.; Emanuel, S.; DeAngelis, A.; Zhang, R.; Connolly, P. J.; Murray, W. V.; Gruninger, R. H.; Sechler, J.; Fuentes-Pesquera, A.; Johnson, D.; Middleton, S. A.; Jolliffe, L.; Chen, X. Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 1886−1900.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1900&author=G.-H.+Kuo&author=A.+Wang&author=S.+Emanuel&author=A.+DeAngelis&author=R.+Zhang&author=P.+J.+Connolly&author=W.+V.+Murray&author=R.+H.+Gruninger&author=J.+Sechler&author=A.+Fuentes-Pesquera&author=D.+Johnson&author=S.+A.+Middleton&author=L.+Jolliffe&author=X+Chen&title=Synthesis+and+discovery+of+pyrazine-pyridine+biheteroaryl+as+a+novel+series+of+potent+vascular+endothelial+growth+factor+receptor-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00018_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520pyrazine-pyridine%2520biheteroaryl%2520as%2520a%2520novel%2520series%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00019"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00019_1"><span><span class="NLM_string-ref">Cross, M. J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis:  Signalling pathways, biological responses and therapeutic inhibition. <i>  Trends Pharm. Sci.</i><b>2001</b>, <i>22</i>, 201−207.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=207&author=M.+J.+Cross&author=L+Claesson-Welsh&title=FGF+and+VEGF+function+in+angiogenesis%3A%E2%80%89+Signalling+pathways%2C+biological+responses+and+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%2BJ.%26atitle%3DFGF%2520and%2520VEGF%2520function%2520in%2520angiogenesis%253A%25E2%2580%2589%2520Signalling%2520pathways%252C%2520biological%2520responses%2520and%2520therapeutic%2520inhibition%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm0501275b00020_1"><span><span class="NLM_string-ref">Gerwins, P.; Sköldenberg, E.; Claesson-Welsh, L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. <i>  Crit. Rev. Onc. Hemat.</i><b>2000</b>, <i>34</i>, 185−194.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2000&pages=194&author=P.+Gerwins&author=E.+Sk%C3%B6ldenberg&author=L+Claesson-Welsh&title=Function+of+fibroblast+growth+factors+and+vascular+endothelial+growth+factors+and+their+receptors+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerwins%26aufirst%3DP.%26atitle%3DFunction%2520of%2520fibroblast%2520growth%2520factors%2520and%2520vascular%2520endothelial%2520growth%2520factors%2520and%2520their%2520receptors%2520in%2520angiogenesis%26jtitle%3DCrit.%2520Rev.%2520Onc.%2520Hemat.%26date%3D2000%26volume%3D34%26spage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00021"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00021_1"><span><span class="NLM_string-ref">Manetti, F.; Botta, M. Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK). <i>  Curr. Pharm. Des.</i><b>2003</b>, <i>9</i>, 567−581.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=581&author=F.+Manetti&author=M+Botta&title=Small-molecule+inhibitors+of+fibroblast+growth+factor+receptor+%28FGFR%29+tyrosine+kinases+%28TK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManetti%26aufirst%3DF.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520fibroblast%2520growth%2520factor%2520receptor%2520%2528FGFR%2529%2520tyrosine%2520kinases%2520%2528TK%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00022"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00022_1"><span><span class="NLM_string-ref">Boehm, T.; Folkman, J.; Browder, T.; O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. <i>  Nature</i><b>1997</b>, <i>390</i>, 404−409.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=409&author=T.+Boehm&author=J.+Folkman&author=T.+Browder&author=M.+S+O%27Reilly&title=Antiangiogenic+therapy+of+experimental+cancer+does+not+induce+acquired+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DT.%26atitle%3DAntiangiogenic%2520therapy%2520of%2520experimental%2520cancer%2520does%2520not%2520induce%2520acquired%2520drug%2520resistance%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00023"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00023_1"><span><span class="NLM_string-ref">(a) Hunt, J. T.; Mitt, T.; Borzilleri, R.; Gullo-Brown, J.; Fargnoli, J.; Fink, B.; Han, W.-C.; Mortillo, S.; Vite, G.; Wautlet, B.; Wong, T.; Zheng, X.; Bhide, R. Discovery of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine nucleus as a new kinase inhibitor template. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 4054−4059.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4059&author=J.+T.+Hunt&author=T.+Mitt&author=R.+Borzilleri&author=J.+Gullo-Brown&author=J.+Fargnoli&author=B.+Fink&author=W.-C.+Han&author=S.+Mortillo&author=G.+Vite&author=B.+Wautlet&author=T.+Wong&author=X.+Zheng&author=R+Bhide&title=Discovery+of+the+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+nucleus+as+a+new+kinase+inhibitor+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520the%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520nucleus%2520as%2520a%2520new%2520kinase%2520inhibitor%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00024"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00024_1"><span><span class="NLM_string-ref">(a) Borzilleri, R. M.; Fargnoli, J.; Fura, A.; Gerhardt, T.; Hunt, J. T.; Mortillo, S.; Qian, L.; Tokarski, J.; Vyas, V.; Wautlet, B.; Zheng, P.; Bhide, R. S. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2005</b>, <i>15</i>, 1429−1433.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1433&author=R.+M.+Borzilleri&author=J.+Fargnoli&author=A.+Fura&author=T.+Gerhardt&author=J.+T.+Hunt&author=S.+Mortillo&author=L.+Qian&author=J.+Tokarski&author=V.+Vyas&author=B.+Wautlet&author=P.+Zheng&author=R.+S+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0501275b00024_2"><span><span class="NLM_string-ref">(b) Leftheris, K.; Ahmed, G.; Chan, R.; Dyckman, A. J.; Hussain, Z.; Ho, K.; Hynes, J., Jr.; Letourneau, J.; Li, W.; Lin, S.; Metzger, A.; Moriarty, K. J.; Riviello, C.; Shimshock, Y.; Wen, J.; Wityak, J.; Wrobleski, S. T.; Wu, H.; Wu, J.; Desai, M.; Gillooly, K. M.; Lin, T. H.; Loo, D.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Shuster, D. J.; Zhang, R.; Diller, D.; Doweyko, A.; Sack, J.; Baldwin, J.; Barrish, J.; Dodd, J.; Henderson, I.; Kanner, S.; Schieven, G. L.; Webb, M. The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 6283−6291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6291&author=K.+Leftheris&author=G.+Ahmed&author=R.+Chan&author=A.+J.+Dyckman&author=Z.+Hussain&author=K.+Ho&author=J.+Hynes&author=+Jr&author=W.+Li&author=S.+Lin&author=A.+Metzger&author=K.+J.+Moriarty&author=C.+Riviello&author=Y.+Shimshock&author=J.+Wen&author=J.+Wityak&author=S.+T.+Wrobleski&author=H.+Wu&author=J.+Wu&author=M.+Desai&author=K.+M.+Gillooly&author=T.+H.+Lin&author=D.+Loo&author=K.+W.+McIntyre&author=S.+Pitt&author=D.+R.+Shen&author=D.+J.+Shuster&author=R.+Zhang&author=D.+Diller&author=A.+Doweyko&author=J.+Sack&author=J.+Baldwin&author=J.+Barrish&author=J.+Dodd&author=I.+Henderson&author=S.+Kanner&author=G.+L.+Schieven&author=M+Webb&title=The+Discovery+of+Orally+Active+Triaminotriazine+Aniline+Amides+as+Inhibitors+of+p38+MAP+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00024_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DThe%2520Discovery%2520of%2520Orally%2520Active%2520Triaminotriazine%2520Aniline%2520Amides%2520as%2520Inhibitors%2520of%2520p38%2520MAP%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00025"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00025_1"><span><span class="NLM_string-ref">Patil, S. A.; Otter, B. A.; Klein, R. S. Synthesis of pyrrolo[2,1-<i>f</i>][1,2,4]triazine congeners of nucleic acid purines via the <i>N</i>-amination of 2-substituted pyrroles. <i>  J. Heterocycl. Chem.</i><b>1994</b>, <i>31</i>, 781−786.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=786&author=S.+A.+Patil&author=B.+A.+Otter&author=R.+S+Klein&title=Synthesis+of+pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+congeners+of+nucleic+acid+purines+via+the+N-amination+of+2-substituted+pyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520of%2520pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520congeners%2520of%2520nucleic%2520acid%2520purines%2520via%2520the%2520N-amination%2520of%25202-substituted%2520pyrroles%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1994%26volume%3D31%26spage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00026"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00026_1"><span><span class="NLM_string-ref">Suzuki, M.; Miyoshi, M.; Matsumoto, K. A convenient synthesis of 3-substituted pyrrole-2,4-dicarboxylic acid esters. <i>  J. Org. Chem.</i><b>1974</b>, <i>39</i>, 1980.</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00927a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1974&pages=1980&author=M.+Suzuki&author=M.+Miyoshi&author=K+Matsumoto&title=A+convenient+synthesis+of+3-substituted+pyrrole-2%2C4-dicarboxylic+acid+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00026_1&amp;dbid=16384&amp;doi=10.1021%2Fjo00927a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00927a056%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthesis%2520of%25203-substituted%2520pyrrole-2%252C4-dicarboxylic%2520acid%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1974%26volume%3D39%26spage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00027"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00027_1"><span><span class="NLM_string-ref">Belley, M.; Scheigetz, J.; Dube, P.; Dolman, S. Synthesis of <i>N</i>-aminoindole ureas from ethyl 1-amino-6-(trifluoromethyl)-1<i>H</i>-indole-3-carboxylate. <i>  Synlett</i><b>2001</b>, <i>2</i>, 222−225.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=225&author=M.+Belley&author=J.+Scheigetz&author=P.+Dube&author=S+Dolman&title=Synthesis+of+N-aminoindole+ureas+from+ethyl+1-amino-6-%28trifluoromethyl%29-1H-indole-3-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelley%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520N-aminoindole%2520ureas%2520from%2520ethyl%25201-amino-6-%2528trifluoromethyl%2529-1H-indole-3-carboxylate%26jtitle%3DSynlett%26date%3D2001%26volume%3D2%26spage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00028"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00028_1"><span><span class="NLM_string-ref">Gangloff, A. R.; Litvak, J.; Shelton, E. J.; Sperandio, D.; Wang, V. R.; Rice, K. D. Synthesis of 3,5-disubstituted 1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst. <i>  Tetrahedron </i><i>Lett.</i><b>2001</b>, <i>42</i>, 1441−1443.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1443&author=A.+R.+Gangloff&author=J.+Litvak&author=E.+J.+Shelton&author=D.+Sperandio&author=V.+R.+Wang&author=K.+D+Rice&title=Synthesis+of+3%2C5-disubstituted+1%2C2%2C4-oxadiazoles+using+tetrabutylammonium+fluoride+as+a+mild+and+efficient+catalyst"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangloff%26aufirst%3DA.%2BR.%26atitle%3DSynthesis%2520of%25203%252C5-disubstituted%25201%252C2%252C4-oxadiazoles%2520using%2520tetrabutylammonium%2520fluoride%2520as%2520a%2520mild%2520and%2520efficient%2520catalyst%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00029"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00029_1"><span><span class="NLM_string-ref">Diana, G. D.; Volkots, D. L.; Nitz, T. J.; Bailey, T. R.; Long, M. A.; Vescio, N.; Aldous, S.; Pevear, D. C.; Dutko, F. J. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity<i>. J. Med. Chem.</i><b>1994</b>, <i>37</i>, 2421−2436.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2436&author=G.+D.+Diana&author=D.+L.+Volkots&author=T.+J.+Nitz&author=T.+R.+Bailey&author=M.+A.+Long&author=N.+Vescio&author=S.+Aldous&author=D.+C.+Pevear&author=F.+J+Dutko&title=Oxadiazoles+as+ester+bioisosteric+replacements+in+compounds+related+to+disoxaril.+Antirhinovirus+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26atitle%3DOxadiazoles%2520as%2520ester%2520bioisosteric%2520replacements%2520in%2520compounds%2520related%2520to%2520disoxaril.%2520Antirhinovirus%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm0501275b00030_1"><span><span class="NLM_string-ref">Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; MacLeod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor.<i>J. Med. </i><i>Chem.</i><b>1990</b>, <i>33</i>, 1128−1138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1138&author=J.+Saunders&author=M.+Cassidy&author=S.+B.+Freedman&author=E.+A.+Harley&author=L.+L.+Iversen&author=C.+Kneen&author=A.+M.+MacLeod&author=K.+J.+Merchant&author=R.+J.+Snow&author=R+Baker&title=Novel+quinuclidine-based+ligands+for+the+muscarinic+cholinergic+receptor.J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DNovel%2520quinuclidine-based%2520ligands%2520for%2520the%2520muscarinic%2520cholinergic%2520receptor.J%26jtitle%3DMed.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00031"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00031_1"><span><span class="NLM_string-ref">Francis, J. E.; Gorczyca, L. A.; Mazzenga, G. C.; Meckler, H. A convenient synthesis of 3,5-disubstituted-1,2,4-triazoles<i>. Tetrahedron Lett.</i><b>1987</b>, <i>28</i>, 5133−5136.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1987&pages=5136&author=J.+E.+Francis&author=L.+A.+Gorczyca&author=G.+C.+Mazzenga&author=H+Meckler&title=A+convenient+synthesis+of+3%2C5-disubstituted-1%2C2%2C4-triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26atitle%3DA%2520convenient%2520synthesis%2520of%25203%252C5-disubstituted-1%252C2%252C4-triazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1987%26volume%3D28%26spage%3D5136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00032"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00032_1"><span><span class="NLM_string-ref">Kuo, S.-C.; Wu, C.-H.; Huang, L.-J.; Yamamoto, K.; Yoshina, S. Synthesis and antimicrobial activity of methyl 5-nitro-3,4-diphenylfuran-2-carboxylate and related compounds. <i>  Chem. </i><i>Pharm. Bull.</i><b>1981</b>, <i>29</i>, 635−645.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=645&author=S.-C.+Kuo&author=C.-H.+Wu&author=L.-J.+Huang&author=K.+Yamamoto&author=S+Yoshina&title=Synthesis+and+antimicrobial+activity+of+methyl+5-nitro-3%2C4-diphenylfuran-2-carboxylate+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.-C.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520activity%2520of%2520methyl%25205-nitro-3%252C4-diphenylfuran-2-carboxylate%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1981%26volume%3D29%26spage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00033"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00033_1"><span><span class="NLM_string-ref">Hervens, F.; Viehe, H. G. Heterocycles from compounds containing two nucleophilic centers and phosgeneimmonium salts. <i>  Angew. Chem., Int. Ed. </i><i>Engl.</i><b>1973</b>, <i>12</i>, 405−406.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1973&pages=406&author=F.+Hervens&author=H.+G+Viehe&title=Heterocycles+from+compounds+containing+two+nucleophilic+centers+and+phosgeneimmonium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHervens%26aufirst%3DF.%26atitle%3DHeterocycles%2520from%2520compounds%2520containing%2520two%2520nucleophilic%2520centers%2520and%2520phosgeneimmonium%2520salts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1973%26volume%3D12%26spage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00034"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00034_1"><span><span class="NLM_string-ref">Chen, P.; Doweyko, A. M.; Norris, D.; Gu, H. H.; Spergel, S. H.; Das, J.; Moquin, R. V.; Lin, J.; Wityak, J.; Iwanowicz, E. J.; McIntyre, K. W.; Shuster, D. J.; Behnia, K.; Chong, S.; de Fex, H.; Pang, S.; Pitt, S.; Shen, D. R.; Thrall, S.; Stanley, P.; Kocy, O. R.; Witmer, M. R.; Kanner, S. B.; Schieven, G. L.; Barrish, J. C. Imidazoquinoxaline Src-family kinase p56<sup>Lck</sup> inhibitors:  SAR, QSAR, and the discovery of (S)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo-[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity. <i>  J. Med. </i><i>Chem</i>. <b>2004</b>, <i>47</i>, 4517−4529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4529&author=P.+Chen&author=A.+M.+Doweyko&author=D.+Norris&author=H.+H.+Gu&author=S.+H.+Spergel&author=J.+Das&author=R.+V.+Moquin&author=J.+Lin&author=J.+Wityak&author=E.+J.+Iwanowicz&author=K.+W.+McIntyre&author=D.+J.+Shuster&author=K.+Behnia&author=S.+Chong&author=H.+de+Fex&author=S.+Pang&author=S.+Pitt&author=D.+R.+Shen&author=S.+Thrall&author=P.+Stanley&author=O.+R.+Kocy&author=M.+R.+Witmer&author=S.+B.+Kanner&author=G.+L.+Schieven&author=J.+C+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A%E2%80%89+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%25E2%2580%2589%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00035"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00035_1"><span><span class="NLM_string-ref">Kim, K. S.; Kimball, S. D.; Misra, R. N.; Rawlins, D. B.; Hunt, J. T.; Xiao, H.-Y.; Lu, S.; Qian, L.; Han, W.-C.; Shan, W.; Mitt, T.; Cai, Z.-W.; Poss, M. A.; Zhu, H.; Sack, J. S.; Tokarski, J. S.; Chang, C. Y.; Pavletich, N.; Kamath, A.; Humphreys, W. G.; Marathe, P.; Bursuker, I.; Kellar, O. K. A.; Roongta, U.; Batorsky, R.; Mulheron, J. G.; Bol, D.; Fairchild, C. R.; Lee, F. Y.; Webster, K. R. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2:  Synthesis, X-ray crystallographic analysis, and biological activities. <i>  J. Med. Chem</i>. <b>2002</b>, <i>45</i>, 3905−3927.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3927&author=K.+S.+Kim&author=S.+D.+Kimball&author=R.+N.+Misra&author=D.+B.+Rawlins&author=J.+T.+Hunt&author=H.-Y.+Xiao&author=S.+Lu&author=L.+Qian&author=W.-C.+Han&author=W.+Shan&author=T.+Mitt&author=Z.-W.+Cai&author=M.+A.+Poss&author=H.+Zhu&author=J.+S.+Sack&author=J.+S.+Tokarski&author=C.+Y.+Chang&author=N.+Pavletich&author=A.+Kamath&author=W.+G.+Humphreys&author=P.+Marathe&author=I.+Bursuker&author=O.+K.+A.+Kellar&author=U.+Roongta&author=R.+Batorsky&author=J.+G.+Mulheron&author=D.+Bol&author=C.+R.+Fairchild&author=F.+Y.+Lee&author=K.+R+Webster&title=Discovery+of+aminothiazole+inhibitors+of+cyclin-dependent+kinase+2%3A%E2%80%89+Synthesis%2C+X-ray+crystallographic+analysis%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26atitle%3DDiscovery%2520of%2520aminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202%253A%25E2%2580%2589%2520Synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00036"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00036_1"><span><span class="NLM_string-ref">The drug concentrations obtained during a mouse coarse oral PK study using a single 50 mg/kg dose of compound <b>13</b> were 1.8 μM at 1 h and 0.23 μM at 4 h.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+drug+concentrations+obtained+during+a+mouse+coarse+oral+PK+study+using+a+single+50+mg%2Fkg+dose+of+compound+13+were+1.8+%CE%BCM+at+1+h+and+0.23+%CE%BCM+at+4+h.+The+drug+concentrations+obtained+during+a+mouse+coarse+oral+PK+study+using+a+single+50+mg%2Fkg+dose+of+compound+13+were+1.8+%CE%BCM+at+1+h+and+0.23+%CE%BCM+at+4+h."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00037"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00037_1"><span><span class="NLM_string-ref">McTigue, M. A.; Wickersham, J. A.; Pinko, C.; Showalter, R. E.; Parast, C. V.; Tempczyk-Russell, A.; Gehring, M. R.; Mroczkowski, B.; Kan, C.-C.; Villafranca, J. E.; Appelt, K.  4008  Crystalstructure of the kinase domain of human vascular endothelial  growth factor receptor 2:  A key enzyme in angiogenesis. <i>  Structure</i><b>1999</b>, <i>7</i>, 319−330.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=330&author=M.+A.+McTigue&author=J.+A.+Wickersham&author=C.+Pinko&author=R.+E.+Showalter&author=C.+V.+Parast&author=A.+Tempczyk-Russell&author=M.+R.+Gehring&author=B.+Mroczkowski&author=C.-C.+Kan&author=J.+E.+Villafranca&author=K.+Appelt&title=Crystalstructure+of+the+kinase+domain+of+human+vascular+endothelial++growth+factor+receptor+2%3A%E2%80%89+A+key+enzyme+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26atitle%3DCrystalstructure%2520of%2520the%2520kinase%2520domain%2520of%2520human%2520vascular%2520endothelial%2520%2520growth%2520factor%2520receptor%25202%253A%25E2%2580%2589%2520A%2520key%2520enzyme%2520in%2520angiogenesis%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00038"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00038_1"><span><span class="NLM_string-ref">Version 3.5, Schrodinger, LLC:  New York, 2005.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Version+3.5%2C+Schrodinger%2C+LLC%3A%E2%80%89+New+York%2C+2005.+Version+3.5%2C+Schrodinger%2C+LLC%3A%E2%80%89+New+York%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00039"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00039_1"><span><span class="NLM_string-ref">Hagler, A. T.; Ewig, C. S. On the use of quantum energy surfaces in the derivation of molecular force fields. <i>  Comput.</i><i> Phys. Comm</i>. <b>1994</b>, <i>84</i>, 131−155.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1994&pages=155&author=A.+T.+Hagler&author=C.+S+Ewig&title=On+the+use+of+quantum+energy+surfaces+in+the+derivation+of+molecular+force+fields"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DOn%2520the%2520use%2520of%2520quantum%2520energy%2520surfaces%2520in%2520the%2520derivation%2520of%2520molecular%2520force%2520fields%26jtitle%3DComput.%2520Phys.%2520Comm.%26date%3D1994%26volume%3D84%26spage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm0501275b00040_1"><span><span class="NLM_string-ref">Kuramoto, Y.; Ohshita, Y.; Yoshida, J.; Yazaki, A.; Shiro, M.; Koike, T. A novel antibacterial 8-chloroquinolone with a distorted orientation of the <i>N</i>1-(5-amino-2,4-difluorophenyl) group. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 1905−1917.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1917&author=Y.+Kuramoto&author=Y.+Ohshita&author=J.+Yoshida&author=A.+Yazaki&author=M.+Shiro&author=T+Koike&title=A+novel+antibacterial+8-chloroquinolone+with+a+distorted+orientation+of+the+N1-%285-amino-2%2C4-difluorophenyl%29+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuramoto%26aufirst%3DY.%26atitle%3DA%2520novel%2520antibacterial%25208-chloroquinolone%2520with%2520a%2520distorted%2520orientation%2520of%2520the%2520N1-%25285-amino-2%252C4-difluorophenyl%2529%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00041"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00041_1"><span><span class="NLM_string-ref">Armarego, W. L. F.; Taguchi, H.; Cotton, R. G. H.; Battiston, S.; Leong, L. Lipophilic 5,6,7,8-tetrahydropterin substrates for phenylalanine hydroxylase (monkey brain), tryptophan hydroxylase (rat brain), and tyrosine hydroxylase (rat brain). <i>  Eur. J. Med. Chem.</i><b>1987</b>, <i>22</i>, 283−291.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1987&pages=291&author=W.+L.+F.+Armarego&author=H.+Taguchi&author=R.+G.+H.+Cotton&author=S.+Battiston&author=L.+Leong&author=+Lipophilic&title=substrates+for+phenylalanine+hydroxylase+%28monkey+brain%29%2C+tryptophan+hydroxylase+%28rat+brain%29%2C+and+tyrosine+hydroxylase+%28rat+brain%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26atitle%3Dsubstrates%2520for%2520phenylalanine%2520hydroxylase%2520%2528monkey%2520brain%2529%252C%2520tryptophan%2520hydroxylase%2520%2528rat%2520brain%2529%252C%2520and%2520tyrosine%2520hydroxylase%2520%2528rat%2520brain%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1987%26volume%3D22%26spage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0501275b00042"><div class="reference"><strong class="refLabel"><a href="#jm0501275b00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm0501275b00042_1"><span><span class="NLM_string-ref">Francisco, J. A.; Gawlak, S. L.; Siegall, C. B. Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1<i>. J. </i><i>Biol. Chem.</i><b>1997</b>, <i>272</i>, 24165−24169.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=24169&author=J.+A.+Francisco&author=S.+L.+Gawlak&author=C.+B.+Siegall&author=+Construction&title=and+characterization+of+BD1-G28-5+sFv%2C+a+single-chain+anti-CD40+immunotoxin+containing+the+ribosome-inactivating+protein+bryodin+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0501275b00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26atitle%3Dand%2520characterization%2520of%2520BD1-G28-5%2520sFv%252C%2520a%2520single-chain%2520anti-CD40%2520immunotoxin%2520containing%2520the%2520ribosome-inactivating%2520protein%2520bryodin%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D24169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021%2Fjm0501275">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A general procedure for the synthesis of the C6-carbamate library, a table of pertinent data for the C6-carbamate analogues, and a table of combustion analysis or HPLC analysis data for key compounds. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0501275/suppl_file/jm0501275si20050404_014025.pdf">jm0501275si20050404_014025.pdf (63.18 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm0501275&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm0501275%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-12%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm0501275" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                299KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b6834ac883d36","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
